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ABSTRACT
The autonomic nervous system (ANS) controls most involuntary functions of the body.
Dysfunctions of the ANS can be life-threatening. However, several critical questions related to
cardiovascular and breathing regulations remain unclear.
One of the open questions is how the system lose control of the vascular tones under certain
circumstances. Using the septic shock model induced by lipopolysaccharide (LPS) in isolated and
perfused mesenteric arterial rings, we found the vascular hyporeactivity is attributed to the
decreased vasoconstriction to α-adrenoceptor agonists. The endotoxin-induced vasodilation can be
intervened with endothelin-1 (ET-1), serotonin (5-HT) or vasopressin, which have never been used
in clinical treatment.

It is unclear how the excitability of endothelium affects vascular tones. Using optogenetics
and transgenic mice with channelrhodopsin expression in endothelial cells (ECs), we found
selective activation of the ECs induces a fast, robust, reproducible and long-lasting
vasoconstriction in isolated and perfused hearts and kidneys.
Breathing control by the ANS within the brain becomes abnormal in certain genetic
diseases, such as Rett syndrome with defected norepinephrine (NE) system in locus coeruleus
(LC). The LC neurons are hyperexcitable while NE release is deficient. Using optogenetics and
double transgenic mice with Mecp2 null and channelrhodopsin expression in LC neurons, we
found the NE-ergic modulation of hypoglossal neurons was impaired in transgenic mice, which
cannot be improved with optostimulation, suggesting that LC neuronal hyperexcitability may not
benefit the NE modulation in Rett syndrome.
Collectively, our results provide insight into the autonomic dysfunctions using
experimental interventions that have barely been used before.

INDEX WORDS: Autonomic nervous system, Dysfunction, Vascular tones, Breathing, Septic
shock, Lipopolysaccharide, Endothelium, Optogenetics, Transgenic mice, Rett syndrome
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SPECIFIC AIMS AND HYPOTHESES

The autonomic nervous system (ANS) plays a critical role in maintaining physiological
homeostasis. The ANS acts through sympathetic and parasympathetic innervation to target
organs and tissues, including cardiovascular, respiratory, nervous, digestive, and reproductive
systems. Therefore, dysfunctions of ANS can affect many parts of the body. Some are temporary
while many worsen over time and can be life-threatening, especially when they affect blood
pressure, heart beat, and breathing activity.
Although the understanding of the ANS function and dysfunction of has been
significantly improved over the last century, there are still critical problems related to
cardiovascular function and breathing activity to be resolved. To my understanding, the key
resolving these problems is to intervene the ANS effectively under physiological and
pathological conditions so that these problems can be well accessed, dissected, and understood.
Therefore, it is necessary to explore innovative research approaches to the ANS. I hypothesize
that certain dysfunctions in vascular tones and breathing can be better understood with
alternative interventions. Thus, we proposed studies to address three specific aims.

Specific Aim 1: Interception of septic shock with pharmacological tools in LPS induced
vasodilation model.
Blood vessels lose response to vascular regulators including epinephrine
(EPI)/norepinephrine (NE) released from sympathetic nerve terminals and the adrenal gland
under certain pathological conditions, such as septic shock. Approximately, 200,000 people die
of severe sepsis or septic shock in the US each year (Martin et al., 2003). Septic shock is
characterized by excessive vasodilation and vascular hyporeactivity to vasoconstrictors,
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especially α-adrenergic agonists. Without effective therapeutic intervention, this leads to
uncontrolled hypotension, hypoperfusion, tissue hypoxia, multiple organ failures and death
(Dellinger et al., 2013; Vincent et al., 2006). The irreversible hyporeactivity could result from
extensive injuries to the vascular smooth muscle (VSM), enhanced endothelium-dependent
vasodilation, or disrupted contraction response to certain types of vasoconstrictor. Therefore, in
this study, we investigated all of the potential mechanisms using in vitro mesenteric septic model
by application of lipopolysaccharide (LPS). This study provides insight into the pathological
development of septic shock and has an impact on potential clinical treatment for the disease.

Specific Aim 2: Intervention to vascular tones via optogenetic approach to vascular
endothelium.
Although accumulating evidence suggests that the primary function of the endothelium in
the vasculature is vasodilation, how vascular endothelial depolarization affects vascular tones is
still unclear. The major obstacle is that these cells cannot be selectively activated without
affecting VSM cells. The information of endothelium activation is necessary for the
understanding vascular physiology as well as the development of several vascular diseases.
Using optogenetics as an innovative intervention to vascular endothelium of transgenic mice.
Therefore, we studied the function of endothelium with direct stimulation and inhibition. Our
results demonstrate a novel intervention to endothelium and reveal the effects of endothelial
depolarization on vascular tones and organ perfusion.

Specific Aim 3: Intervention to NE-ergic defects in Mecp2 knockout mice by
optostimulation of locus coeruleus neurons.
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Another important function of the ANS is respiratory regulation where several groups of
neurons in brainstem play a role. Dysfunction in the brainstem neuronal networks underscores
certain diseases. Rett syndrome (RTT) is a neurodevelopmental disease that is caused by
mutation of a transcriptional regulator, Methyl CpG binding protein 2 (MECP2) and
characterized by life-threatening breathing abnormalities. The breathing disorders in RTT mouse
model with Mecp2 disruption are found to be associated with the defects in locus coeruleus (LC)
neurons located in the pons (Roux et al., 2010; Zhang et al., 2010). This group of neurons is the
principle site of norepinephrine NE-ergic projection in the CNS. The NE synthesis enzymes are
found deficient in both RTT patients and animal model (Viemari et al., 2005). However, the
causal relationship between NE deficiency and LC neuron disruption in the etiology of RTT
breathing disorder is unclear. Based on one of most widely used Mecp2 gene knock-out RTT
mice model, we developed a new double transgenic RTT mouse model with light sensitive opsin
knock-in in the NE-ergic neurons. Our results showed that the double transgenic mice had
significant RTT phenotypes, including breathing disorder, lower body weight, and hypomotility.
The NE-ergic projection to hypoglossal neurons (HN) was disrupted in these mice with
significant breathing disorders comparing to control TH-ChR mice. This study opens a new
avenue for the study of causality in etiology of neurodevelopmental diseases.

2
2.1

INTRODUCTION

Autonomic nervous system

2.1.1 Overview and anatomy of the autonomic nervous system
The function of the nervous system is coordinating the voluntary and involuntary actions
of the body. In vertebrate species, the nervous system mainly consists of two components, the
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central nervous system (CNS) containing the brain and spinal cord, and the peripheral nervous
system (PNS) consisting of nerves that connect the CNS to the different parts of the peripheral
system. Nerves that carry sensory impulses from different parts of the body to the brain are
sensory/afferent nerves while those nerves transmitting information from the CNS to muscles
and organs are motor/efferent nerves. The PNS includes two parts, the somatic nervous system
(SoNS) and the autonomic nervous system (ANS). The SoNS associates with skeletal muscles to
control voluntary function of the body while the ANS controls involuntary/autonomic function,
such as the activity of the cardiomyocytes, smooth muscle, and the internal organs (Schmidt and
Thews, 1989). Thus, dysfunction of the ANS can lead to disorder in multiple organs and
systems.
The ANS controls most involuntary function, including blood pressure, heart beat,
respiration, gastrointestinal (GI) tract motility, pupillary diameter, and accommodation, urinary
and bowel excretion, salivation, perspiration, metabolic and endocrine physiology, and sexual
arousal. This system has two components: sympathetic and parasympathetic systems that are the
primary control of the fight-or-flight response and the freeze-and-dissociate response (Schmidt
and Thews, 1989). Both sympathetic and parasympathetic divisions require a sequential twoneuron efferent pathway, which the preganglionic neurons must synapse onto the ganglionic
neurons first. Then the ganglionic neurons innervate the target organs. The sympathetic system
has short preganglionic fibers originating from the spinal cord from T1 to L2-3. Long ganglionic
fibers run from the sympathetic ganglia adjacent to the spinal cord to effector organs. The
parasympathetic division has a craniosacral outflow, where the long preganglionic fibers exit
cranial nerves of the brainstem, including oculomotor, facial, glossopharyngeal, and vagus
nerves, and sacral spinal cord (S2-S4). The vagus nerve contains about 75% of all
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parasympathetic fibers. Parasympathetic ganglia are located within the effector organs, so the
ganglionic fibers are short. This anatomy structure allows the sympathetic division functions
quickly with short preganglionic nerves, whereas the parasympathetic division functions without
an immediate reaction but a more specific and localized response with long preganglionic nerves
projected into the effector organs (Drake et al., 2005).
2.1.2 Function and regulation of the ANS
The sympathetic and parasympathetic divisions have a complementary function to each
other. In both systems, preganglionic nerves are cholinergic that release acetylcholine (ACh) as
neurotransmitters to stimulate the ganglionic cells. In response to the stimulation, their
ganglionic nerves release different neurotransmitters into the target organs and induce opposite
effects. In the sympathetic nervous system, norepinephrine (NE) is secreted by most adrenergic
ganglionic fibers and acts on different receptors in target organs to promote a fight-or-flight
response, such as diverting blood away from the GI tract through vasoconstriction, relaxing the
coronary vessels of the heart, increasing heart rate and contractility of the cardiomyocytes, and
dilating bronchioles of the lung to increase oxygen (O2) exchange (Pocock and Richards, 2006).
In contrast, ACh is secreted from cholinergic ganglionic fibers of the parasympathetic nervous
system to promote a "rest and digest" response, which calms the nerves down to regular function.
When activated, the parasympathetic division functions to increase blood flow to the GI tract
through vasodilation, reduce heart rate, and constrict respiratory airways (Pocock and Richards,
2006).
There are exceptions in sympathetic neurotransmission. The sweat glands are stimulated
by ACh released from ganglionic fibers, and the renal blood vessels are innervated by dopamine
(DA) released from dopaminergic nerves (Noback et al., 2005). Also, there is no ganglionic
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neuron innervating adrenal medulla. Instead, the preganglionic neuron releases ACh to activate
nicotinic receptors located in the adrenal medulla, which in turn stimulate the adrenal medulla
releasing hormones EPI and NE into the bloodstream. These hormones then act on adrenoceptors
to trigger a widespread sympathetic activity (Wakade and Wakade, 1983). A third sub-division
neurons using nitric oxide (NO) as neurotransmitters have been found to be essential in
autonomic function, especially in the gut and the lungs, and named as 'non-adrenergic and noncholinergic' neurons (Belvisi et al., 1992).
At the effector organs, most sympathetic ganglionic neurons release NE acting on
adrenoceptors in different tissues and organs but the sweat glands. The adrenoceptors are G
protein-coupled receptors (GPCR), which are the largest and most diverse group of membrane
receptors distributed throughout the whole body in eukaryotes (Eisen et al., 2013). GPCR receive
messages from external signaling molecules, such as neurotransmitters, to be activated and
induce a variety of cellular signaling pathways. When GPCR is stimulated by ligand molecule, a
conformational change of the GPCR occurs so that it interacts with a nearby G protein. G protein
is a specialized heterotrimeric protein consisting of three different subunits: an alpha subunit
(Gα), a beta subunit (Gβ), and a gamma subunit (Gγ). Two of them, Gβ and Gγ, are attached to the
plasma membrane. Gα subunit binds to inactive guanosine diphosphate (GDP) forming Gα-GDP
complex in the absence of a signal stimulus. This complex binds to a nearby GPCR until the
external signal acts on the GPCR. At this point, guanosine triphosphate (GTP) replaces the GDP
bound to the G protein so that the G protein is activated. Consequently, the Gα-GTP complex
dissociates from the Gβγ dimer. Both of these two subunits can interact with other membrane
proteins involved in different signaling transductions. (Wettschureck and Offermanns, 2005).
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G proteins can be classified into four major subfamilies depending on their different Gα
subunits and associated downstream signaling pathways: Gαs, Gαi, Gαq/11, and Gα12/13. The effector
of Gαs pathway is a direct stimulation of the membrane-associated enzyme adenylate cyclase
(AC), which catalyzes the formation of the second messenger cyclic adenosine monophosphate
(cAMP) from cytosolic adenosine triphosphate (ATP). The downstream signal of this pathway is
protein kinase A (PKA), which in turn, phosphorylates many different downstream signals
(Tamaki, 2007; Taylor et al., 2008). In contrast, activation of Gαi inhibits AC from generating
cAMP. Thus, activation Gαs and Gαi signaling pathways have a compensatory effect on each
other. Gαq/11 activates membrane-associated phospholipase C-β (PLCβ), which in turn, catalyzes
the formation of inositol (1,4,5) trisphosphate (IP3) and diacylglycerol (DAG), which both can
increase intracellular Ca2+ concentration. IP3 binds to its receptors located in the membrane of
the endoplasmic reticulum (ER) so that Ca2+ inflexed from the ER into the cytosol, while DAG
activates protein kinase C (PKC), which can also be activated by increased intracellular Ca2+
(Kadamur and Ross, 2013). The Gα12/13 pathway is through RhoGEF superfamily, which binds to
and allosterically activates the cytosolic small GTPase, Rho (Kozasa et al., 1998). Once bound to
GTP, Rho then activates various proteins, such as Rho-kinase (ROK), which is involved in
myosin phosphorylation and contraction of VSM (Noda et al., 1995). Most GPCRs that couple to
Gα12/13 also couple to other sub-classes, often Gαq/11 (Takashima et al., 2008). In addition to
involvement in the Gαi cascade, Gβγ targets on various ion channels, such as G protein-regulated
inwardly rectifying K+ channel (GIRK), and P/Q- or N- type voltage-gated Ca2+ channels
(Takahashi et al., 1996).
There are mainly two types of adrenoceptors, α and β with several subtypes. The α
receptors have the subtypes α1, a Gαq coupled receptor, and α2, a Gαi coupled receptor, while the
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β receptors have the subtypes β1, β2, and β3, which are all linked to Gs proteins. The β2 also
couples to Gαi proteins (Johnson and Liggett, 2011). These receptors play different roles in
different tissues. The general function of α receptors is vasoconstriction. Specifically, the α1
receptors are located in almost all of tissues throughout the body with a particularly important
function in smooth muscles (Bulbring and Tomita, 1987). Activation of α1-adrenergic receptors
also mediates cardiac stimulation, cellular proliferation, activation of glycogenolysis and
gluconeogenesis in adipose tissue and liver, secretion of sweat gland, and Na+ reabsorption from
the kidney (Graham et al., 1996). Noticeably, the α1 receptors located in the CNS are involved in
regulation of neuronal activity (Carette, 1999). The α2 receptors are mostly located in some
VSM, platelets, and fat cells. In addition to the general effect of the α receptors, the activation of
the α2 receptors have individual functions, including mediating synaptic transmission in pre- and
postsynaptic nerve terminals to decrease release of ACh and NE, inhibiting lipolysis in adipose
tissue, inhibiting insulin-releasing in pancreas inducing glucagon release from the pancreas,
contracting sphincters of the GI tract, and increasing thrombocyte aggregation (Molinoff, 1984).
The β1 receptors are mainly located in the heart, the β2 receptors distribute in respiratory,
uterine, and VSM, and the β3 receptors are mainly exist in fat cells. The β1 and β2 receptors
mediate cardiovascular response to NE released from sympathetic nerve terminals and to
circulating adrenaline. When β1 receptors are activated, the cardiac output increases through the
augmentation of the heart rate, conduction velocity, stroke volume, and the renin secretion from
the kidney and ghrelin secretion from the stomach increase as well. The activation of the β2
receptor leads to vascular and nonvascular smooth muscle relaxation, lipolysis in adipose tissue,
dilation of arteries to skeletal muscle, glycogenolysis and gluconeogenesis, insulin secretion,
thickened secretions from salivary glands, increases in renin secretion from kidney, and
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relaxation of bronchioles. The β3 receptors are responsible for the enhancement of the lipolysis in
adipose tissue. Taken together, the α receptors are mainly distributed throughout the vascular and
nonvascular smooth muscle (SM) while the β receptors are mainly expressed in the heart and
some SM (Minneman et al., 1981; Molinoff, 1984).
In the parasympathetic division, ACh released from ganglionic fibers acts on the
muscarinic (M) cholinergic receptors of effector organs. There are five types of M receptors,
M1-M5, which also function through binding to G proteins (Hulme et al., 1990). The M1, M4,
M5 receptors are mainly expressed in the neural system and contribute to the CNS effects. The
M2 receptors locate in the heart regulating cardiac function. The M3 receptors distribute in many
parts of the body, such as endothelial cells (ECs), lungs, and GI tract, inducing vasodilation,
bronchoconstriction, and intestinal motility and dilating sphincters. Besides, the M3 receptors
also located in many glands helping glandular secretions (Caulfield and Birdsall, 1998).
Depending on the distribution of adrenoceptors and muscarinic receptors, the ANS
maintains physiological homeostasis through the sympathetic and parasympathetic innervating
target organs and tissues. Dysfunction of ANS can occur alone or result from other diseases,
such as Parkinson’s disease, alcoholism, and diabetes. These problems affect many parts or the
whole system. Some are temporary, but many worsen over time and can be life-threatening,
especially when they are associated with blood pressure, breathing activity, and heart beating.
This dissertation is mainly focused on the cardiovascular and respiratory system of the ANS.
2.1.3 Neural control of the cardiovascular and respiratory systems
Cardiovascular control is indispensable for the timely needs of the body to survive. The
control of the cardiovascular system can be grouped as neural, humoral, and local control
(Sparks and Rooke, 1987). The neural control is fundamentally important because it regulates
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multiple cardiovascular functions quickly that involves the blood flow, the contractility of the
heart, and the arterial pressure (Thomas, 2011). Structurally, the neural control system consists
of the medulla oblongata, afferent and efferent autonomic nerves, and peripheral sensory
receptors. The medulla is a major control center of autonomic functions that contains vasomotor,
cardiac and respiratory centers. These three control centers together belong to the sympathetic
division. The vasomotor centers regulate vasoconstriction and vasodilation while the cardiac
centers consisted of cardioacceleratory and cardioinhibitory centers regulate cardiac output.
Respiratory centers located in medulla regulate rate and depth of breathing (Clark, 2005).
The activity of medullary neurons is modulated by afferent signals from the peripheral
system and other brain regions, such as the hypothalamus and higher centers. The medullary
parasympathetic center including nucleus ambiguus (NA) and the medullary relay center
neucleus tractus solitaries (NTS) responds to cardiorespiratory afferents (Dampney, 1994). The
medullary parasympathetic center receives afferents via NTS and, in turn, sends inhibitory
regulatory information through the vagal fiber to the heart to decrease heart rate and the
contractile force (Taylor et al., 1999). Medullary relay center NTS receives signals from sensory
receptors, such as baroreceptors and chemoreceptors in peripheral system. Then the NTS relays
the information to vasomotor center and cardiac vagal center, those control sympathetic and
parasympathetic outputs, respectively (Paton et al., 2001).
2.2

Regulation of vascular tone

2.2.1 Anatomy and physiology of the vasculature
The vasculature is part of the circulatory system that transports blood throughout the
whole body. There are three types of blood vessels, the arteries, which deliver the oxygenated
blood from the heart to peripheral tissues; the capillaries, which enable the exchange of water
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and molecules between the blood and peripheral tissues; and the veins, which carry
deoxygenated blood from the capillaries back to the heart.
Vascular tone refers to the degree of vasoconstriction of a blood vessel relative to its
maximally dilated state. All blood vessels exhibit basal vascular tone to maintain adequate
perfusion to peripheral organs. The basal vascular tone varies in different organs and tissues.
Those organs with a large vasodilatory capacity, such as myocardium, skeletal muscle, skin,
splanchnic circulation system, have high vascular tone whereas organs with relatively low
vasodilatory capacity, such as cerebral and renal circulation systems, have low vascular tone
(Brayden and Nelson, 1992). The vascular tone determines the resistance of the circulation so
that it plays a critical role in the regulation of blood pressure and organs perfusion. The vascular
tone is determined by a balance between vasoconstrictor and vasodilator factors, including
neurotransmitters, paracrine molecules, and hormones.
The arteries and veins regulate blood flow to downstream organs by contracting or
dilating the muscular layer, which is mainly determined by the ANS innervation. Sympathetic
vasoconstrictor fibers have tonic discharge to maintain basal vascular tone (Joyner et al., 1992).
When sympathetic innervation is increased beyond the tonic level, the vasoconstrictor fibers
produce vasoconstriction in most arteries, arterioles, and veins (Thomas, 2011). NE as the
primary neurotransmitter released from vascular sympathetic fibers induces direct rapid
vasoconstriction in VSMC through increasing intracellular Ca2+ concentration (Guimaraes and
Moura, 2001). Some other neurotransmitters, such as neuropeptide Y (NPY) or ATP can also be
released as cotransmitter potentiating the effect of NE (Pablo Huidobro-Toro and Veronica
Donoso, 2004). Besides, the sympathetic nervous system also exerts indirect prolonged effects
on cardiovascular system through humoral systems, the adrenal medulla and the renin-
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angiotensin-aldosterone system (RAAS). After receiving sympathetic preganglionic innervation,
the adrenal medulla releases circulating catecholamines, epinephrine, and NE, into the blood
stream, which in turn, activate vascular adrenergic receptors and cause vasoconstriction. The
RAAS releases renin into the blood after stimulated by sympathetic fibers. Renin helps to
convert angiotensinogen into angiotensin II (Ang II), which is a potent vasoconstrictor. Ang II
also increases blood volume through stimulation of aldosterone release (Ebert and Stowe, 1996).
Collectively, the vasoconstriction increases peripheral resistance and diastolic blood pressure,
which leads to a decrease in venous capacity, an increase in venous return, end-diastolic volume,
stroke volume, cardiac output, and systolic blood pressure.
The vasodilation, an opposite process of vasoconstriction, is attributed to inhibited
sympathetic effect and activated parasympathetic effect (Thomas, 2011), which lead to a
decrease in discharges of sympathetic vasoconstrictor nerves, activation of sympathetic
cholinergic vasodilator nerves, and activation of parasympathetic vasodilator nerves. Indeed, the
vasodilation is produced by drawbacks in the tonic discharge of vasoconstrictor nerves in most of
the vascular beds (Boron and Boulpaep, 2009). Otherwise, blood vessels located in some organs,
such as skeletal muscles, receive innervation from both sympathetic vasoconstrictor adrenergic
nerves and sympathetic vasodilator cholinergic nerves, which are not tonic active but only
activated by stress, such as exercise and giving birth. Blood vessels do not receive
parasympathetic innervation except those located in sexual organs and salivary gland (Pocock
and Richards, 2006).
2.2.2 Function and dysfunction of the vascular smooth muscle
The VSMC is the essential component of the vasculature. The major function of VSMC
is to maintain the local blood pressure by vasocontraction and vasodilation. The most

13

characteristic feature of VSMC is the capability of contraction that is slow, sustained, and tonic
(Tanaka et al., 2008). The VSMC is primarily innervated by the sympathetic nervous system
through adrenoceptors, α1, α2, and β2 (as described above). The sympathetic constrictor fiber
release NE that bind to α1 receptors causing vasoconstriction. The α1 receptors are activated by
low blood pressure and defensively restore the blood pressure through vasoconstriction.
Activation of α2 receptors leads to vasoconstriction as well. In contrast, stimulation of β2
receptors causes vasodilation and decreasing blood pressure. Under certain physiological
conditions, such as pregnancy, exercise, and vascular injury, the VSMC is also involved in
vascular remodeling, including synthesizing extracellular matrix components and increasing
proliferation and migration (Louis and Zahradka, 2010). Taken together, the VSMC is involved
in the short-term regulation of the vasomotor and long-term vascular remodeling.
The contraction in the excitable VSMC can be triggered by mechanical, electrical, and
chemical stimuli. The VSMC contraction is induced by an increase in intracellular Ca2+
concentration due to Ca2+ release from intracellular sarcoplasmic reticulum (SR) (Laporte et al.,
2004) and Ca2+ influx from the extracellular space through the membrane potential-dependent
Ca2+ channels (Hill-Eubanks et al., 2011). Increased intracellular Ca2+ binds to calmodulin
(CAM) to form a Ca2+-CAM complex, which activates myosin light chain kinase (MLCK) and
MLC phosphorylation. Phosphorylated MLC catalyzes interaction between two contractile
proteins, myosin, and actin, forming cross-bridge, which leads to vasoconstriction (Kamm and
Stull, 1989). On the other hand, vasodilation in VMSCs resultes from a decrease in intracellular
Ca2+ concentration due to Ca2+ uptake by SR through Ca2+ pump and Ca2+ extrusion via Na+/Ca2+
exchanger and plasmalemmal Ca2+ pump. The decreased intracellular Ca2+ leads to dissociation
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of Ca2+-CAM complex and dephosphorylation of MLC, which causes vasodilation (Laragh and
Brenner, 1995).
In addition to intracellular Ca2+, another major determinant of the maintained agonistinduced contraction of VSMC is activation of PKC, which increase the myofilament force
sensitivity to intracellular Ca2+ (Nishimura et al., 1990) and MLC phosphorylation so that the
VSMC contraction can be maintained with a smaller increase in intracellular Ca2+ concentration
(Khalil, 2010). PKC with different isoforms and subcellular distribution undergo differential
translocation during cell activation. The interaction of a PKC isoform with its substrate can
trigger a cascade of protein kinases that ultimately stimulate VSMC contraction (Andrea and
Walsh, 1992). PKC translocation to cell surface may trigger activation of cytosolic mitogenactivated protein kinase (MAPK) and MAPK kinase (MEK). After that, both MEK and MAPK
translocate to the surface membrane and form a surface kinase complex, where MEK
phosphorylates MAPK at both Thr and Tyr residues so that MAPK return to the cytoskeleton and
phosphorylate the actin-myosin interaction and VSM contraction (Khalil et al., 1995). PKC may
also phosphorylate CPI-17, an inhibitor of MLC phosphatase, to increases MLC phosphorylation
and enhance VSMCs contraction (Woodsome et al., 2001). PKC also phosphorylate an actinbinding protein calponin to reverses its inhibition of actin-activated myosin ATPase so that the
VSM contraction is enhanced (Kim et al., 2008).
The ROK signaling pathway enhances the myofilament force sensitivity to intracellular
Ca2+ concentration as well (Kizub et al., 2010). GPCR agonist, particularly those coupling to
Gα12/13, can activate the small G protein RhoA, which in turn stimulates the activity of ROK.
ROK then phosphorylates and inactivates MLC phosphatase so that the VSMC contraction is
enhanced (Somlyo and Somlyo, 2003). ROK signaling pathway is independent of intracellular
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Ca2+ concentration change, which is therefore considered as Ca2+-sensitization mechanism (Gong
et al., 1997).
All of these Ca2+-dependent and Ca2+-sensitization mechanisms work synergistically for
VSMC contraction. The collaboration alters under pathological conditions. Increased membrane
permeability to Ca2+ has been reported in VSMC isolated from animal models of hypertension
(Crews et al., 1999; Sugiyama et al., 1986). PKC has been suggested to play a role in the
pathogenesis of several cardiovascular diseases, including coronary and cerebral vasospasm,
hypertension, atherogenesis, and diabetic vascular complications (Ito et al., 1994; Salamanca and
Khalil, 2005). These vascular disorders are characterized by increased contractile or hypertrophic
response of the VSMC, which is resulted from increased production of and/or sensitivity to
vasoactive stimuli and vascular growth factors, such as AngII, vasopressin, NE, and plateletderived growth factor. These molecules bind to receptors and activate the G protein mediated
PLC – DAG – PKC signaling pathway (Griendling et al., 1986; Takagi et al., 1988). Dysfunction
of ROK signaling pathway is important in vascular hyperactivity associated with hypertension as
well. The ROK inhibitors, Y-27632, and fasudil, normalized arterial pressure in animal models
of hypertension (Uehata et al., 1997). An increased RhoA/ROK activity has been found in
arteries from animal models of hypertension (Seko et al., 2003). In addition, mechanical stress on
the vessel wall is increased that stimulates the VSMC proliferation in hypertension (Hishikawa et
al., 1994). The stretch-induced activation of MAPK and the VSMC growth were inhibited by
ROK inhibition (Numaguchi et al., 1999; Zeidan et al., 2003). Indeed, excessive RhoA/ROK
activity also participated in the endothelial dysfunction and the decreased NO production
associated with arterial diseases (Zhou and Liao, 2009). In pulmonary hypertension, studies on
human pulmonary endothelial cells demonstrated that hypoxia-induced decrease in endothelial
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NOS (eNOS) expression is mediated by ROK (Takemoto et al., 2002). Studies have also shown
that activation of the RhoA/ROK pathway contributes to both vasoconstriction and vascular
remodeling associated with pulmonary hypertension (Guilluy et al., 2005). Taken together, these
findings indicate a prominent role of ROK in hypertension.
2.2.3 Function and dysfunction of the vascular endothelium
The endothelium is a specialized active organ lining the luminal side of vasculature
throughout whole body (Villar et al., 2006). It is acknowledged that the primary function of the
endothelium is maintaining vascular homeostasis and preventing initiation and/or development
of cardiovascular diseases by releasing a variety of vasoactive substances. These substances not
only alter the vascular tone and growth acting on the VSMCs but also regulate the activities of
circulating blood cells and govern vascular permeability.
Cytoplasmic Ca2+ concentration is a key regulator of endothelial function, including the
synthesis and release of vasoactive substances, vascular remodeling and permeability, cell
proliferation and angiogenesis (Busse et al., 2002; Tran and Watanabe, 2006). Increased
intracellular Ca2+ concentration responding to receptor activation activate downstream second
messengers and a variety signaling pathways. Theoretically, the change of intracellular Ca2+
concentration is determined by membrane potential, the activity of various ionic pumps and
channels for excitable cells, such as the VSMC and immune cells. But how endothelium release
vasoactive substances remain unknown as the ECs are considered as “non-excitable”.
The most significant endothelium-derived vasodilators include NO (Palmer et al., 1987),
prostacyclin (PGI2) (Moncada et al., 1976), and the endothelium-derived hyperpolarizing factor
(EDHF) (Chen et al., 1988). NO is converted from L-arginine by NO synthases (NOS) In the
presence of cofactors tetrahydrobiopterin (BH4) (Forstermann and Munzel, 2006). NO then
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diffuses into the VSMC and causes vasodilation via activation of soluble guanylyl cyclase (GC)
and cyclic guanosine monophosphate (cGMP) (Moncada et al., 1991). There are three forms of
NOS, predominant eNOS, lesser extent neuronal NOS (nNOS), and inducible NOS (iNOS)
expressed in inflammatory cells. The eNOS is the predominant NOS isoform responsible for
most of NO production in the vasculature, where the NO dilates all types of blood vessels
through GC – cGMP pathway (Forstermann et al., 1994). The nNOS is mainly expressed in
nervous tissue and skeletal muscle type, facilitating intercellular communication (Forstermann
and Sessa, 2012). The iNOS is located in immune and cardiovascular systems defending the
immune system against pathogens (Hauser et al., 2004). Shear stress is the major activator of
eNOS in normal physiology for adequate organ perfusion (Corson et al., 1996). The enzyme is
also activated by several signaling molecules, such as bradykinin, adenosine, vascular
endothelial growth factors, and serotonin (5-HT) (Govers and Rabelink, 2001). NO is also
involved in the regulation of vascular permeability, synthesis of monocyte and lymphocyte
adhesion molecules, platelets aggregation, tissue oxidation and inflammation, activation of
thrombogenic factors, cell growth, proliferation and migration, and atherogenesis (Esper et al.,
2006).
PGI2 is formed primarily in ECs. Indeed, it is a metabolic product of arachidonic acid
(AA) catalyzed by cyclooxygenase (COX) (Gryglewski, 1983). Two isozymes of COX have
been identified, COX-1 and COX-2. COX-1 is a constitutive enzyme expressed in the
endothelium that contributes to the maintenance of vascular homeostasis. COX-2 is an inducible
isozyme expressed in the cardiovascular system during pathogenesis (Parente and Perretti, 2003).
PGI2 induce vasodilation of the VSMC through AC – cAMP – PKA singling pathway, which
results in a decrease in MLCK (Mitchell and Warner, 2006).
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EDHFs induce vasodilation by hyperpolarizing the VSMC independently from NO and
PGI2. Although how EDHFs induce vasodilation is unclear, several candidates of EDHF have
been proposed, including epoxyeicosatrienoic acids (EETs), K+, reactive oxygen species (ROS),
H2O2, the spread of electronic current, and C-type natriuretic peptide (CNP) (Khazaei et al.,
2008). It is widely acceptable that EDHFs are released from the ECs through the opening of
small conductance calcium-activated potassium channels (SKCa) and intermediate conductance
calcium-activated potassium channels (IKCa) (Edwards et al., 1998). Indeed, these vasodilators
compensate for a loss of NO-mediated vasodilator tone, particularly in the microcirculation
(Edwards et al., 2010; Feletou, 2011). EETs diffuse from ECs to VSMC and open Ca2+-activated
K+ channel causing the VSMC hyperpolarization and vasodilation (Pratt et al., 2001). Bradykinin
or ACh stimulate EETs synthesis in the ECs (Fisslthaler et al., 1999).
ROS are oxygen derived molecules, including superoxide (O2−•), hydroxyl radical (OH•),
hydrogen peroxide (H2O2), and peroxynitrite (ONOO−•), which some are vasodilators and some
are vasoconstrictors. Thus, the ROS have a critical impact on both vascular physiology and
pathophysiology. The generation of ROS is in a balance between oxidant and antioxidant
reactions in ECs, and the imbalance between leads to endothelial dysfunction. Under stress or
pathological conditions, the production of ROS increases. ROS mediated vasodilation is through
the activation of K+ channels (Barlow and White, 1998; Ellis and Triggle, 2003). K+ induced
vasodilation is found related to Na+/K+-ATPase activation, which increases extracellular K+
concentration and hyperpolarization of the VSMC (De Mey and Vanhoutte, 1980; Fleming,
1980). Another involved factor is gap junctions, which enables electrical coupling between ECs
and VSMC through a bi-directional delivery of vasoactive signals (Emerson and Segal, 2000).
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These factors work in a complex but integrated manner to maintain the vascular
homeostasis (Emerson and Segal, 2000). Indeed, each factor can interact with and manipulate
any components of the synthesis process of other mediators. Basal NO tonically inhibits the
effect of EDHFs until the NO diminishes, whereas the response of EDHFs then increases to
maintain the absolute vasodilation of the arterial system (Bauersachs et al., 1996; Nishikawa et
al., 2000). Similarly, the endothelium-dependent vasodilation induced by PGI2 is significant only
after the NOS is inhibited. This mechanism may also contribute to the basal NO tonic inhibitory
effect (Wu et al., 2001).
The endothelium regulates vasomotion not only by releasing vasodilators, but also by
secreting vasoconstrictors, such as endothelin-1 (ET-1), constricting prostaglandins,
prostaglandin H2 (PGH2), thromboxane A2 (TXA2) and 20-hydroxyeicosatetraenoic acid (20HETE), constricting ROS, and Ang II (Khazaei et al., 2008). ET-1 is a strong vasoconstrictor and
produced in the ECs only (Inoue et al., 1989). Many factors including hypoxia, adrenaline, shear
stress and ischemia, can stimulate the release of ET-1, which binds to GPCR coupled ET-1
receptors, ETA and ETB receptors. The vasoconstrictor ETA receptors are located on VSMC and
vasodilator ETB receptors are located on ECs (Boulanger and Luscher, 1990; Herrmann and
Lerman, 2001). ET-1 binds to G-protein coupled ETA receptor and induces vasoconstriction
through PLC – IP3 – DAG signaling pathway (Kiely et al., 1997; Pernow et al., 1996). Both
PGH2 and TXA2 are derived from AA that trigger vasoconstriction through inhibited cAMP
and/or increase cytosolic Ca2+ concentration in the VSMC (Halushka et al., 1989; Smith et al.,
1994). PGH2 is catalyzed by COX-1 and -2 from AA and then is converted into TXA2 by TX
synthase (Stankevicius et al., 2003). 20-HETE is another major metabolite of AA that has a
central role in the regulation of pulmonary, renal and cerebral vascular function (Makita et al.,
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1996). An increase in cytoplasmic Ca2+ activates PLA2, which catalyzes AA into 20-HETE.
Then 20-HETE diffuse from the endothelium to the VSMC and promote vasoconstriction
through inhibiting large conductance KCa channels and Ca2+ influx (Gebremedhin et al., 2000).
Some ROS are vasodilators and/or vasoconstrictors depending on the species, the location, and
the concentration, such as H2O2 produced by both the VSMC and ECs (Ellis and Triggle, 2003).
These vasoconstrictors act on local tissue predominantly, but may also have a systemic impact
on blood pressure.
The endothelium is also important for controlling thrombosis and thrombolysis,
coagulation, platelet-leukocyte interaction. Under physiological conditions, the ECs provide a
non-thrombogenic inner layer to maintain hemostasis of blood fluidity by promoting different
anticoagulant and antiplatelet mechanisms. (Stern et al., 1991). Once the endothelium is activated,
clot formation, bleeding or thrombosis may occur through the induction of procoagulant and the
suppression of anticoagulant mechanisms (Atherton and Born, 1972). After that, the damaged
endothelium areas induce platelet adhesion to and leukocyte accumulation, which in turn, leads to
extravasation of white blood cells to the sites of inflammation/infection. Then the plateletleukocyte interaction and aggregation, which lead to vascular occlusion occur in the endothelium
finally (Smyth et al., 2009). The endothelium also plays an important role in the regulation of
vascular growth, cell proliferation, and angiogenesis. Vascular endothelial growth factors
(VEGFs), angiopoietins, and ephrin family have been identified as regulators of endothelial
growth.
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vasculogenesis/angiogenic sprouting. Then the angiopoietins and ephrin are recruited for further
remodeling and maturation (Michiels, 2003).
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Endothelial dysfunction was originally identified as impaired vasodilation to specific
stimuli, such as ACh or bradykinin. Indeed, the dysfunction of the endothelium also involves a
proinflammatory and prothrombic state (Endemann and Schiffrin, 2004). In vascular diseases,
endothelial dysfunction is defined as an imbalance between vasodilators and vasoconstrictor
produced by the endothelium (Deanfield et al., 2005). Endothelial dysfunction has been
implicated in resulting from and/or contributing to the pathology of several diseases, including
hypertension, hypercholesterolemia, diabetes, septic shock, atherosclerosis, angiogenesis, and
stroke. It also results from environmental factors, such as from smoking, air pollution, and aging
(Endemann and Schiffrin, 2004).
The dysfunction of the endothelium involves a number of mechanisms. Reduced NO has
been reported associated with the impaired endothelial function. NO, one of the most important
vasodilators released from the endothelium, inhibits growth, inflammation, and platelets
aggregation (Taddei et al., 2003). Decrease in NO under pathological conditions is attributed to
several reasons: 1) Reduced activity of eNOS decreases the bioavailability of NO (Koppenol et
al., 1992). 2) ROS quenches NO to form peroxynitrite, which is a cytotoxic oxidant affecting
protein function in endothelium (Griendling and FitzGerald, 2003). Peroxynitrite also mediates
oxidation of low-density lipoprotein (LDL) and degradation of the eNOS cofactor BH4 (Milstien
and Katusic, 1999). Under this situation, the oxygenase function to produce NO is inhibited,
which is known as eNOS uncoupling, whereas the reductase function of eNOS is activated so
that a lot of more ROS are produced (Landmesser et al., 2003). The consequence of this process
is the deleterious effect on endothelial and vascular function. Exaggerated ROS also link to the
proinflammatory state of the vessel wall by upregulating adhesion and chemotactic molecules
that further decreases NO bioavailability (Landmesser et al., 2003). Moreover, ROS is involved
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in mediating endothelial injury through apoptosis and anoikis (detachment of ECs) (Taniyama
and Griendling, 2003). 3) A relative new mechanism related to NO reduction and endothelial
dysfunction is asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of
eNOS.
Moreover, it is reported that ONOO−· inactivates the prostacyclin synthase, which
inhibits the effect of vasodilator PGI2 and increases the release of vasoconstrictors, PGH2, and
TXA2 (Zou et al., 2004). The chronic action of ROS inhibits the activity of KCa channel, which
is involved in EDHF-mediated vasodilation (Xiao et al., 2001). Ang II has been noticed to
increase ROS level by stimulating NADPH oxidase and promotes vascular inflammation and
endothelial dysfunction (Diep et al., 2002; Rajagopalan et al., 1996). In addition to disabled
vasodilation, ROS also promotes the contraction of the VSMC through promoting mobilization
of Ca2+, increasing the sensibility of the contractile proteins to Ca2+ (Suzuki and Ford, 1992),
activating endothelial enzymes that can synthesize endothelium-derived contracting factors
(Vanhoutte et al., 2005). A significant increase in ET-1 is also found in many cardiovascular
diseases, such as hypertension, atherosclerosis, coronary artery disease, and renal failure (Bohm
and Pernow, 2007).
Taken together, a reduced bioavailability of NO, an alteration in the generation of
prostanoids, and the impairment of endothelium-dependent hyperpolarization, as well as an
increased release of ET-1, can individually or in association contribute to endothelial
dysfunction.
2.2.4 Disorder of vascular tones in multiple cardiovascular diseases
It is critical to maintaining basal vascular tone and adequate blood pressure under the
physiological condition for proper organ function. Low blood pressure (hypotension) leads to
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organ failures whereas elevated blood pressure (hypertension) causes cardiovascular diseases,
such as hypertension, stroke, and chronic renal failure, which affect about 1 billion population
worldwide (Porth et al., 2009). The arterial blood pressure is determined by cardiac output
(blood volume pumped by the heart) and the peripheral resistance of the vasculature (vascular
tone).
Up to date, there still many unanswered questions related to regulation of vascular tone.
One of the most important unsolved problems associated with vascular tone dysfunction is the
acute circulatory failure and vascular hyporeactivity in septic shock. Septic shock is persistent
hypoperfusion and organ dysfunction in severe sepsis, a whole body infection (Dellinger et al.,
2013). Sepsis affects approximately 750,000 people in the US each year (Goyette et al., 2004).
Even with international guidelines for the management, septic shock is still the primary cause of
death in ICU (Angus et al., 2001). Usually, application of vasoactive drugs, such as
catecholamines and vasopressin, is the major approach to intervening low blood pressure and
restore hemodynamic stability (Dunser et al., 2003). However, these vasoactive drugs cannot
effectively restore the blood pressure in septic shock patients (Hollenberg, 2007). The
irreversible hypotension in septic shock, therefore, leads to hypoperfusion to major organs,
multiple organ failures, and death. Therefore, it is urgently needed to find out the underlying
mechanisms and effective management for the hyporeactive vascular tone in septic shock.
Another mysterious mechanism related to vascular function is the function of the
endothelium. Although a plenty of studies have done related to the mechanisms of endothelium
under health and disease in multiple species and arteries, whether the change of membrane
potential regulates the release of the vasoactive substances from the ECs remains elusive. Most
cells are excitable, such as the VSMCs, neurons, and endocrine cells, which secrete hormones
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and transmitters via depolarization and firing activity (Hill-Eubanks et al., 2011; Lowe et al.,
1988; Ozawa and Sand, 1986). It is known that the membrane potential can affect a number of
ion channels, transporters, intracellular Ca2+, intracellular pH, etc. The activity of these
molecules, in turn, change cellular functions. However, the ECs are non-excitable. They release
the endothelium-derived vasoactive substances while cytosolic Ca2+ concentration increases. But
the primary function of the ECs in response to direct depolarization remains unknown.
To solve these unknown questions, innovative approaches are needed so that we can
reveal the underlying mechanisms without interference from existing barriers, including
irreversible hyporeactivity of blood vessels and hypotension in septic shock and non-excitability
and inaccessibility of the ECs that located on the lumen side of blood vessels.
2.2.5 Intervention to vasculature: from tradition to optogenetics
The typical research approaches to study the vascular function includes vascular tension
measurement of different arteries and regular molecular biology analysis, such as western blot,
PCR, and real-time PCR. To dissect the potential signaling pathways, agonists and antagonists of
receptors, inhibitors of enzymes and second messengers are commonly employed and combined
with traditional approaches. The most classic and widely used approach is isolated tissue bath
system, which has over 150-year history in academic research. The therapies formed based on
this approach have treated millions of people with cardiovascular diseases, such as hypertension,
heart failure, diabetes, GI diseases, and so on (Jespersen et al., 2015). The advantage of the
method includes follows: 1) The experiments can be performed in almost all kinds of acutely
dissociated and cultured tissues and organs. Under these situations, the tissues are still living and
functioning, either contraction or relaxation, that is relevant to the body response. 2) Underlying
cellular and molecular mechanisms, including drug-receptor interaction, signaling pathways,

25

second messenger activation, the VSMC excitability, and the change in tissue function, can be
evaluated and dissected with different agonists and antagonists in dose-dependent manner. The
agonists or antagonists can be combined and applied to the tissue for revealing the signaling
pathway and/or potential treatment in vitro. The advantage is the integration of all these steps,
whereas other techniques may only allow each of these steps (Kenakin, 1984). Indeed, this is a
pharmaceutical research approach that allows researchers to look up the effective drugs within an
active dose range. Besides, the retaining tissue function permits calculation of important
pharmacological variability that is more meaningful in a tissue versus a cellular setting
(Jespersen et al., 2015). 3) Technically, this method is real time so that the researcher can
observe the experiments and the results at the same time. Then the researcher can make the
decision for next steps and/or troubleshoot during experiments rapidly. 4) A multiple-baths
system allows measurement on target tissues from both experimental and control animal at the
same time. Likewise, one drug can be tested on multiple tissues in one day. Besides, the
experimental design can be extensively modified by introducing of external stimuli in addition to
drugs, such as electrode stimulation on innervating nerves of the tissue (Heppner et al., 2009),
thermal (Fitch and Yasunobu, 1975) or pH regulation (Hyvelin et al., 2004) in the water bath,
and deprivation on certain extracellular ions (K+ or Ca2+). Moreover, the tissues after the test can
be collected and rapidly freeze during a response for further signal transduction studies using
western blot.
However, as every coin has two sides, the traditional approach has certain weaknesses
that may contribute to the unsolved questions about the regulation of vascular tones. One of the
most significant bottleneck problems is the accessibility to endothelium bypassing the second
signaling pathway. The evaluation of the endothelial function with isolated tissue bath system is

26

the application of ACh, which erects a concentration-related relaxation through the M receptor in
ring segments pre-contracted with NE. This vasodilation is abolished by endothelium
denudation. Besides, the application of exogenous blockers and/or activators in different
concentrations is very likely to interfere the primary vascular tone. Moreover, the dissection of
blood vessels out of different organs in different species, especially with small size, could be a
challenge. The tissues including the VSMC and ECs may experience certain levels of damage
during surgical dissection, or placement of rings on setup hooks. Furthermore, some drugs, such
as Ang II, cause receptor desensitization, which could mask the real effect from tissues (Thomas
et al., 1996).
Therefore, an innovative research approach that can overcome these problems is needed.
One of the most promising research tools is optogenetics, which has been applied in
neuroscience widely in recent years (Boyden et al., 2005; Fenno et al., 2011). Generally,
optogenetics is a combination of genetics, electrophysiology, and optics to control well-defined
events within specific cells of living tissues by expressing an opsin protein in the target
cells/tissues. By using the corresponding wavelength light stimulation on the target cells/tissues,
this approach allows researchers to control membrane potentials and excitability of the opsinexpressing cells, which has been achieved in various types of neurons (Williams and Deisseroth,
2013), glia (Figueiredo et al., 2011), myocardium (Arrenberg et al., 2010), skeletal muscles
(Sakar et al., 2012). This innovative research tool with high temporal and spatial resolution to
access the target cells/tissues while ruling out the internal and external interferences, including
activation of tissue nearby and associated second signaling pathways.
The control on spatial precision is achieved by optogenetic actuators, light-sensitive
proteins, which contain three different types, channelrhodopsin (ChR), halorhodopsin (NpHR),
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and archaerhodopsin (Arch) (Warden et al., 2014). The millisecond-scale temporal precision is
determined by optogenetic sensors of Ca2+, chloride, or member voltage (Boyden et al., 2005).
ChRs are endogenous sensory photoreceptors in unicellular green algae controlling
movement in response to light. They function as light-gated ion channels. Expression of ChRs in
cells of other organisms enables light to control electrical excitability, intracellular acidity, Ca2+
influx, and other cellular processes (Boyden et al., 2005). Most types of ChRs are nonspecific
cation channels that conduct H+, Na+, K+, Ca2 and lead to cell depolarization extremely fast and
robust. Structurally, ChRs contain a seven-transmembrane proteins, which is GPCR, with the
light-isomerizable chromophore all-trans-retinal covalently lined to the rest of the protein (Nagel
et al., 2002; Nagel et al., 2003). After absorbing blue light with a wavelength at ~470 nm, the
intracellular all-trans-retinal complex absorbs a photon, which induces a conformational change
from all-trans to 13-cis-retinal. This process induces pore opening of the transmembrane protein
so that cation influx (Nagel et al., 2003). Each type of ChRs has unique intrinsic membrane
properties, which have a significant impact on light stimulation, including channel conductance,
ion selectivity, kinetics (opening and closing rates of ChR), desensitization and recovery, light
sensitivity, spectral response and membrane trafficking and expression level (Lin, 2011).
Channelrhodopsin-2 (ChR2), a member of ChRs, was the first opsin used to control neural
activities and demonstrated by several groups around the same time (Boyden, 2011; Boyden et
al., 2005). ChR2 works in a comparatively narrow wavelength range that is maximally excited
by 470 nm blue light. It induces a rapid on-rate and moderate channel closing rate. The main
deficiency of ChR2 is the high level of desensitization, which reduces the current by about 80%
at physiological pH. This desensitization recovers in 25 s in the dark completely. (Ishizuka et al.,
2006; Lin et al., 2009; Nagel et al., 2003). So far, the ChR2 is still the most widely used in
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optogentic studies. Further development of opsin protein is concentrating on the magnitude and
kinetics of photocurrent for more rapid, accurate, and efficient control.
Similarly, NpHRs are light-gated chloride channels, found in archaea originally (Lanyi et
al., 1990). NpHRs share similar sequence to ChRs that also has a seven transmembrane protein
of retinylidene protein (Zhang et al., 2011a). In contrast to ChRs, NpHRs silence excitable cells
with brief pulses of yellow light. After stimulation with yellow light at ~580 nm wavelength,
NpHRs move chloride ions into the cytoplasm causing cell hyperpolarization. Therefore, ChRs
and NpHRs together create a powerful toolbox, which enables multiple color optical activation,
silencing, and desynchronization of cellular activity (Han and Boyden, 2007). Another
optogenetic tool is Archs, which respond to ~525 nm yellow light stimulation and are commonly
used for neuronal inhibition by pumping H+ out of target cells (Chow et al., 2010).
The action spectrum for each type of opsin is broad. The blue light activating ChRs has a
peak activation wavelength of 470 nm, but the wavelength of 430-520 nm works with over 50%
efficacy. The yellow light activating NpHRs and green light activating Archs work at the
wavelength of 500-600 nm with over 50% efficacy (Chow et al., 2010; Han and Boyden, 2007;
Nagel et al., 2003). This characteristic enables optogenetic control of larger target tissue volume.
The magnitude of photocurrent depends on the speed of ion flux through a single opsin proteins
and the expression level of the opsin proteins in the membrane. The ChRs mediate larger
photocurrent using photonic energy to gate the channel opening, whereas the NpHRs and Archs
transport ions through photon absorption.
There are two choices of the light source, laser and LED light source, with their
advantages and drawbacks according to the requirements of the experimental design (Warden et
al., 2014). Diode lasers and diode-pumped solid state (DPSS) lasers are more commonly used in

29

neuroscience research field for the last decade. The main advantage of lasers is the intrinsically
highly collimated beam, which can focus to a very small point and provide with high efficient
coupling to very thin optical fibers (< 50 µm in diameter). Lasers also have a narrow spectral
width, which can activate opsin protein specifically (Britt et al., 2012). However, some
disadvantages of laser light source may handicap their application in optogenetic studies
including 1) Lasers are costly, fragile and need high maintenance (Warden et al., 2014). 2) They
introduces noise because of simultaneous emission at close wavelengths. 3) Most DPSS lasers do
not have the well-defined temporal controller, which is critical for optogenetic studies. 4) Lasers
have random spatial intensity variation at illumination site, which is called speckle pattern that
introduce noise in response to even minor changes in temperature and/or current in the lasers or
at fiber banding. 5) The collimation beam can be dangerous and cause eye and skin injury. 6)
The focused collimated beam can be a disadvantage if they are applied to wide field microscopy
(Hertsens, 2005).
The LED illumination system provide with many advantages without most of above
drawbacks of lasers, including 1) LEDs illumination is homogeneous and stable. 2) Most LEDs
current drivers come with a microseconds delay when switch on/off, which is much faster than
millisecond pulses required for the optogenetic application. 3) LEDs illumination intensity can
be controlled manually. 4) LEDs are comparatively cheaper, smaller, and reliable. The main
drawback of this light source is that the coupling of the light source with fiber optic cable always
loses efficiency. The coupling efficiency of the LED light sources is less than 10% comparing to
the 50% of the laser light source (Warden et al., 2014). Taken together, increasing coupling
efficiency could lead to that the LED light sources become the most optimal light source for
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optogenetic studies. Thus, it is necessary to evaluate the above characteristics based on the
experimental design before making the final decision on which type of light source is needed.
In addition to the light source itself, the light intensity, stimulation duration, optic fiber
type and diameter, and target tissue depth and texture are also important to perform the
optogenetic studies. Light intensity (mW/mm2) is the light power from an optic fiber at the
surface of the tissue. It decreases with tissue depth (Aravanis et al., 2007). A safe range for in
vivo experiments on neurons is up to ~75 mW/mm2 for short pulses at ~0.5-50 ms (significant
tissue damage in the cortex was observed with sustained stimulation > 500 ms duration at
intensity > 100 mW/mm2) (Cardin et al., 2010). Besides, it is necessary to consider the duration
and strength of the light pulse in the CNS as a continuous light application can cause abnormal
levels of neural activity and excitotoxicity, which may lead to local tissue damage during an
experiment (Cardin et al., 2010). But in peripheral system, especially in the vasculature, it is
possible to apply light stimulation continuously because of the different characteristic of the
VSMC and ECs (Wu et al., 2015; Zhang et al., 2015). In addition, the power transmitted by the
optic fiber varies with the different type of fibers, such as multimode or single-mode. The spread
of light from the optic fiber is partially determined by the numerical aperture. The low numerical
aperture corresponds to a narrow angle light spread and vice versa. The radius (r) of the optic
fiber also has an impact on the power delivered to the tissue as the area of the initial crosssection of the light at the tip of the fiber increases as the distance between the light fiber and the
tissue becomes further (Cardin et al., 2010). The potential impact of light stimulation may come
from blood and device. Current opsins operate at the visible light wavelength range from 450 nm
to 600 nm, where the hemoglobin, oxygenated (HbO2) and deoxygenated (Hb) in blood, are the
major light absorbers as well (Han, 2012). Furthermore, various tissue damages can be attributed
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to optic fiber insertion procedure and heat produced from the device. Minimize devices size can
reduce mechanical tissue damage. Heat generated by the device can introduce tissue damage
although it remains difficult to evaluate the exact damage from heat. Most optogenetic studies
used light intensity up to ~300 mW/mm2, or a few mW of total light intensity in vivo without
noticing heat damage (Han, 2012).
2.2.6 Animal models and transgenic mice
Transgenic mice with high-level expression of cellular markers in specific tissues is a
versatile and powerful platform for the application of optogenetic approaches. Several techniques
have been widely employed to generate transgenic animal models, including breeding, viral
based gene delivery, and non-viral based gene delivery approaches.
Cre-loxP recombination system has been demonstrated effective for conditional
expression of optogenetic probes from a defined genomic locus (Madisen et al., 2012; Zeng and
Madisen, 2012). Two 34 base pair loxP recognition sequences flanking genes of interest are
catalyzed by Cre enzyme, which is used to restrict the expression of genes in target cells. This
technology can be applied to carry out deletions, insertion, translocation, and inversions at
specific sites in the DNA of cells depending on the location and orientation of loxP sequences
(Zheng et al., 2000).
To generate desired transgenic mice, crossing cell-specific Cre expressed mice with opsin
expressed downstream of loxP-flanked (floxed) stop cassette mice is widely utilized to date
(Madisen et al., 2012). The cell specificity is achieved by the availability of cell-type specific
Cre drive lines either commercially and/or academically. The Cre-responsive allele driven by a
cell-specific strong and ubiquitous promoter is inserted into a modified Gt(ROSA)26Sor locus,
which is a ubiquitously expressed locus that can be targeted easily (Irion et al., 2007). We used
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this system to generate transgenic mice with optic accessibility to either the VSMC or ECs
specifically. The advantage of this method to get transgenic mice is 1) Most of the breeding pairs
are available commercially from companies, such as Jackson Laboratory, Allen Brain Institute,
and so on. 2) The expression of ChR2 lasts lifelong in transgenic mice. 3) The expression level
can be controlled maintained by manipulating parental zygosity. 4) The transgene can be
visualized with fluorescence reporter, such as eYFP.
Another way to express optogenetic probe is virus injection. In genetically intractable
species, the most commonly used technology is virus transduction. The viral injection introduced
the expression of ChR2 usually lasts for couple month maximally. But the time to express light
sensitive opsin in mice can be controlled by researchers. Among all of the virus vectors,
Lentivirus and adeno-associated virus (AAV) are widely engineered with excellent transduction
efficiency and little/no toxicity (Atasoy et al., 2008). However, there are drawbacks associated
with intrinsic stability of the viral particles that cannot be overcome easily: 1) Packing of viral
particles is increasing difficult with larger DNAs. 2) The injected virus could be dangerous to the
host DNA without persistent expression. 3) The injection may not cover all of the required
neurons within the target region (Madisen et al., 2012).
Nowadays, more and more nonviral methods have been developed for gene delivery,
such as using cationic lipid, cationic polymer, nanoparticles, carbon nanotubes, gene guns, and
calcium phosphate nanoparticles (Bhakta et al., 2005; Boussif et al., 1995; Felgner et al., 1987;
Kam et al., 2005; Kneuer et al., 2000; Nishikawa and Huang, 2001; Roy et al., 2003; Roy et al.,
2005; Salem et al., 2003). Although these methods have low transduction efficiency in vivo in
general, a potential advantage is that this method can introduce larger DNAs into cells and
enable targeting specific cells.
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2.3

Regulation of cardiac function in ANS

2.3.1 Anatomy and physiology of the Cardiac Muscle
The heart pumps blood to the whole body through the circulatory system. Blood provides
the body with O2 and nutrients and assists in the removal of metabolic waste. The coronary
circulation is the driving force of the heart.
The heart wall contains three layers, epicardium, myocardium, and endocardium. The
innermost layer of the heart wall endocardium is made of a lining of ECs and connective tissues
that cover the heart chambers and valves. The endocardium joins to the middle layer
myocardium through a layer of connective tissue. The major component of the myocardium is
cardiac muscles, which are involuntary striated muscles that produce autorhythmicity of the heart
beating. This unique capability is the driving force initiating cardiac action potentials at a certain
frequency. The cardiac action potentials spread rapidly to trigger the contraction of the entire
heart. The myocardium is supplied with blood vessels and nerve fibers those are involved in the
modulation of the autorhythmicity by the ANS and endocrine hormones. The outermost layer of
the heart wall is pericardium that is made of an inner serous membrane (epicardium) and an outer
fibrous membrane. These two layers of membranes enclose the pericardial cavity with
pericardial fluid that lubricates the surface of the heart (Boron and Boulpaep, 2009; Clark, 2005).
As one of three major types of muscle, the others being skeletal and smooth muscle,
cardiac muscle is composed of cardiomyocytes (also known as myocardiocytes or cardiac
myocytes), which have striations similar to those in skeletal muscle cells, whereas they contain
only one nucleus (Olivetti et al., 1996), which is different from multinucleated skeletal muscle
cells (Okazaki and Holtzer, 1966). Cardiomyocytes contain high mitochondria content allowing
them to produce ATP quickly and highly resistant to fatigue (McBride et al., 2006), and
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specialized organelle myofibrils that consist of long chains of sarcomeres, the fundamental
contractile units of muscle cells (Severs, 2000). There are two types of cardiac muscle cells:
cardiomyocytes and modified cardiomyocytes, the pacemaker cells of the conducting system.
The major component of atrium and ventricles are cardiomyocytes that are contractile while the
pacemaker cells make up about 1% of the cardiac muscle. The pacemaker cells are less
contractive and smaller than the cardiomyocytes because they contain fewer myofibrils. They
distribute throughout the heart and are responsible for heart beating, including spontaneously
generating and sending out electrical impulses, transferring electrical impulses from cell to cell,
and receiving and responding to electrical impulses from the brain. (Arrigo and Avanzino, 1979).
Indeed, cardiac pacemaker cells function the way more similar to neurons. All of the
cardiomyocytes are connected by intercalated discs, a porous junction between cells allowing
quick delivery of action potentials from the pacemakers. The intercalated discs enable Na+, K+,
and Ca2+ to diffuse from cell to cell easily so that the depolarization and repolarization are easy
in the myocardium (Pocock and Richards, 2006).
2.3.2 Cardiac function and the neural control
Cardiac Output is the volume of blood pumped by the heart per minute (ml/min). The
cardiac output can be evaluated by the heart rate (beats/min) and stroke volume (ml/beat). Heart
rate is mainly determined by the pacemaker SA node, and the automaticity of the SA node is
determined by spontaneous changes in cationic conductance, including Ca2+, Na+, and K+
(Irisawa et al., 1993). This intrinsic automaticity is regulated by neural and humoral factors.
Neural mechanism primarily involves the sympathetic adrenergic and parasympathetic
cholinergic branches of the ANS. Activation of the parasympathetic system decreases heart rate.
The increase in heart rate can be attributed to withdrawal of vagal tone and/or activation of
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sympathetic nerves innervating SA node. The humoral factors include circulating catecholamines
that act on β1 adrenoceptors located on SA nodes, renin-angiotensin system, circulating thyroxin,
vasopressin, atrial natriuretic peptide, ET-1, and changes in core body temperature. The stroke
volume is the volume of blood pumped out of the heart with each beat (Mangoni and Nargeot,
2008).
The stroke volume is regulated by ventricular contractility, end-diastolic volume
(preload), and afterload (Bishop et al., 1976). Ventricular contractility determines the force of
blood ejection and the stroke volume. Sympathetic activation increase ventricular contractility,
which in turn, enhance the stroke volume, whereas the parasympathetic stimulation has no
significant impact on stroke volume (Pocock and Richards, 2006). Preload/end-diastolic volume
is the volume of a ventricle at the very end of filling and right before systole begins. Preload is
variable because the ventricles are flexible and the blood flowing into changes when ventricles
relax. Less blood flowing into the ventricles leads to reduced end-diastolic volume and vice
versa. Preload is the most concerned affecting stroke volume through the Frank-Starling
mechanism. The Frank-Starling mechanism refers to that the cardiomyocytes respond to stretch
by contracting more forcefully because of increased expenditure of ATP energy. Therefore, an
increase in preload enhances cardiac muscle stretching force and stroke volume (Pocock and
Richards, 2006). Afterload is also known as aortic pressure during ejection that directly
influences the blood volume flowing into the aorta during systole. If the aortic pressure
increases, then the blood volume that flows into the aorta during systole reduces (Pocock and
Richards, 2006).
The pacemakers located in the SA node of the conduction system initiates action
potentials on its own, forming the basal rhythm of the heart. Then the action potentials are
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conducted from the SA node to AV node. The conduction of impulses slows at the AV node
allowing sufficient time for atrial depolarization and contraction. The impulses then enter the
base of ventricle through the bundle of His, which contain the left and right branches along the
interventricular septum. The branches divide into an extensive Purkinje fibers that continually
conduct the impulses throughout the ventricles resulting in rapid depolarization of both
ventricles. This conducting system within the heart is important for rapid and organized
depolarization of ventricles, which indeed, to generate systolic pressure efficiently. The
conducing system is regulated by ANS through AV node mostly (Pocock and Richards, 2006).
Sympathetic activation increase conduction velocity of the AV node by increasing the rate of
depolarization of action potentials. Adjacent cells are affected by this faster depolarization,
leading to a faster conduction of impulses. Then the conducting time between atria and ventricles
is reduced. In contrast, parasympathetic activation decreases the slope of AV nodal action
potentials, which reduces the velocity of conduction throughout the heart (Gordan et al., 2015).
The ANS regulate cardiac function spontaneously in response to the signals from sensory
receptors located in the peripheral system. These sensory receptors monitor physiological
function and generate actions potentials in response to stimuli, including mechanical, chemical
and thermal changes. The sensory receptors respond to stretching of the blood vessel wall, or
cardiac chambers are called baroreceptors, which are located in the heart and major blood
vessels. The other type of sensory receptors in the peripheral system is chemoreceptors, which
are small, highly specialized and are primarily located at the bifurcation of the common carotid
arteries and aorta. The chemoreceptors directly respond to the change of partial pressure of O2
and CO2 in the blood (Pocock and Richards, 2006). Both sensory receptors convey their status
via afferent systems to the NTS, which relays the information to other brain regions that
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coordinate the activity of efferent motor pathways targeting on cardiac muscles, smooth muscles,
and other tissues (Critchley and Harrison, 2013).
The sympathetic fibers release NE, which binds to β adrenergic receptors located in the
heart, and activates GPCR and downstream AC – cAMP – PKA signaling pathway. There are
two types of β adrenergic receptors involved in sympathetic innervation in the heart. β1 receptors
couple to Gs-protein and activate cAMP primarily, whereas β2 receptors couple to both Gs and
Gi-proteins. Collectively, the activation of β receptors in the heart increases the slope of diastolic
depolarization in the SA node and the conduction in the AV node, which leads to increased heart
rate. Activation of β receptors also increases intracellular Ca2+ concentration through membrane
Ca2+ channels and Ca2+ releasing from the SR, resulting in increased force of contraction. In
addition, associated Ca2+ reuptake into the SR accelerates relaxation. Taken together,
sympathetic effects on cardiac contractibility, heart rate, and impulse conduction result in larger
stroke volume (Triposkiadis et al., 2009). The parasympathetic stimulation causes ACh release,
which activates M2 muscarinic receptors, then K+ conductance increase of nodal cells. Then the
intrinsic heart rate decreases. Given the ability to regulate both cardiac rate and stroke volume,
ANS remotely modulate cardiac function to meet a short-term change in the body’s needs
(Harvey and Belevych, 2003).
For example, when blood pressure rises, baroreceptors are activated and sending
corresponding signals to the brain control center. The sympathetic stimulation is inhibited. In
parallel, the activity of the parasympathetic system, including vagus and the NA that influence
heart rate, is stimulated. As a result, the stimulator noradrenergic effects of sympathetic
innervation to the cardiac pacemaker and cardiac muscle is reduced, whereas the cholinergic
parasympathetic innervation to the heart is activated. This process inhibits the pacemakers
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discharge rate and slows down the ventricular conduction system. Finally, the heart rate and
effectiveness of the myocardial contraction reduce, the peripheral arterioles dilate, and the blood
pressure decreases. When hypoxia or hypercapnia occurs, a lower level O2 or a higher level CO2
will be detected by chemoreceptors. In response to the increased firing frequency from peripheral
chemoreceptors, the central control enhances sympathetic stimulation to arterioles and veins so
that the blood vessel contract and the blood pressure increases. Indeed, the chemoreceptors
simultaneously stimulate central respiratory control centers to increase O2 supply and reduce the
CO2 level.
Taken together, the neural control of the heart has a profound influence to maintain the
homeostasis. The regulation on the heart rate and conduction velocity are performed with the
innervation to the SA and AV nodes by both parasympathetic and sympathetic fibers while the
contractility and relaxation are mainly mediated by sympathetic fibers innervating atrial and
ventricular myocytes.
2.3.3 Coronary circulation and regulation
While providing the blood to the whole system, the cardiomyocytes need to be supplied
with O2 and nutrients, and a way of removing metabolic waste. This is achieved by the coronary
circulation. The major vessels of the coronary circulation are the right main coronary artery and
the left main coronary, which divide into left circumflex and anterior descending branches. Both
left and right coronary arteries originate from aortic root right above the aortic valve (called the
coronary ostia). The two coronary arteries and their branches lie on the surface of the heart (also
known as epicardial coronary vessels). As in all vascular beds, the arteries and arterioles branch
into numerous capillaries that lie adjacent to the cardiac myocytes. The large coronary arteries
conduct blood with little resistance, whereas the small coronary arteries are the principle
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resistance vessels of the heart that change their diameter to regulate the coronary blood flow
(Pocock and Richards, 2006).
Factors that have an impact on coronary circulation include mechanical, metabolic reflex,
and neural effects (Rubio and Berne, 1975). Mechanical influence is passive that is mostly
determined by the myocardial extravascular compression. The metabolic factors affect coronary
flow include lactic acid, adenosine, O2, CO2, K+, and a variety of endothelium-derived
vasoactive molecules in cardiac muscles (Feigl, 1983). Hormonal factors mainly involve 5-HT,
vasopressin, and bradykinin. 5-HT has a different effect on the coronary circulation. It increases
coronary blood flow through vasoconstriction effect in coronary arteries and vasodilation in
coronary arterioles. Similar, vasopressin promote a different response in the coronary system, but
collectively it induces coronary vasoconstriction (Tune, 2014). Bradykinin induces significant
vasodilation of coronary arterioles through multiple signaling pathways (Groves et al., 1995).
The reflex control contains carotid sinus reflex that promotes coronary vasodilation through
inhibiting parasympathetic discharge and activating sympathetic nerves in response to the
decrease of blood pressure. Carotid body chemoreceptor reflex induces coronary vasodilation
through activating vagal parasympathetic nerves in response to hypoxia and hypercapnia (Feigl,
1983).
The neural factors affect coronary flow through direct and/or indirect ways. The direct
effect is moderate involving both sympathetic and parasympathetic divisions. The sympathetic
stimulation acts on both α and β receptors expressed in the coronary vessels causing slight
vasoconstriction. The distribution of parasympathetic vagus nerves is slight in coronary vessels
so that the innervation triggered vasodilation is mild as well. In contrast, indirect effect plays a
far more important role in the regulation of coronary flow through an effect on extravascular
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compression. The sympathetic innervation increases both heart rate and myocardial contractility,
which in turn, positively increase coronary flow. Increased heart rate and myocardial
contractility also result in high metabolism and more metabolites that can dilate coronary vessels
and increase coronary flow (Tune, 2014).
2.3.4 Disorder and intervention of the cardiac function
According to WHO and the CDC reports, heart disease is the leading cause of death in
the western societies. Over 11% of the US adults are diagnosed with heart disease and about
25% of all death in the US nowadays are caused by heart disease (CDC, 2013). Since the heart is
one of the most important and complex organs, dysfunction of the heart lead to multiple and
lethal diseases, such as heart attack, heart failure, arrhythmias, atherosclerosis, atrial fibrillation,
cardiomyopathy, congenital heart defects, etc.
The research approaches to study the cardiac function are quite similar to that of
vasomotor, including molecular biology, electrophysiology, and heart perfusion. Otherwise, the
innovative application of optogenetics is way earlier in the heart since 2010. Bruegmann et al.
generated ChR2 expressed cardiomyocytes in vitro with optical pacing and transgenic mice with
ChR2 expression in cardiac muscles (Bruegmann et al., 2010). At the same year, another group
led by Dr. Emilia Entcheva at Stony Brook University in New York developed a non-viral cell
delivery system, tandem cell unit, for expression of rhodopsin channels in vitro (Jia et al., 2011).
These innovative development in the study of heart diseases has many advantages over the
traditional approaches, including 1) application in both in vitro and in vivo systems; 2)
stimulating and silencing cardiomyocytes with different rhodopsin protein expression but the
interference from exogenous drugs; 3) feasibility of micro-manipulation in coronary circulation
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system with optogenetics; 4) highly precision on spatial and temporal control over
cardiomyocytes.
2.4

Regulation of respiration

2.4.1 Anatomy and Physiology of Respiratory System
In addition to regulation of vascular tone and cardiac function, ANS also plays a critical
role in the respiratory system to maintain levels of PO2 and PCO2 in the arterial blood through
both peripheral and central chemoreceptors. As important as heart beat and vasomotor, the
respiration is crucial to every human being. The major function of the respiratory system is to
provide adequate O2 into the blood stream and take CO2 out of the body. The structure of
respiratory system contains upper respiratory tract and lower respiratory tract. The upper
respiratory tract involves nostrils, nasal cavities, pharynx, epiglottis, and larynx while the lower
respiratory tract includes trachea, bronchi, bronchioles, and lungs (Pocock and Richards, 2006).
Homeostasis is maintained by the respiratory system in two ways, gas exchange and
regulation of blood pH. Gas exchange includes external and internal respiration along partial
pressure gradients. External respiration is the exchange of O2 and CO2 occurring between
external environment/atmosphere and capillaries in the lungs. This is efficient because of bulk
exchange between alveoli and capillaries. Internal respiration is the intracellular use of O2 to
make ATP. It provides the body with O2 for further cellular respiration while eliminates CO2.
Maintaining the acid/base balance of the blood is critical for the system to survive as well.
Normal blood pH ranges from 7.38 to 7.42. For human beings, if the blood pH drops below 7.2
or increase above 7.4, then the brain would cease functioning normally. Blood pH below 6.9 or
above 7.9 for a short period would be fatal.
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The body copes with the change of blood pH through the buffer, respiratory, and renal
systems. The primary defense for blood pH is the buffers that are molecules that take in or
release ions, in turn, to maintain the H+ concentration at a certain level (Adrogue and Adrogue,
2001). There are two types of buffers inside and outside of cells. The extracellular buffers
contain bicarbonate (HCO3−) and ammonia while the intracellular buffers are proteins and
phosphate. Among all of these buffers, the most important buffer is the bicarbonate system (a
mixture of bicarbonate and CO2). The CO2 forms carbonic acid (H2CO3), which can be dissolved
in water and acts as acid giving away H+ when needed (Garrett et al., 2013), such as in alkalosis,
which is an excess of base. HCO3− is a base that can take in H+ when blood pH is too low
(Garrett et al., 2013), such as acidosis, which is an excess of acid or the CO2 concentration is
high in the blood. Protein molecules contain basic and acidic groups and can act as H+ acceptors
or donors, respectively. The phosphate (H2PO4− and HPO42−) buffer is an important intracellular
buffer that moderately efficient at physiological pH level (Garrett et al., 2013).
The acid-base imbalance that overcomes the buffer system can be compensated rapidly
and effectively by the ventilation rate, which is the second defense. The change of the ventilation
rate indeed alters the CO2 concentration in the blood, which in turn, contribute to the blood pH.
The renal system as the third defense to compensate the change of blood pH has a slower effect
through excretion of excess acid and reabsorb of filtered bicarbonate (Adrogue and Adrogue,
2001).
2.4.2 Regulation of Respiration
The respiratory control system consists of three basic elements: a central controller,
sensors, and effectors. The central controller includes brainstem and other parts of the brain, such
as cortex. The efferent nerves from respiratory centers descend and terminate in the motor
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neurons located in the cervical and thoracic segment of spinal cord. Two sets of nerve fiber arise
from the motor neurons and innervate effectors. The effectors are respiratory muscles including
the diaphragm, intercostal muscles, and accessory muscles, which receive efferent signals from
central control centers. The sensors gather information and send afferent input to the respiratory
centers. The sensors include peripheral and central chemoreceptors and pulmonary receptors.
Afferent signals are transmitted through vagus and glossopharyngeal nerve to respiratory center
in the brainstem (West and West, 2012).
The respiratory center is composed of several groups of neurons located in the medulla
oblongata and pons of the brainstem. The dorsal respiratory groups (DRG) diffusely located in
the dorsal medulla, which generates inspiratory ramp by the virtue of their autorhythmic
property. They are mainly composed of NTS. The ventral respiratory groups located in the
ventrolateral medulla control expiration. Another breathing center located in the ventrolateral
medulla is Pre-Bötzinger complex (pre-BötC), which is formed by a groups of pacemaker
neurons generating the rhythmic respiratory impulses. These groups of neurons compose the
intrinsic periodic firing rate controlling the respiratory rhythm.
The apneustic center located in the reticular formation of lower pons controls the depth of
inspiration by sending excitatory impulses into the DRG. The pneumotaxic center, also known as
the pontine respiratory group (PRG), located in the dorsolateral part of the reticular formation in
upper pons inhibits inspiration ramp and thus the inspiration duration and volume and,
secondarily respiratory rate. The PRG is composed of Kölliker-Fuse nucleus and medial
parabrachial nucleus. The expiration is passive response resulted from the diaphragm and
intercostal muscles relaxation and elastic recoil of the lungs under physiological condition. The
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ventrolateral medulla respiratory center is an overdrive center for high-level pulmonary
ventilation, such as heavy exercise (West and West, 2012).
The breathing activity is controlled by both central and local manners. The central
regulation consists of the involuntary and voluntary controls (Gallego et al., 2001). Involuntary
control affecting respiratory centers in brainstem include 1) chemoreceptor reflexes; 2) impulses
from stretch receptors of lungs; 3) impulses from Juxtacapillary (J) receptors of lungs; 4)
impulses from irritant receptors of lungs; 5) impulses from proprioceptors; 6) impulses from
thermoreceptors; 7) impulses from pain receptors; 8) cough reflex; 9) sneezing reflex; and 10)
deglutition reflex.
Chemoreceptor reflex refers to the central and peripheral chemoreceptors that detect
changes in chemical composition of the blood and cerebrospinal fluid. Peripheral
chemoreceptors located in the carotid and aortic bodies, as introduced above, are sensitive to the
change of partial pressure of O2 in arterial blood. Hypoxia is the most potent stimulant for
peripheral chemoreceptors. When the partial pressure of O2 decreases, the chemoreceptors are
activated and send impulses to both cardiac and inspiratory centers and stimulate them. Then the
respiratory rate and force increase to compensate the lack of O2. In addition to hypoxia,
peripheral chemoreceptors also mildly respond to hypercapnia and increased H+ concentration in
the blood (Kumar and Prabhakar, 2012).
Central chemoreceptors act slowly but effectively. It has been reported that the central
chemosensitive neurons are found in many brain regions including the ventral surface and
midline of the medulla and dorsal areas of the brainstem. The ventral chemosensitive groups
include the retrogtrapezoid nucleus (RTN), parapyramidal region of raphe nuclei, and ventral
respiratory group. Dorsal chemosensitive groups contain NTS (Nattie and Li, 2002), LC
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(Biancardi et al., 2008; Coates et al., 1993), and area postrema (AP) (Belegu et al., 1999).
Norepinepherinergic neurons (NE-ergic) in the LC are inherently CO2 sensitive, which will be
further discussed below. Midline raphe nuclei in the medulla are also well accepted
chemosensitive neurons (Bernard et al., 1996; Nattie and Li, 2001). These central
chemoreceptors have several specific characteristics, 1) These neurons exhibit c-fos expression
when whole-body animals are exposed to hypercapnia, which is a condition that excessive CO2
level in the blood because of inadequate respiration (Okada et al., 2002; Sato et al., 1992). 2) The
neuronal activities, including firing rate and membrane potential, can be stimulated or inhibited
by the change of CO2 or pH levels in vitro (Filosa et al., 2002; Okada et al., 2002). 3) Focal
acidification in vivo increases ventilation (Bernard et al., 1996; Nattie and Li, 1996).
Different from peripheral chemoreceptors, central chemoreceptors are exquisitely
sensitive to the concentration of H+ of nearby cerebral spinal fluid that cannot cross the bloodbrain barrier (BBB). Increased H+ in the blood cannot stimulate the central chemoreceptors
directly. But when CO2 concentration is high in the blood stream, it crosses the BBB easily and
enters the interstitial fluid or the cerebrospinal fluid of the brain. CO2 combines with H2O
forming carbonic acid, which is unstable and immediately dissociates into H+ and HCO3-. The
increased H+ then stimulates central chemoreceptors, which subsequently, send impulses into
DRG to increase respiratory rate and force. This process washes out excess CO2 and brings
respiration back to normal (Nattie, 2006).
The sensing mechanism of these central chemoreceptors is achieved through CO2/pH
sensing molecules located in one or more of these receptors. These molecules can be stimulated
by the change of CO2/pH level, which in turn, affect the membrane excitability of the central
chemoreceptors (Bayliss and Barrett, 2008; Filosa and Putnam, 2003; Jiang et al., 2001; Kersh et
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al., 2009). Several identified CO2/pH sensing molecules include inward rectifier K+ (Kir)
channels, TASK, gap junction channels, Ca2+-activated non-selective cation (CAN) channels,
voltage-gated Ca2+ channels, transient receptor potential (TRP) channels and proton-activated
receptor GPR4. The primary function of the Kir channel is to modulate cellular excitability by
inward rectification at voltages near the resting potential in various types of cells (Fang et al.,
2005; Seifert et al., 2009). It has reported that Kir channels are found to mediate CO2-induced
neuronal response in the LC neurons and rostroventrolateral medulla (Pineda and Aghajanian,
1997; Schultz et al., 2003). High-level CO2/pH inhibits channel activities, which in turn, leads to
membrane depolarization and higher firing frequency. It remains unknown that which subtype of
Kir channel plays the role in chemoreception in CNS, whether the Kir channels are necessary
and sufficient for CO2/pH chemoreception, and why the Kir channels are specifically utilized by
certain groups of chemosensitive groups but not others. TWIK-related acid-sensitive K+ (TASK)
channels, TASK-1, and TASK-3, may be responsible for pH sensitivity in dorsal raphé and
hypoglossal motor neurons (HNs) (Bayliss et al., 2001; Washburn et al., 2002). Another
noticeable sensor is proton-activated receptor (GPR4) expressed in RTN, that senses protons
generated by H2CO3 in the blood. Genetic knock-out of GRP4 disturbed acidosis-dependent
activation of RTN whereas reintroduction of GPR4 into RTN restored RTN neuronal activities
and ventilation in mice (Kumar et al., 2015).
When the lungs are overstretched, the stretch receptors expressed in the walls of bronchi
transmit signals through the vagus nerves into the DRG to stop excess inspiration. This process is
called the Hering-Breuer inflation reflex, which protectively prevents excess lung inflation.
Besides, J receptor located in the wall of the alveoli that are stimulated by certain conditions like
pulmonary edema, pulmonary congestion, pneumonia, and exposure to the exogenous and
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endogenous chemicals like histamine and 5-HT. Stimulation of J receptor results in a reflex
response apnea. Another type of receptors in the lungs is irritant receptors that also located on
the wall of bronchi and bronchioles. They are stimulated by harmful chemicals, such as ammonia
and sulfur dioxide and produce a cough and prolonged inspiration along with bronchospasm to
prevent harmful chemicals from entering into the alveoli (Perez et al., 2015). Proprioceptors
located in joints, muscles, and tendons, are sensitive to the change in the position of different
parts of the body. They are stimulated during exercise and sends impulses to the cerebral cortex,
which in turn, activate medullary respiratory centers causing hyperventilation (Proske and
Gandevia, 2012). Thermoreceptors give a response to the change of body temperature. When
they are stimulated, they send signals to the cerebral cortex, which in turn, stimulate the
respiratory center leading to hyperventilation (Kozyreva and Simonova, 1998). Pain receptors
responding to pain stimuli send impulses to the cerebral cortex, which in turn, stimulate
respiratory center inducing hyperventilation (Borgbjerg et al., 1996). Cough reflex is a protective
reflex caused by irritation of respiratory tract through the vagus nerve. Sneezing reflex is also a
protective reflex occurs due to the irritation of nasal mucus membrane through olfactory
receptors and trigeminal nerve endings (Sant'Ambrogio et al., 1995). Deglutition reflex occurs
during swallowing of the food. The temporary arrest of the respiration during swallowing is
called swallowing apnea or deglutition apnea, which prevents the food particles entering into the
respiratory tract (Nishino, 1993).
The voluntary control of breathing originates in the motor cortex of frontal lobe of the
cerebrum that sends action potentials along the corticospinal tracts to respiratory neurons in
spinal cord bypassing medullary impact (McKay et al., 2003). The voluntary control, however,
can be overridden by chemical factors, such as O2, CO2, and H+ level.
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Local control of respiration is automatic control independent of the CNS including
adjustments of pulmonary blood perfusion and alveolar ventilation (Grant et al., 1976). Lung
perfusion is controlled by vasomotor of arterioles supplying lungs areas according to the partial
pressure of O2. When O2 is insufficient in a region of alveoli, local receptors in the capillaries
can detect it, which in turn, induce vasoconstriction of arterioles reducing blood flow to this area
and preventing wasted perfusion into poorly oxygenated alveoli. The adjustment of alveolar
ventilation is completed by changing the size of bronchioles in response to alveolar PCO2. For
instance, decreased alveolar PCO2 leads to local bronchodilation so that more air enters into the
area allowing O2 to reach alveoli and facilitating CO2 removal (Hughes, 1975).
2.4.3 Chemosensitive NE-ergic neurons in the LC
In the CNS, neurotransmitters and neuromodulators act at different levels of the
respiratory reflex to influence respiration comprehensively including the magnitude, frequency,
duration, and regularity (Doi and Ramirez, 2008). The major neurotransmitters and
neuromodulators include several categories: amino acids, peptides, gasotransmitters, purines, and
monoamines. Amino acids consist of glutamate, aspartate, D-serine, γ-aminobutyric acid
(GABA), and glycine. Peptides include somatostatin, substance P, cocaine, amphetamine, and
opioid peptides. Gasotransmitters are NO, carbon monoxide (CO), and H2S. Purines refer to ATP
and adenosine. Monoamines, as one of the most important class of neuromodulators, is derived
from aromatic amino acids, including DA, NE, epinephrine, and 5-HT. Among these
monoamines, the first three are also known as catecholamine, and the last one is known as
indoleamine. NE and adrenaline groups within the brainstem are numbered from caudal to rostral
direction, which A1-A7 groups contain NE while C1-C3 are adrenergic groups. A5-A7 groups
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are located in the pons and all other groups are located in the medulla (Pocock and Richards,
2006).
The central monoamines have multiple impacts on brain function, especially those related
to autonomic regulation, such as respiration (Haxhiu et al., 2001; Zhao and Debski, 2005).
Monoaminergic neurons modulate the basal breathing rhythm and chemosensitivity by
widespread projection to respiratory nuclei in the brainstem. Notably, some of the monaminergic
neurons are chemosensitive themselves, such as NE-ergic neurons in the LC, and 5-HT neurons
in the raphé nuclei (Haxhiu et al., 2001).
NE plays an important role in the regulation of breathing activity. Normally, NE
stabilizes respiratory network activity (Hilaire et al., 2004). Many studies have demonstrated that
NE regulates respiration through modulating respiratory rhythmic generation neurons in the
medulla, and the respiratory center in the CNS (Viemari et al., 2004; Viemari et al., 2005). NE
exerts excitation and inhibition by acting on different α-adrenoceptors. The A6 LC group
contains the majority of the central NE-ergic neuron and is the principle site of NE synthesis in
the CNS. Application of α1 receptor agonist to the LC neurons accelerates breathing frequency in
brainstem-spinal cord preparations in vitro, whereas the application of α1 receptor antagonist,
prazosin, to A5 region in the pons seems to inhibit breathing activity (Hilaire et al., 2004). NE
modulates respiratory rhythmic activity in both the preBötC (Viemari et al., 2013; Viemari and
Ramirez, 2006) and the HNs (Parkis et al., 1995; Rukhadze and Kubin, 2007). The preBötC is a
cluster interneurons located in the ventrolateral medulla that is essential for the generation of
respiratory rhythm. The HNs located in causal brainstem innervates the tongue muscles,
controlling tongue movements, food manipulation, and swallowing. Therefore, the innervation of
the HNs plays a critical role in maintaining upper airway patency during breathing.
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The LC is located in the posterior area of the rostral pons in the lateral floor of the fourth
ventricle. The LC provides more than 70% of noradrenergic innervation in the CNS (Viemari,
2008). The projection of this nucleus reaches far and wide areas, including brainstem and spinal
cord, cerebellum, cerebral cortex, hypothalamus, and amygdala, which influence many systemic
functions and cognitive behaviors, such as cardiorespiratory activity, stress response, motor
control, arousal status, and attention (Aston-Jones and Cohen, 2005). The NE-ergic neurons in
the LC area have excitatory effect on most of the projected nuclei through adrenoceptors while
these neurons receive both excitatory and inhibitory afferents, such as glutamate, GABA, opiate,
5-HT, and DA from some other brain regions (Samuels and Szabadi, 2008). The integrative
innervation may lead LC neurons functioning differently, although the LC neurons are primarily
homogeneous regarding morphology and neurochemical properties (Nestler et al., 1999).
The LC has been identified as a central chemoreceptor since the 1980s (Elam et al.,
1981). When CO2 level increases, the firing rate of the LC neurons in rat increases while the
ventilation is enhanced in rats. This effect is independent of peripheral input. After that, more
evidences were reported that the NE-ergic neurons in the LC area play a critical role in central
chemoreception. Indeed, over 80% of the LC neurons were activated by hypercapnia or acidic
pH (Putnam et al., 2004). The acidification of the LC region raises discharge frequency of
phrenic nerves in cats, which accounts for ~30% of the overall response to hypercapnia (Coates
et al., 1993). Selectively destroying NE-ergic neurons in the LC area significantly reduces the
CO2 induced the respiratory response in rats (Biancardi et al., 2008). Beside, considering the
widespread projection from the LC neurons to other CO2 sensitive sites, the LC neurons may
also act as a relay center for further process of the afferent signals in response to the change of
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CO2/pH level in respiratory neural networks. Therefore, the chemosensitive NE-ergic neurons in
the LC region is essential in the regulation of breathing activity.
2.4.4 Mecp2 and Rett Syndrome
Dysfunction of monoaminergic systems in the CNS is associated with several severe
breathing disorders, such as Rett syndrome (RTT) (Viemari et al., 2005), congenital central
hypoventilation syndrome (CCHS) (Gaultier, 2004) and sudden infant death syndrome (SIDS)
(Hilaire, 2006). Among all of these disorders, the RTT as a neurodevelopmental disease is
demonstrated to be related to an abnormality of NE level by overwhelming studies. RTT affects
female children worldwide because of the genetic defect of a transcriptional regulator, Methyl
CpG binding protein 2 (MECP2) (Neul et al., 2008). As an X-linked gene, MECP2 encode for
the MeCP2 protein, which has two major domains, the methyl- binding domain (MBD) and the
transcriptional repression domain (TRD). The MBD directs the specific binding of MeCP2 to
methylated DNA, and the TRD conducts a repressive function in gene transcription. In addition,
MeCP2 may also act as a transcriptional activator that contributes to alternative gene splicing
(Chahrour et al., 2008; Young et al., 2005). Mutation of MeCP2 always occurs in the MBD and
TRD leading to RTT and other neurological diseases (Moretti and Zoghbi, 2006).
Because the LC region is the principle synthesis location of NE and project NE to other
brain regions, the alteration of these neurons contributes to several symptoms in RTT, such as
cognitive, motor, and autonomic dysfunction (Bengzon et al., 1999; Funk et al., 1994;
Sparenborg and Gabriel, 1992). Breathing disorder may be one of the most severe symptoms
including episodic breath-holding, apnea, respiratory irregularity, apneusis, Valsalva breathing,
and air swallowing, etc (Ogier and Katz, 2008). Most of these breathing abnormalities during the
development of RTT lead to further brain damage and even asphyxiation, and they are difficult
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to be watched by parents of the patient. Consistent with the abnormal breathing, the defected
neuronal properties of the LC neurons, hyperexcitability and decreased NE innervation have
been found in RTT mouse models. Also, a reduced mRNA level of rate-limiting enzyme,
tyrosine hydroxylase (TH), in catecholamine synthesis was detected in the pons of Mecp2-null
male and heterozygous female mice (Taneja et al., 2009). Decreased TH protein staining level,
the number of TH-expressing neurons in the LC area, and density of dendrites were seen in
symptomatic Mecp2-null male mice (Roux et al., 2010). The application of exogenous NE or the
NE uptake inhibitor improves respiratory rhythm, the number of TH-positive neurons in the
medulla, and extends the lifespan of Mecp2−/Y mice (Berridge and Waterhouse, 2003; Roux et
al., 2010; Taneja et al., 2009). Otherwise, the relationship between the deficiency in NE
synthesis enzymes and the defects of the LC neuronal activities in RTT remain unclear.
2.4.5 Intervention of neuronal activities
In the recent decade, the rapid development of optogenetics, transgenic animal model,
gene delivery strategies, and bioinformatics allows neuroscientists to go beyond observation of
neurons with spatially selective and temporally precise manipulation of specific neuronal circuits
and individual neurons with light stimulation in vitro and in vivo. By utilizing different light
sensitive opsins, researchers can either stimulate or silence the specific neurons or circuits with
light at a different wavelength as discussed above.

3

SIGNIFICANCE

The ANS innervates different parts of the body, including the cardiomyocytes, vascular
smooth muscles, respiratory system and other internal organs to maintain the normal involuntary
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function of the body. Although progress has been achieved in understanding the mechanisms and
functions of the ANS, there are still many problems in health and disease remained unknown.
Uncontrolled excessive vascular hyporeactivity in septic shock is one of the critical
unsolved problems. Septic shock is a server hypotension that occurs during sepsis, a whole-body
inflammation. In the US, septic shock is the leading lethal symptom in ICU (Fitch and Gossage,
2002) that kills about 800,000 people annually (Goyette et al., 2004). The most characterized
symptom of the septic shock is persistent vasodilation and hypotension despite clinical treatment
with α-adrenergic receptor agonist or intravenous fluids. Indeed, the current clinical guideline to
manage the hypotension in septic shock heavily relies on α-adrenoceptor agonists including NE,
EPI, vasopressin, DA, and phenylephrine (PE) (Dellinger et al., 2013). However, these
vasoconstrictors are ineffective to reverse the low blood pressure in septic shock. The
irreversible hypotension leads to hypoperfusion to pivotal organs, tissue hypoxia, multiple organ
failures, and death. Besides, the application of antibiotics causes bacterial cell lysis that induces a
release of more septic pathogens to the blood stream and worsens the symptom (Lepper et al.,
2002). The pathophysiology of the septic shock is not completely understood, especially the
uncontrolled vasodilation throughout the body. Therefore, understanding the mechanism
underlying the excessive hypotension in septic shock is significant and critical for an effective
clinical management.
Another unsolved problem related to the cardiovascular system is the primary function of
the endothelium, which has been studied for over a century. The endothelium is considered as
the largest tissue in the body (Endemann and Schiffrin, 2004). It resembles the endocrine system
in addition to being a barrier between blood and other tissues. The acknowledged function of the
endothelium is to release vasoactive substances leading to vasoconstriction and vasodilation.
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How the non-excitable ECs respond to direct activation per se and how they selectively release
vasoactive substances are unclear. This is mainly because of limited accessibility to the
endothelium. Therefore, effectively approach and test the endothelium is highly significant to
understand their primary function.
Breathing activity in health and disease is another essential function regulated by the
ANS, which has not been understood well. For example, the mechanism of the lethal breathing
disorder in RTT remains unknown. With high disability rate and high unexpected death rate,
RTT is a severe neurodevelopmental disorder (Kerr et al., 1997) that occurs one out of every
10,000 female worldwide. Indeed, over 25% of RTT patients die of unexplained causes (Kerr et
al., 1997). This high sudden death rate is mostly attributed to the respiratory disorder, such as
episodic apnea, hyperventilation, and air swallowing (Glaze, 2005). Although it does not lead to
death in some patients, the breathing disorder may cause further brain damage, which in turn,
contributes to multiple brain dysfunction. Meanwhile, the breathing abnormalities are difficult to
be monitored and corrected in RTT patients, especially when the patients are little.
Although RTT has an equal prevalence of amyotrophic lateral sclerosis, Huntington’s and
cystic fibrosis, it is recognized only 25 years ago and poorly studies because of underfunding in
comparison to other disorders. So far there is no cure beyond symptomatic and supportive, which
is often ineffective. Therefore, understanding the cellular and molecular mechanism of breathing
and breathing disorder in RTT is clinically significant. The results of the proposed experiments
will enrich the database of mechanism and regulation in breathing under both physiological and
pathological RTT conditions, and thereby improve the deterioration of neuronal dysfunction and
decrease sudden death in RTT patients.
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4
4.1

EXPERIMENTS

Animals
All animal procedures were conducted in accordance with the National Institutes of

Health Guidelines for the Care and Use of Laboratory Animals and approved by the Georgia
State University Institutional Animal Care and Use Committee.
4.1.1 Rats
Male Sprague-Dawley rats, ~300-400 g in body weight were purchased from Charles
River Laboratories for mesenteric artery ring preparation and tension measurement.
4.1.2 Mice
4.1.2.1 Transgenic mice with ChR expression in endothelium
Transgenic cdh5-ChR mice with fluorescence labeled endothelium were generated by
mating the cdh5 promoter-driven Cre mice (B6.FVBTg(Cdh5-Cre)7Mlia/J, Stock No. 006137;
Jackson Laboratory) and ChR-loxP mice (B6; 129S-Gt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J,
Stock No.012569; Jackson Laboratory).
4.1.2.2 Double transgenic RRT mice with ChR expression in LC
The following mouse lines were used for the breeding of double transgenic mice :
TH::IRES-cre (Jackson Laboratory, stock number: 008601, strain name: B6.Cg-Tg(Thcre)1Tmd/J) (Lindeberg et al., 2004), ChR-loxP, which is ChR-eYFP downstream of a floxed
STOP cassette (Jackson Laboratory, stock number: 012569, strain name: B6;129SGt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J) (Madisen et al., 2012), female heterozygous
Mecp2+/− mice (Strain name: B6.129P2(C)-Mecp tm1.1Bird/J; Stock number 003890) (Guy et al.,
2001). The TH::IRES-cre mice were cross-bred with the ChR-loxP mice to produce single
transgenic TH-ChR mice. The TH-ChR mice then were cross-bred with female Mecp2+/− mice to
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generate double transgenic TH-ChR-Mecp2−/Y. All experiments were performed in double
transgenic hemizygous Mecp2-null males (TH-ChR-Mecp2−/Y) and control males (TH-ChR).
4.1.2.3 Genotyping
Genotyping were done with PCR using punched ear or tail tissue and suggested primers
from Jackson Laboratory.
4.2

Mesenteric arterial septic shock model preparation
Male Sprague–Dawley rats were anesthetized by inhalation of saturated isoflurane. Under

sterilized condition, mesenteric arteries were dissected in ice-cold phosphate buffer solution
(PBS) (containing in mM: 137.0 NaCl, 2.7, KCl, 10 Na2HPO4, 2 KH2PO4). The secondary and
tertiary mesenteric arteries were cut into 6-8 rings of 3-4 mm in length. The rings were then
transferred into the Dulbecco's Modified Eagle Medium (DMEM, Cellgro, Manassas, VA) with
4.5 g/L glucose, 10% fetal bovine serum (FBS) and 2% penicillin–streptomycin (Cellgro,
Herndon, VA). The rings were cultured in the DMEM for 20 h in a CO2 incubator at 37 °C with
5% CO2. Before culture, 1 μg/ml LPS (from Escherichia coli 0127:B8, Sigma, St. Louis, MO)
was added into one Petri dish with 3 rings, and another 3 rings in a separate Petri dish without
LPS served as sham control. ED rings were also used in which the endothelium was removed by
rolling the rings on tweezers for 4-5 times back and forth. The success of endothelium
denudation was accepted if the ring lost > 80% relaxation to ACh (10−6 M) after PE (10−4 M)
pre-contraction.
4.3

Blood vessel tension measurement
The cultured mesenteric artery rings were mounted on a 6-channel force-electricity

transducer (i-DAQ-4 Data Acquisition System, Globaltown Microtech, Sarasota, FL) in 3 ml 37
°C water organ bath perfused with Krebs solution (containing in mM: 118.0 NaCl, 25.0
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NaHCO3, 3.6 KCl, 1.2 MgSO4, 1.2 KH2PO4, 11.0 glucose, and 2.5 CaCl2), gassed with 95% O2
and 5% CO2. Before the experiment, the rings were given a 0.4 g pre-load and equilibrated for 30
min. The vitality of control rings and septic model rings was confirmed with the vasoconstriction
to PE at a dose from 10−9 to 10−4 M. The hyporeactivity to PE was accepted when the rings lost
80% contractility after LPS treatment in comparison to the sham control. Otherwise, the
preparation was considered as a failure and rejected for further studies. Another criterion of
variability of the ring preparation was the response to high dose KCl (60mM) at the end of each
experiment, indicating the intact of contractile machinery of VSMs in both control and LPStreated groups.
4.4

Histology of ChR labeled Endothelium in Multiple Organs
Heart and kidney from cdh5-ChR and wild type (WT) mice were fixed in 1%

paraformaldehyde at room temperature for over 4 hrs and then dehydrated in 30% sucrose in
PBS at 4 °C for 24 hrs. Fixed tissues were embedded in the Tissue-Tek OCT Compound
(Andwin Scientific, Torrance, CA), and cut into 8-10 μm slices by using the Microm HM 550
Cryostats system (Thermo Scientific, PA). Dura mater was peeled off from the inner side of skull
and mount on glassed slices directly. YFP fluorescence was detected with 514/527 nm
(excitation/emission wavelength) filters under the microscope (Carl Zeiss, Gottingen, Germany).
4.5

Acute dissociation of ECs
ECs were acutely dissociated from aorta obtained from both cdh5-ChR and WT mice by

enzymatic dissociation for 10-15 min at 37 ̊C using neutral protease (8 U/ml, obtained from
Sigma, St. Louis, MO) and elastase (2 U/ml, Worthington, Lakewood, NJ, USA) mg/ml in the
following digestion buffer (in mM): 138 NaCl, 5 KCl, 1.5 MgCl2, 0.42 Na2HPO4, 0.44 NaH2PO4,
0.1 CaCl2, 10 HEPES, 4.2 NaHCO3 and 0.3% BSA. This was followed by a 1-2 min 37 ̊C
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incubation with collagenase type IA (120 U/ml, obtained from Sigma, St. Louis, MO). The tissue
segments were then washed with digestion buffer and gently triturated with a fire-polished glass
pipettes. The trituration solution containing ECs was dropped on a Petri dish coated with poly-Llysine (Sigma, P8920) and easily identified via fluorescence microscopy.
4.6

Electrophysiology on acute dissociated ECs
Dissociated ECs were placed in the recording chamber and identified by YFP

fluorescence using the same microscope set up as described under histology section. Whole-cell
currents and membrane potentials of the dissociated ECs were recorded at room temperature in
the voltage and current clamp mode, respective. Recorded signals were amplified with an
Axopatch 200B amplifier (Molecular Devices, Union City, CA), digitized at 10 kHz, filtered at 2
kHz, and collected with the Clampex 10 data acquisition software (Molecular Devices, Union
City, CA). The patch pipettes with the resistance of 4-6 MΩ were made with 1.2 mm borosilicate
glass capillaries (Sutter Instrument CO., Novato, CA). The optical stimulation was delivered by
using a xenon arc lamp with high-speed switcher (Lambda DG-4, Sutter Instruments, Novato,
CA). The light source was connected to the incident-light illuminator port of the microscope, and
passed through a 470 nm bandpass filter (~20 mW/mm2). Light pulse trains were generated with
the Digitimer D4030 pulse generator (Digitimer Ltd, Letchworth Garden City, UK). The solution
applied to the bath contained (in mM) 130.0 NaCl, 10.0 KCl, 1.0 MgCl2, 1.5 CaCl2, 10.0
glucose, 10.0 HEPES, and 3.0 NaOH (pH 7.4). The internal (pipette) solution contained (in mM)
10.0 KCl, 133.0 K-gluconate, 5.0 EGTA, 5.0 glucose, 1.0 K2-ATP, 0.5 Na-ADP, and 10.0
HEPES (pH 7.4), and the final Mg2+ concentration was adjusted to 1 mM using a [Ca2+] / [Mg2+]
calculation software Maxchelator (Chris Patton, Stanford University, Pacific Grove, CA).
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4.7

Langendorff Heart perfusion
Coronary circulation resistance was studied in the Langendorff isolated and perfused

heart preparation. The heart and lungs were entirely removed from terminally euthanized mice,
and placed in the ice-cold Krebs-Henseleit (KH) solution containing (in mM): 119 NaCl, 4.7
KCl, 2.5 MgSO4, 2.5 CaCl2, 10 glucose, 0.5 disodium EDTA, 25 NaHCO3. All of pulmonary
arteries and veins were tightened by cotton thread followed by removal of lungs. Then a cannula
was inserted into the ascending aorta connected to the perfusion apparatus. This cannula is
attached to the outflow of a reservoir containing an oxygenated KH solution, maintained at > ~35
°C, and continuously gassed with 5% CO2 and 95% O2. The perfusion solution was delivered to
coronary arteries in the retrograde direction through the aorta. For each heart, the hydrostatic
pressure (80 cm H2O) and perfusion speed at 0.2 - 0.4 ml/min was determined with a calibrated
roller pump (Syringe Pump, Farmingdale, NY, NE-300, NE-4000). The perfusate exited the
coronary venous circulation through the coronary sinus in the open vena cava. The viability of
the isolated and perfused heart was assessed by its spontaneous beating (> 250 beats/min),
coronary vasoconstriction to 10-5 M PE and 60 mM KCl, and coronary vasodilation response to
the β receptor agonist isoproterenol (Isop, 10-5 M).
4.8

Renal perfusion
Kidneys from both cdh5-ChR and WT mice were isolated, cannulated through the renal

arteries, and perfused at a constant rate (0.2-0.4 ml/min at baseline) with KH solution at 37 °C as
described above. The viability of the isolated and perfused kidneys was assessed by the renal
vascular response to 10-5 M PE, 10-5 M Isop and 60 mM KCl.
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4.9

Immunohistochemistry
Double transgenic mice, TH-ChR-Mecp2−/Y, at seven weeks of age were anesthetized

with inhalation of saturated isoflurane and transcardially perfused with 0.9% saline and 4% (w/v)
paraformaldehyde sequentially. Then the brain was removed, and the transverse pontine sections
(30-40 μm) were cut from the brainstem on a cryostat (Leica, Wetzlar, Germany).
Catecholaminergic neurons in both LC and medullary areas were labeled with anti-dopamine
beta-hydroxylase (DBH, red) and anti-GFP (green) antibodies that also detect YFP. Briefly, the
frozen sections were incubated with primary GFP/YFP monoclonal antibodies (1:400, life
technologies) and anti-DBH (1:1000, sigma), followed by AF488 conjugate donkey anti-mouse
(1:400, life technologies) and biotin conjugate goat anti-rabbit (1:400, Sigma) secondary
antibodies. Finally, the slides were treated with Texas Red-conjugated antibody (1:400, Jackson
ImmunoResearch), followed with dehydration. After mounted with 2,2'-Thiodiethanol (Sigma),
the fluorescence images were taken with a LSM 510 Zeiss confocal microscope (Jena,
Germany).
4.10 Plethysmograph
Breathing activity was recorded from conscious mice of 4-5 weeks old without
anesthesia. The mice were kept in a plethysmograph chamber (~ 40 ml) with a same volume
reference chamber connected to the same gas source. Mouse breathing signals were
barometrically recorded continuously by measuring the pressure changes between the animal
chamber and a reference chamber with a force-electricity transducer (PanaVise Products, Inc.
Nevada). The chambers were constantly ventilated with air at a flow rate of 50 ml/min, and the
animal was allowed to stay in the chamber for 10 min to adapt to the chamber environment
before recording, followed by a recording of 20 minutes at room temperature. The signal was
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collected and analyzed with Clampfit software (Molecular Devices). The variability of breathing
frequency (f) was calculated as the division of standard deviation (SD) divided by arithmetic
mean of breathing interval. All of the SD and mean values were measured from at least 200
successive breathing cycles. Apnea (apneas / h) was counted only if a breathing cycle was longer
than two prior breathes.
4.11 Brain slice preparation and electrophysiology
Brain slices were prepared as described previously (Zhang et al., 2010). In brief, THChRMecp2−/Y and control mice at 4-6 week-old were anesthetized as described above. The brainstem
was obtained rapidly and placed in an ice-cold, sucrose-rich artificial cerebrospinal fluid (sucrose
aCSF) containing (in mM) 200 sucrose, 3 KCl, 2 CaCl2, 2 MgCl2, 26 NaHCO3, 1. 25 NaH2PO4
and 10 D-glucose. The solution was bubbled with 95% O2 and 5% CO2 (pH 7.40). Transverse
pontine sections (300 μm) containing the LC area and transverse medullary slices (200 μm)
containing the HNs were obtained using a vibratome (1000 Plus, Vibratome, St. Louis, MO).
The slices were transferred to normal aCSF in which the sucrose was substituted with 124 mM
NaCl, allowed to recover at 33°C for 1 h, and then kept at room temperature before being used
for recording.
One slice was transferred to a recording chamber that was perfused with oxygenated
aCSF at a rate of 2 ml/min and maintained at 32–35°C. LC neurons were identified as described
previously (Zhang et al., 2010). Whole-cell current clamp was performed in brain slices, and LC
neurons were patched. Sutter pipette puller (Model P-97, Novato, CA) was used to pull the patch
pipettes with a resistance of 3–5 MΩ. The pipette solution (in mM) contained 130 K-gluconate,
10 KCl, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP and 0.4 EGTA (pH 7. 3). The bath solution was
normal aCSF bubbled with 95% O2 and 5% CO2 (pH 7. 40). In one set of experiments, α-
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adrenoceptors were blocked by adding phentolamine (10 μM, Sigma) to the bath solution.
Recorded signals were amplified with an Axopatch 200B amplifier (Molecular Devices, Union
City, CA), digitized at 10 kHz, filtered at 1 kHz, and collected with the Clampex software. The
temperature was maintained at 33°C during recording by a dual automatic temperature control
(Warner Instruments).
4.12 Data Analysis
The relationship of contractile force with agent concentration was described using the
Hill equation: f = FMax/[1 + (EC50/x)h], where f is the contractile force, FMax is the maximum
contractile force, x is agent concentration, and h is the Hill coefficient.
Delayed excitation (DE) was described as the time delay of the first action potential at the
end of each hyperpolarization command, which was fit with a Boltzmann equation as normalized
D = 1 /{1 + exp [− (V − V½) / k]} where D is the delay period, V is the hyperpolarizing
membrane potential, V½ is the half-inactivation, and k is the slope factor.
Data are presented as the means ± S.E. The electrophysiological data were analyzed with
Clampfit 10.3 software. Data are presented as means ± SE. Differences were evaluated using
Student t-tests for a pair data, ANOVA for three groups or more, and Mann–Whitney U test for
breathing activity. Statistical significance was accepted if when P ≤ 0.05.
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5

RESULT 1: INTERVENTION TO VASCULAR TONES IN LPS INDUCED
VASODILATION MODEL

Published as Shuang Zhang, Ningren Cui, Shanshan Li, Lei Guo, Yang Wu, Daling Zhu
and Chun Jiang. Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.
Vascul Pharmacol. 2014 Jul;62(1): 15-23.

Note: Elsevier, the publisher of Vascular Pharmacology, automatically granted the authors the
permission for using article in a thesis and/or dissertation.
5.1

Abstract
Septic shock is a severe pathophysiologic condition characterized by vasodilation,

hypotension, hypoperfusion, tissue hypoxia, multiple organ failures and death. It is unclear what
causes the septic vasodilation that may result from general dysfunction of vascular smooth
muscles (VSMs) or selective disruption of vasomotor balances in VSMs. The latter could be due
to enhanced vasorelaxation and/or depressed vasoconstriction. Understanding these may lead to
pharmacological interventions to septic vasodilation. Therefore, we performed studies in isolated
and perfused mesenteric arterial rings. A 20-h exposure of the rings to LPS (1µg/ml) led to
hyporeactivity to PE. However, the responses of the LPS-treated rings to high concentrations of
KCl (60mM) and ATP remained comparable to control rings, suggesting that contractility of
VSMs is retained. The hyporeactivity was marginally affected by atropine, indomethacin and LNAME, suggesting that endothelium-dependent vasorelaxation does not play a major role. In
addition to PE, the LPS-treated rings were hyporeactive to dopamine, histamine and angiotensin
II. They showed intermediate hyporeactivity to the thromboxane-A2 receptor agonist U46619.
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Little hyporeactivity to endothelin-1 (ET-1), serotonin (5-HT) and vasopressin was found. ET-1induced vasoconstriction occurred without endothelium, whereas the effect of serotonin was
endothelium dependent. Although rings were hyporeactive to some of the vasopressors, their
vasoconstriction effects were significantly potentiated by PE co-application. Taken together,
these data suggest that the endotoxin-induced vasodilation may not result from general
dysfunction of VSMs, neither from the endothelium-dependent vasorelaxation. The promising
vascular response to various vasoconstrictors found in this study warrants further investigations
of therapeutic potentials of these agents.
5.2

Introduction
Approximately, 200,000 people die of severe sepsis or septic shock in the United States

each year (Angus et al., 2001; Martin et al., 2003). Septic shock is characterized by excessive
vasodilation and vascular hyporeactivity to vasoconstrictors, especially α-adrenergic receptor
agonists. The vascular response handicaps therapeutic interventions to vascular tones, leading to
uncontrolled hypotension, hypoperfusion, tissue hypoxia, multiple organ failures and death
(Dellinger et al., 2013; Vincent et al., 2006). Even the application of antibiotics is hindered by
the cascade of events, as the bacterial cell lysis induced by certain antibiotics leads to a release of
more septic pathogens such as LPS from Gem-negative bacteria to the blood stream (Lepper et
al., 2002). A treatment with LPS, also known as endotoxins, can produce most the features of the
cascade of events in sepsis, including the vascular hyporeactivity to α-adrenergic activators
(Medzhitov, 2001; O'Brien et al., 2001).
Interruption of the cascade of events in sepsis and endotoxemia relies on restoration or
management of vascular responsiveness to vasopressors, while it is unclear how LPS causes the
vascular hyporeactivity to vasoconstrictors. Such a vascular response may result from injuries to
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VSMCs or the contractile machineries in the cells leading to dysfunction of VSM contractility;
LPS may activate extensively the vasodilatory mechanisms disrupting the balance of
vasoconstriction versus vasodilation; alternatively, the regulation of the VSM by certain
vasoconstrictors may be impaired.
The understanding of how these potential cellular mechanisms contribute to the vascular
hyporeactivity in endotoxemia may lead to novel therapeutic interventions to septic shock. With
the belief, we performed these studies in isolated and perfused mesenteric arterial rings. Our
results suggest that the vascular hyporeactivity does not seem to result from general injuries to
VSM contractility, neither from the enhanced endothelium-dependent vasorelaxation.
Remarkably, we found that the regulation of the VSM by certain vasopressors appeared to be
disrupted. The disruption of vasoconstriction was selective for several vasoconstrictors.
Surprisingly, none of the vasopressors recommended in the current guidelines for management
of severe sepsis and septic shock produced effective vasoconstriction in our endotoxin model,
while none of the three promising vasopressors, ET-1, 5-HT, and TXA2 receptor agonist found in
our study has been considered for the treatment of septic shock.
5.3

Results

5.3.1 Hyporeactivity of mesenteric arterial rings to PE with LPS treatment
LPS is known to cause systemic hypotension and the vascular hyporeactivity to
circulating vasoconstrictors, both of which are characteristic symptoms of septic shock.
Therefore, endotoxins are ideal for the study of the vascular hyporeactivity although it may not
produce all clinical manifestations of sepsis (Deitch, 1998). To achieve reliable vascular
hyporeactivity and to demonstrate unambiguously its reversibility, we chose to use a high
concentration of LPS (1μg/ml) as described in our previous studies (Shi et al., 2010). An over-
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night exposure of the isolated mesenteric rings to LPS caused clear hyporeactivity to PE (Fig. 51). In response to a graded increase in PE concentrations, the endothelium-intact (EI) rings
cultured without LPS showed a concentration-dependent increase in contractility. An obvious
increase in the contractile force was seen with 10-7 M PE, and the maximum vasoconstriction
was reached at 10-5 M. In contrast, rings treated with LPS for the same period as for the sham
control failed to respond to PE at 10-7 M, and 10-5 M PE produced only a transient
vasoconstriction with the much smaller amplitude than that of the sham control rings (Fig. 5-1A).
When the contractile force was plotted against PE concentration, the concentration dependence
was observed in the control rings, which was described by the Hill equation with EC50 7 × 10-7
M (h = 1.1). The force-concentration relationship curve shifted to the right in rings treated with
LPS with EC50 3.3×10-6 M (h = 1.6) (Fig. 5-1B). Meanwhile the mean maximal force response to
PE was decreased from 0.74 g to 0.18 g (Fig. 5-1B). The difference in the contractile force at the
concentration of 10-6 M PE was statistically significant between these two groups of rings (P <
0.01, n = 20). Therefore, the vascular hyporeactivity to PE was produced by LPS under our
experimental condition.
5.3.2 The effect of LPS on contractile capability of the VSM
One potential mechanism for the vascular hyporeactivity is the injury to VSM contractile
capability or even to the cell viability caused by endotoxins. To test the viability of VSM
contractile machineries, vasoconstrictions were produced by high concentrations of K+ and
certain ionotropic receptor ligands that are independent of the conventional circulating
vasoconstrictors and membrane receptors. Surprisingly, we found that rings treated with LPS
responded to high concentration of KCl (60mM) very well, even though they showed marked
hyporeactivity to PE and histamine, another vasoconstrictor inducing hyperactivity in LPS-
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treated rings (Fig. 5-2A). There was no significant difference in contraction forces between these
LPS-treated rings and the sham controls indeed (P > 0.05, n = 12) (Fig. 5-2C). Pinacidil was
applied as a vasodilator to confirm the capability of vasodilation is maintained in both control
and LPS-treated groups. In EI rings, the application of pinacidil (10-5 M) after vasoconstriction
completely relaxed both control and endotoxin treated mesenteric arterial rings to the precontraction level, which was also observed with 1 μM ACh.
ATP is a natural ligand of the purine receptors including P2X and P2Y receptors. The
P2X receptors are ionotropic and permeable to cations non-selectively. Previous studies have
shown that ATP produces vasoconstriction by acting on the P2X receptors (Li et al., 2011). We
found that the vasoconstrictive effect of ATP was not compromised by the LPS treatment.
Instead, the LPS-treated rings showed even stronger vasoconstriction response to ATP than the
control group (Fig. 5-2B,D). These results indicate that the constriction capability of the isolated
mesenteric rings is still retained when the vascular hyporeactivity to PE has developed after the
LPS treatment. Therefore, it is unlikely that the vascular hyporeactivity with LPS exposure
results from injuries of the VSM cells or their contractile machineries.
5.3.3 Contribution of endothelium-dependent relaxation
Although vasodilation can be produced by several circulating hormones, they are either
absent, or present in very low concentrations, in isolated mesenteric rings. Thus, the major
vasodilators should be those originated from endothelial cells in our in vitro preparation. NO is a
strong vasodilator released from the endothelium. A 10-min treatment of rings with the NO
synthase inhibitor L-NAME (100 μM, 10 min) did not have any effect on the LPS-induced
vascular hyporeactivity (Fig. 5-3A,B). Similar results were obtained with the cyclooxygenase
inhibitor indomethacin (10 μM, 10 min) and the muscarinic receptor blocker atropine (0.5 μM,
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10 min) (Fig. 5-3B), suggesting that the endothelium-dependent vasodilators do not play a major
role in the LPS-induced vascular hyporeactivity. To strengthen these findings, experiments were
performed in endothelium-denuded (ED) rings. Mechanical removal of endothelium followed by
LPS exposure (1 µg/ml, 20 h) did not affect the hyporeactivity, although the ED rings had
slightly higher contractile response to PE than EI rings with or without LPS treatment (Fig. 53C,D). In the ED rings, the PE induced vasoconstriction curve was shifted rightward with EC50 5
× 10-7 M (h = 1.0) in control group compared to the LPS group with EC50 3 × 10-6 M (h = 1.8,
Table 5-1). The EC50 was not affected by removing endothelium when compared to those in EI
rings. These results suggest that the endotoxin-induced vascular hyporeactivity cannot be
attributed to the vasodilators released from the endothelium.
5.3.4 Responses of mesenteric arterial rings to various vasoconstrictors with endotoxin
exposure
Several circulating hormones, neurotransmitters and local mediators have
vasoconstriction effects. Some of the vasoconstrictors such as epinephrine and norepinephrine
may be involved in the maintenance of basal vascular tones under normal conditions. An
inadequate response of the VSM to these vasopressors may lead to hypotension and shock. Since
several different cellular mechanisms can be activated by the vasoconstrictors to produce VSM
contractions, it is possible that endotoxin exposure may cause the vascular hyporeactivity to
some of the vasoconstrictors, and allow the mesenteric arteries to respond to the others. To test
this possibility, we screened all known vasoconstrictors whose pharmacological agents are
available commercially.
Similar to PE, histamine (Hist), Ang II, and dopamine produced much smaller, or not at
all, vasoconstriction after LPS treatment, suggesting that the mesenteric rings become

69

hyporeactive to these vasoconstrictors. We compared the effect of all of vasoconstrictors in both
control and endotoxin groups under the concentration at or near to their EC50 in LPS-treated
group (Fig. 5-6C). EC50 and h value for dopamine, Hist, and Ang II are listed in Table 5-1.
ET-1 is a peptide vasoconstrictor that activates both endothelin A (ETA) and endothelin B
(ETB) receptors (Rubanyi and Polokoff, 1994). Strikingly, we found that ET-1 remained to
produce strong vasoconstriction in the mesenteric rings treated with LPS (Fig. 5-4A, B). When
the contractility was compared between the LPS-treated rings and the sham controls, we found
that LPS had no significant effect on the maximum contractile force although the EC50 increased
from 5×10-8 M (h = 1.0) to 8×10-8 M (h = 1.2) (Fig. 5-4B; Fig. 5-6C,D). Endothelium had very
little contribution to the ET-1 mediated vasoconstriction, as similar contractility was observed in
ED rings with and without LPS treatment (Fig. 5-4C,D; Fig. 5-6C,D). In ED rings, EC50 of
vasoconstriction curve induced by ET-1 increased from 5×10-8 M (h = 1.2) in control group to
1.4×10-7 M (h = 1.4) in LPS-treated group (Table 5-1). In addition, the mean maximal force in
response to ET-1 was even increased slightly from 1.82 g in control group to 1.88 g in LPStreated group (Fig. 5-4B).
5-HT is another vasoconstrictor acting on the resistant arteries of cerebral, coronary and
pulmonary circulations (Faraci and Heistad, 1990; Lamping et al., 1989; MacLean et al., 2000).
Rings with LPS treatment did not show obvious hyporeactivity to 5-HT (Fig. 5-5A). No
significant changes in the maximum constriction were observed (P > 0.05) except a slight
increase in EC50 from 9×10-7 M (h = 1.5) to 1.2×10-6 M (h = 1.6, Fig. 5-5B, Table 5-1). Unlike
ET-1, the effect of 5-HT relied partially on endothelium, as ED rings showed a marked reduction
in their contractility after LPS exposure (Fig. 5-5C,D; Fig. 5-6C,D). EC50 in control group was
increased from 7×10-7 M (h = 1.3) to 1.4×10-6 M (h = 1.5, Fig. 5-5D, Table 5-1). No evident
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hyporeactivity to arginine vasopressin (AVP) was found in LPS-treated rings (EC50 2.5×10-9 M
were same in both control and endotoxin groups, but h value was increased from 1.2 to 1.8).
Meanwhile the maximal vasoconstriction in control rings was increased from 0.06 g to 0.09 g in
LPS-treated rings. Nevertheless, further studies were not attempted because of AVP triggered
weak vasoconstrictive effect (Fig. 5-6D).
The mesenteric ring response to the TXA2 receptor agonist U46619 was retained by over
70% with an EC50 increase from 1.3×10-8 M (h = 1.2) to 4.5×10-8 M (h = 1.2) after LPS treatment
(Fig. 5-6 A,B), suggesting an intermediate hyporeactivity to the TXA2 receptor agonist.
5.3.5 Vascular reactivity to a combined application of PE with another vasoconstrictor
Since some of the vasoconstrictors were used together with PE in septic therapies, we
also examined their joint effects on the vascular hyporeactivity. PE (10-9 to 10-4 M) was
combined with ET-1 (10-10 to 10-6 M), 5-HT (10-9 to 10-4 M), dopamine (10-6 to 10-2 M), Hist
(10-7 to 10-2 M), Ang II (10-9 to 10-5 M), AVP (10-9 to 10-5 M), U46619 (10-10 to 10-6 M). Each
combination was applied to both control and LPS-treated rings. At the concentration for the
maximal vasoconstriction under the control condition without LPS, the ring response to the
combined application of the vasoconstrictors was smaller than, or similar to, the arithmetic
addition of two individual responses to the vasoconstrictors (not shown). When the joint effects
under endotoxin-induced conditions were compared with those of the control, interestingly, only
Hist/PE showed significant hyporeactivity (Fig. 5-7), suggesting a potential approach to reverse
the endotoxin-induced vascular hyporeactivity by a joint application of these vasoconstrictors
with PE.
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5.3.6 Vasoconstriction signaling pathways of ET-1 and 5-HT
ET-1 activates multiple signaling systems. To dissect the ET-1 signaling for mesenteric
arterial constriction, responses of mesenteric rings to ET-1 were compared in the presence versus
absence of various blockers targeting specific signaling pathway. There are two ET receptors,
ETAR and ETBR. The ET-1 induced vasoconstriction was significantly suppressed by BQ-123,
an ETAR antagonist, but not by BQ-788, an ETBR antagonist (Fig. 5-8A1-A3). The ET-1
signaling was inhibited by pertussis toxin suggesting the involvement of Gi/o – AC – PKA
signaling pathway (Fig. 5-8A4). The ET-1 effects were mostly eliminated by the blocker of the
phosphatidylcholine-specific phospholipase C (PC-PLC, D609) (Adibhatla et al., 2012) but not
the blocker of inositol triphosphate specific phospholipase C (PI-PLC, U73122) (Zizzo et al.,
2006). Interestingly, the protein kinase C inhibitor Calphostin C did not inhibit the ET-1
vasoconstriction (Fig. 5-8A5-A7). Also, the ROK pathway does not seem to be involved as the
ROK inhibitor Y27632 had no significant effect on the ET-1 vasoconstriction (Fig. 5-8A8).
Serotonin receptors 5-HT1BR, 5-HT2AR and 5-HT2BR are the major serotonergic players
in vasculatures (Monassier et al., 2010). These metabotropic receptors produce their functions by
activating Gi/o and Gq/11 proteins. Using a similar approach as above, we found all of these 5-HT
receptors were involved in mesenteric constriction by activating Gi/o – AC – PKA pathway and
the Gq/11 – PC-PLC – Calphostin C-insensitive signaling pathway (Fig. 5-8B1-B6). In addition,
the ROK pathway appeared to play a role that is known to be activated by 5-HT2AR (Fig. 5-8B7).
5.4

Discussion
Excessive vasodilations are seen in several types of shock, while most of them can be

controlled by α–adrenoceptor agonists or intravenous fluids (Laffon et al., 1999). None of these
treatments, however, is effective for septic shock. The systemic hypotension and vascular
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hyporeactvity to α-adrenergic agonists are found in the rat model with LPS injection (Bermejo et
al., 2003; Cena et al., 2010). The vascular hyporeactivity is likely due to 1) poor response of the
resistance arteries to vasopressors, and 2) refractory hypotension that hinders the blood pressure
response to intravenous fluid resuscitation. As a result, the uncontrolled vasodilation develops in
sepsis, leading to hypotension, hypoperfusion, tissue hypoxia, acidosis, multiple organ
dysfunction and death. These two events may link to each other, as the hyporeactivity to
circulating vasopressors can drastically compromise the vasomotor function, impair the
myogenic autoregulation of basal vessel tones, reduce blood perfusion to several vital organs
including the heart, decrease cardiac output, and resist to intravenous infusion. Therefore, the
hyporeactivity of resistance arteries to vasoconstrictors is a critical event in septic shock, and
better therapeutical interventions to the hyporeactivity are needed for the management of septic
shock.
The management of septic shock could be very challenging if septic pathogens caused
injuries to VSM cells. This is not simply a theoretical concern because accumulating
experimental evidence indicates that several apoptotic events are initiated by endotoxins in both
VSMs and endothelium (van Geel et al., 2000). The consequences of VSM cell apoptosis would
be the impairment of contractility and vasodilation. Indeed, the cell injury hypothesis has been
proposed to explain the excessive vasodilation and hyporeactivity in sepsis (Bannerman and
Goldblum, 2003; Tesse et al., 2005). In the present study, we have found that the contractile
capability of mesenteric arterial rings does not seem to be disrupted in 20-h endotoxin exposure.
In rings that showed clear hyporeactivity to PE, a high concentration of KCl (60 mM) produces
vasoconstriction as strongly as in the control rings, indicating that the VSM contractility is not
lost. Consistent with this finding, the P2X receptor ligand ATP produces a similar level of
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vasoconstriction with or without LPS treatment. It is known that high concentrations of
extracellular K+ bring about depolarization, and raise intracellular Ca2+ to initiate filament sliding
and muscle contraction, while the activation of P2X receptors tends to have similar effect to a
smaller degree though (Bean, 1992; Ganitkevich and Isenberg, 1991). Therefore, it is very likely
that the filament-based contractile machineries remain functional during a 20-h endotoxin
exposure when severe hyporeactivity to PE takes place in mesenteric arteries. Thus there must be
other underlying mechanisms for vascular hyporeactivity.
The maintenance of the VSM contractile capability in endotoxin exposure is an
encouraging finding, which motivated us to examine potential regulatory mechanisms for the
hyporeactivity. Our results suggest that the endotoxin-induced vascular hyporeactivity cannot be
attributed to the vasodilators released by local endothelium. NO is a powerful vasodilator, which
has been shown to play a role in septic vasodilation (Pedoto et al., 1998). In the presence of LNAME, however, the mesenteric rings show clear hyporeactivity to PE, suggesting that locally
released NO may not be a major player in the endotoxemic vascular hyporeactivity. Several
prostaglandins have vasodilatory effects, including PGI2, PGE1 and PGE2, arachidonic acid
products catalyzed by COX (Mollace et al., 2005). Inhibition of COX1 and COX2 with the COX
inhibitor indomethacin does not alleviate the endotoxemic hyporeactivity. The hyporeactivity is
not affected by prevention of endothelium from being activated by muscarinic acetylcholine
receptor using atropine either. Consistent with these observations, the hyporeactivity remains
after the endothelium is mostly removed in ED rings. These results strongly suggest that the
vascular hyporeactivity may not result from the release of vasodilators from the endothelium in
local vasculature, although these results do not exclude the possibility that endothelium may be
involved in the regulation of basal vascular tones as well as the vascular responses to exogenous
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vasoactive substances in endotoxin exposure. In addition, by taking advantage of this ex vivo
vascular model, our results may rule out the involvement of the circulating hormones and
cellular metabolites in the LPS-induced vasodilation.
Our results indicate that several vasoconstrictors are spared from the hyporeactivity,
although the mesenteric arteries are hyporeactive to many other vasoconstrictors after the rings
were treated with LPS. ET-1 produces strong vasoconstriction that is barely affected by
endotoxins. Endothelium is not critical for the ET-1 effect as no clear hyporeactivity is seen in
ED rings treated with LPS. 5-HT is another strong vasoconstrictor for the mesenteric rings. Its
vasoconstricting effect is not diminished by endotoxins when endothelium is intact. The rings are
not hyporeactive to AVP either, although its effect on mesenteric vasoconstriction is only
modest. In addition, the TXA2 receptor agonist U46619 is capable of constricting the LPStreated mesenteric rings by >70% of the control level in comparison to PE (10-20%). Agonists of
the ET-1, 5-HT and TXA2 receptors are commercially available (Green et al., 1981; Hassid,
1984; Watts, 2010) ; they have been widely studied in-vitro and in-vivo (Bender and Klabunde,
2007; Tanaka et al., 2004; Xie et al., 2012); their side-effects are largely known (Bonsi et al.,
2007; Ohkubo et al., 1996; Prasanna et al., 2001); and their effective concentrations for
vasoconstriction are relatively low (Matsumoto et al., 2010; Takata et al., 1999; Zhou et al.,
2006). Therefore, it is possible that some of them may turn out to be effective vasoconstrictive
agents for the treatment of septic shock if these novel findings in the present study are confirmed
by further studies.
None of ET-1 and 5-HT has been used as effective vasoconstricting agents for septic
shock. Currently, norepinephrine, phenylephrine, dopamine, epinephrine, and vasopressin (as
well its analogue terlipressin) are the only five vasopressors available for the treatment of septic
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shock in the United States (Ferguson-Myrthil, 2012). Serum ET-1 concentrations increase in
sepsis (Huribal et al., 1995). A previous study has shown that the nonselective endothelin
receptor antagonist TAK-044 improves renal hemodynamics and renal function in endotoxemia
(Mitaka et al., 1999). Because of this finding, more attention has been paid to endothelin receptor
antagonists (Gardiner et al., 2001; Krejci et al., 2003). 5-HT has been studied under normal
condition as a vasoconstrictor, acting on the resistant arteries of cerebral, coronary and
pulmonary circulations (Faraci and Heistad, 1990; Lamping et al., 1989; MacLean et al., 2000).
Experimental evidence indicates that 5-HT plays a role in regulating pulmonary circulation in
sepsis (Spapen and Vincken, 1992), and its effect on vasculatures relies on NO and endothelium
(Mostefai et al., 2008). Our data suggest that in rat mesenteric arteries ET-1 acts on the Gi – AC
– PKA and Gq/11 – PC-PLC – DAG – PKC signaling systems through ETAR. In addition to these
two signaling pathways, 5-HT seems to activate ROK through 5-HT1BR leading to inhibition of
the MLCP and vasoconstriction (Fig. 5-8C).
The demonstration that the mesenteric arteries are capable of maintaining their responses
to certain vasoconstrictors in endotoxin exposure is promising, as this finding encourages further
research for more potent and effective vasoconstrictors with little, or not at all, hyporeactivity in
sepsis. As a result, new and more effective therapeutical modalities for the treatment of septic
shock may be discovered. Therefore, our findings in the present study may have impact beyond
the demonstration of a few vasoconstrictors effective for the control of endotoxin-induced
vasodilation.
Since many of the natural counterparts of the vasoconstrictors that we have studied exist
in the circulation or local tissues, they may play a role not only as an individual but also as
combination. Also, multiple vasopressors have been used in combination to treat septic shock
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(Meidan et al., 1992). Thus, we have examined the joint application of two vasoconstrictors in
the control of endotoxin-induced vasodilation. The rings are hyporeactive to some
vasoconstrictors such as PE, U46619, Hist and Ang II with LPS treatment. When the joint
contractile forces are compared, the mesenteric arteries are hyporeactive only to Hist/PE, while
all other vasoconstrictors produce vasoconstriction as potent as their effects on control rings.
High dose dopamine induced vessel tissue damaged so that we did not perform the combination
experiment on it. These results suggest that a joint application of these agents with PE may help
to achieve better vasoconstriction in endotoxin exposure and perhaps sepsis as well.
In conclusion, three potential mechanisms have been studied in the endotoxin-induced
vascular hyporeactivity. The vascular hyporeactivity does not seem to be a result of general
injuries to VSM contractility, neither the endothelium-dependent vasorelaxation. Instead, the
regulation of the VSM by certain vasoconstrictors appears to be disrupted, while the mesenteric
arteries respond very well to other vasoconstrictors. The disruption of vascular responses to
selective vasoconstrictors including α-adrenergic agonists used widely in the control of the
excessive vasodilation in septic shock indicates the necessity to consider alternative agents for
shock control, while the demonstration of the vasoconstriction to certain vasopressors in the
present study suggests that the alternative therapeutic approaches are highly feasible.
5.5
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Table 5.1 EC50 and h values for various vasoconstrictors.
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Figure 5-1 The hyporeactivity of mesenteric rings to α-adrenergic agonist in endotoxin
exposure.
A. Concentration-dependent vasoconstrictions are clearly seen in the control ring (upper) with
PE (10-9 to 10-4 M). The same PE exposure had rather weak effect on the mesenteric ring treated
with LPS (1µg/ml) overnight (lower). Both control and LPS-treated rings in each set
comparative experiment, cultured in the same condition for 20 h except LPS, and treated in the
same way during the experiment. Lower trace is sharing same label with the upper trace. B. The
contractility of the rings is a function of PE concentrations. The relationship of the contractile
force vs. PE concentration can be described by the Hill equation with EC50 7×10-7 M and h 1.1
for the control group (n=12), and 3.3×10-6 M and h 1.6 for LPS treated rings (n=12),
respectively. Data are presented as means ± S.E.
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Figure 5-2 VSM contractile capability in endotoxin exposure.
A. Parallel comparisons of the contractility of cultured mesenteric rings with and without LPS
treatment. While the contractile force was developed well in the control ring (upper) in response
to PE or histamine plus PE, the LPS-treated ring showed marked hyporesponsiveness to both
vasoconstriction treatments (lower). Despite this, the LPS-treated ring responded to high
concentration KCl (60 mM) as strongly as the control ring. Pin, pinacidil, a vasodilator. Note
that there is a gap of 45 min between two arrows. B. Similar studies on the vasoconstriction
effect of ATP, the natural agonist of P2X receptor. Although the LPS-treated ring was
hyporeactive to PE, its vasoconstriction responses to ATP and KCl did not show any reductions.
Instead, the contractility of the LPS-treated ring was slightly stronger than the control. C.
Statistically, no significant difference in contractile forces was found between the LPS-treated
and control rings (P > 0.05, n = 12). D. No clear reduction in contractile force in the LPStreated rings in response to ATP (10-3 M) either (P > 0.05, n = 6).
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Figure 5-3 Endothelium-derived vasodilators.
A. A treatment with the NOS inhibitor L-NAME (100 μM) for 10 min did not eliminate mesenteric
arterial hyporeactivity to PE. B. Significant reduction in the vascular response to PE was seen in
the LPS-treated rings in the presence of L-NAME. The hyporeactivity existed in the presence of
the muscarinic receptor antagonist atropine (0.5 μM) and the nonselective COX inhibitor
indomethacin (10 μM) as well. **, P<0.01 (n =14 to 27). C. The mesenteric ring remained
hyporeactive to PE after the endothelium was removed mostly as evidenced by the lack of
response to Ach. D. The force-PE concentration relationships in the ED rings were comparable
to those shown in Fig. 5-1B.
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Figure 5-4 Lack of hyporesponsiveness to ET-1 in endotoxin exposure.
A. In EI rings, ET-1 exposures produced strong vasoconstrictions in presence and absence of
LPS in the culture media. B. Concentration-response curves of ET-1 in LPS-pretreated rings
resemble that in control rings. See Table 1 for the EC50 and h values (n=6). C,D. Similar effects
of ET-1 were observed in ED rings.
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Figure 5-5 5-HT in the endotoxin-induced hyporeactivity.
A,B. Concentration-dependent vasoconstrictions were found with 5-HT (10-9 to 10-5 M) with or
without LPS treatment in EI rings. C,D. The contractility of mesenteric rings in response to 5-HT
(10-9 to 10-5 M) was reduced after endothelium was removed from the rings before tissue culture.
See Table 1 for the EC50 and h values.
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Figure 5-6 Responses of mesenteric rings to various vasoconstrictors.
A,B. The ring responses to the TXA2 receptor agonist U46619 (10-10 to 10-5 M) were reduced
only moderately with the LPS treatment. C. The LPS exposure caused significant reductions in
the vascular responses to PE, U46619, Hist, dopamine (DA) and Ang II in EI rings. The ED
rings were significantly hyporeactive to 5-HT. D. Concentration-responses curves of AVP in
control and LPS-treated groups. *, P<0.05; **, P<0.01 (n= 4 to 38).
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Figure 5-7 Effects of joint application of two vasopressors on the hyporeactivity.
A. Although the LPS-treated ring was hyporeactive to PE, its responses to a joint application of
U46619 (10-10 to 10-6) and PE (10-9 to 10-5) resembled those of the control ring. B. Comparison
of the joint effect between the control and LPS group. Significant hyporeactivity was found only
to the Hist/PE group.
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Figure 5-8 Dissection of cellular signaling systems for mesenteric constriction by ET-1 and 5HT.
A1-A8. Comparison of vasoconstriction in the presence versus absence of blockers. BQ-123,
ETAR antagonist; BQ-788, ETBR antagonist; PTX, pertussis toxin, a Gi/o protein inhibitor; D609,
PC-PLC inhibitor; U73122, PI-PLC inhibitor; Y27332, Rho kinase inhibitor. Numbers in
parentheses are inhibitor concentrations. B1-B7. Effect of blockade of 5-HT signaling on
vasoconstriction. Ketanserin, 5-HT2AR antagonist; SB206553, 5-HT2B/2CR antagonist;
GR127935, 5-HT1BR antagonist. C. Schematic cellular signaling pathways for ET-1 and 5-HT in
the mesenteric arterial smooth muscles. Players in parentheses are 2nd messengers that are
commonly accepted in the pathway. All others are supported by our data.

87

6

RESULT 2: OPTOGENETIC INTERVENTION TO THE VASCULAR
ENDOTHELIUM

Published as Shuang Zhang, Ningren Cui, Yang Wu, Weiwei Zhong, Christopher M.
Johnson, Jiang C. Vascul Pharmacol. Optogenetic intervention to the vascular endothelium.
Vascul Pharmacol. 2015 Nov;74: 122-9.

Note: Elsevier, the publisher of Vascular Pharmacology, automatically granted the authors the
permission for using article in a thesis and/or dissertation.

6.1

Abstract
Endothelium lining the interior of cardiovascular system and most visceral organs plays

an important role in vascular function. Its dysfunction occurs in some of the most challenging
diseases. An important function of the endothelium is to release vasoactive substances that act on
the smooth muscle to change vascular tones. Substance secretion from endocrine cells relies on
membrane potentials and firing activity, while it is unclear whether the membrane potential
regulates substance release from the ECs. Understanding of this requires selective intervention to
membrane potentials of the endothelial cells in situ. Here we show a novel intervention to
endothelial cells using the optogenetic approach. A strain of transgenic mice was developed with
the Cre-loxP recombination system. These transgenic mice expressed channelrhodopsin (ChR) in
endothelial cells driven by the vascular endothelial cadherin or cdh5 promoter. Linked in a
tandem with YFP, the ChR expression was detected by YFP fluorescence in various
endothelium-lining tissues and organs. The YFP fluorescence was observed in the lumen of
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blood vessels and pericardium, but not in tissues beneath the endothelium lining.
Optostimulation of dissociated endothelial cells evoked inward currents and depolarization. In
the isolated and perfused heart, surprisingly, optostimulation of endothelial cells produced fast,
robust, reproducible and long-lasting vasoconstriction that was not blocked by either ET-1A or
TXA2 receptor antagonist. Similar optical vasoconstriction was found in the isolated and
perfused kidney. These results indicate that the optogenetics is an effective intervention to
vascular endothelium where optostimulation produces vasoconstriction.
6.2

Introduction
Endothelium, a single layer of cell lining in the cardiovascular system, lymph vessels and

several internal organs, plays a critical role in vascular function including substance exchange,
vascular tone regulation, angiogenesis and thrombosis (Lerman and Zeiher, 2005). Endothelial
dysfunction contributes to several cardiovascular diseases such as hypertension, shock, stroke
and diabetic vascular complications (Endemann and Schiffrin, 2004).
The endothelium is a major tissue with approximately 1013 cells in an adult human (Cines
et al., 1998), a number that is 100 times more than all neurons in the brain. The endothelium
tissue not only is a mechanical barrier between blood and other tissues, but also resembles the
endocrine system (Inagami et al., 1995). Indeed, a prominent function of ECs is to release
vasoactive substances that act on the SM to produce vasoconstriction or vasodilation,
maintaining a homeostatic state of vascular tones under different conditions. How the ECs
selectively release vasodilators or vasoconstrictors is unclear.
Most endocrine cells are excitable, which secrete hormones and transmitters via
depolarization and firing activity (Lowe et al., 1988). In contrast, ECs are nonexcitable. Whether
the membrane potential regulates substance release from the ECs remains elusive. It is known
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that the membrane potential can affect a number of ion channels, transporters, intracellular Ca2+,
intracellular pH, etc. Activity of these molecules can in turn change cellular functions. Therefore,
it is reasonable to believe that depolarization can affect the endothelium function. If such an
assumption is proven correct, then it would be possible to reveal whether the endothelial
depolarization results in vasodilation or vasoconstriction. To address these issues, novel methods
are needed to selectively intervene to the membrane potentials of ECs when they remain
interacting with vascular SM in situ, which will help to understand EC function in vascular tone
regulation, and may have impacts on therapeutic designs for several cardiovascular diseases.
The successful development of optogenetics in neuroscience research (Boyden et al.,
2005; Nagel et al., 2005) provides a unique way to access the endothelial membrane potentials
with light. Generally, the optogenetics is a combination of genetics, electrophysiology and optics
to control well-defined events within specific cells of living tissue by expressing an opsin in the
cells. This approach allows to control membrane potentials and excitability of the opsinexpressing cells, which has been achieved in various types of neurons (Williams and Deisseroth,
2013), glia (Figueiredo et al., 2011), myocardium (Arrenberg et al., 2010), skeletal muscle cells
(Sakar et al., 2012) and the vascular smooth muscle (Wu et al., 2015).
To demonstrate whether the EC function can be manipulated by optogenetics, we
developed a new strain of mice that expressed channelrhodopsin (ChR) in ECs. The expression
of ChR was detected in the lumen of blood vessels from multiple organs. Characteristics of
optoactivation of ECs, including membrane excitability and vasomotor reactivity, were studied
in the heart and kidney using combined optostimulation and traditional physiological techniques.
Surprisingly, our results indicated that optostimulation of ECs can produce fast, reproducible,
long-lasting vasoconstriction that is comparable in strength to the popular vasoconstrictor PE.
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6.3

Results

6.3.1 Generation of transgenic mice with ChR expression in ECs
To achieve endothelial expression of ChR, we took the advantage of two strains of
commercially available mice, cdh5 promoter-driven Cre mice (B6.FVB-Tg(Cdh5-Cre)7Mlia/J,
Stock No. 006137; JaxMice) (Alva et al., 2006) and ChR-loxP mice (B6; 129SGt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J, Stock No.012569; JaxMice) (Madisen et al., 2012),
to generate a new strain of transgenic mice driven by the cdh5 promoter. The cdh5 is gene
encoding VE-cadherin, also known as cadherin 5 or CD144, expressed mainly in endothelium.
The cdh5 promoter has been previously demonstrated in adult/quiescent endothelium (Gory et
al., 1999; Hisatsune et al., 2005), and also successfully used to direct EC-specific expression of
several genes (Liu et al., 2013). Therefore, we employed the homozygous cdh5-Cre mice to
cross-bred with heterozygotous ChR-loxP mice. Fifty percentage of their offspring mice were
tested positive for both Cre and ChR-loxP expression (Fig. 6-1B), suggesting that these cdh5ChR mice have gained the expression of ChR as a result of the Cre-loxP mediated crossover.
6.3.2 Expression of ChR-eYFP in the endothelium
The expression of ChR was indicated by YFP fluorescence as it was fused to a tandem
protein (Fig. 6-1A). Indeed, the Cre and ChR-loxP positive mice showed strong YFP
fluorescence on the luminal side of the aorta, pulmonary artery and coronary artery (Fig. 62A,B). In the transverse section of the heart, YFP fluorescence was detected in the surface
pericardium and interior blood vessels, while the myocardia did not show YFP fluorescence (Fig.
6-2C). A large number of blood vessels in the dura matter of the brain were YFP-positive (Fig.
6-2D). In the transverse section of the kidney, glomeruli, arcuate artery, and interlobular artery
were also fluorescent in cdh5-ChR mice (Fig 6-2E). In mesentery membrane from cdh5-ChR,
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both of vein and artery were clearly seen fluorescent (Fig. 6-2F). In contrast, such YFP
fluorescence was not seen in any of these tissues obtained from the WT mice (Fig 6-2G-L).
6.3.3 Effects of ChR activation on membrane potentials and ionic currents in acutely
dissociated ECs
The presence of YFP fluorescence in a variety of blood vessels suggests that ChR is
expressed in ECs. To demonstrate that is indeed the case, we performed functional studies of
ionic currents in acutely dissociated ECs. In voltage clamp, ECs from WT mice showed wholecell currents that did not respond to optostimulation (Fig. 6-3A). In ECs obtained from cdh5-ChR
mice, optostimulation at 10, 50 and 100 ms of blue light (470 nm) produced an inward current
(Fig. 6-3B). The amplitude of this current was large at hyperpolarizing membrane potential,
decreased with depolarization, and reversed its polarity when the membrane potentials were
more positive than 0mV. The current showed almost no adaptation with long-lasting
optostimulation (Fig. 6-3C). In I/V plot, the current showed a weak inward rectification with a
reversal potential at -10mV (Fig. 6-3D). Activation of this current led to strong depolarization of
the ECs, which averaged by -15.2 mV from baseline at -45.3 ± 11.6 mV (n=4) (Fig. 6-3E,F). The
optical depolarization was also seen in longer time optostimulation up to 50 and 100 ms (Data
are not shown).
6.3.4 Contraction of coronary arteries by optostimulation in isolated and perfused hearts
The large inward current and depolarization produced by optostimulation should have
impacts on endothelial function and vascular tones. To reveal the functional consequences of the
optostimulation, we studied the coronary circulation in the Langendorff heart preparation. The
specificity of optostimulation was tested with both blue (470 ± 40 nm) and yellow light (602 ±
70 nm). Only blue light triggered significant vasoconstriction, but not yellow light (Fig. 6-4A,B).
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When the heart was exposed to blue light covering either left or right coronary arteries on
ventricle, the resistance of coronary circulating increased markedly with perfusion pressure
changes by 23.5 ± 6.9 cm H2O (n=5), indicating coronary vasoconstriction (Fig. 6-4C,E). The
light beam covered main left coronary artery, left circumflex branch, left anterior descending
branch, left marginal artery and great cardiac vein on the left side of ventricle. On the right
ventricle surface, the light beams covered main coronary artery and major branches, including
conus arteriosus branch, right anterior ventricular and right marginal arteries, and anterior and
small cardiac veins. No obvious different responses were seen between the left and right optical
approaches to the heart ventricle. The heart rate and pulse pressure were not affected by
optostimulation (Fig. 6-4 C,G). The coronary vasoconstriction by optostimulation was nicely
reproducible with repetitive light exposures, and showed no adaption with a long optostimulation
up to 6 min (Fig. 6-4C). Interestingly, a prior exposure to PE (10-5 M) or Isop (10-5 M) largely
diminished the coronary vasoconstriction by optostimulation, suggesting that they may share the
same ionic mechanisms in the SM. In comparison, the optostimulation produced coronary
vasoconstriction to the degree that was comparable to 10-5 M PE (26.0 ± 9.1 cm H2O, n=4) and
60 mM KCl (24.2 ± 7.9 cm H2O, n=4) with no significant difference (P > 0.05, Fig. 6-4C,E). The
coronary vasoconstriction by optostimulation had fast time response with the onset and offset
time to be ~ 10 sec (Fig 4F). Such coronary vasoconstriction was not found in WT heart when it
was exposed to the same light stimulation (Fig. 6-4D).
6.3.5 Optical vasoconstriction in isolated and perfused kidney
Optostimulation also produced vasoconstriction in the renal circulation. When blue light
was applied to the surface of the isolated and perfused kidney. In the kidney, repetitive
optostimulations gave rise to repetitive increases in the perfusion pressure (13.9 ± 3.3 cm H2O,

93

n=9) with no clear adaptions (Fig. 6-5A). The optostimulation-induced renal vasoconstriction
was significantly reduced when vasoconstriction was induced by PE (10-5 M) (Fig 5A). It was
partially recovered when the effect of PE largely declined (Fig. 6-5A). The onset and offset times
of the optical vasoconstriction was similar to those in the heart (11-14 sec) (Fig. 6-5C). The
optical vasoconstriction was reproducible without marked adaptation (Fig. 6-5A,D). Compared
to the vasoconstriction produced by 10-5 M PE (110.0 ± 35.2 cm H2O) and 60 mM KCl (84.9 ±
20.9cm H2O), the optical vasoconstriction of the renal circulation was significantly smaller (P <
0.001, freedom=11 and 14, separately). In contrast, optostimulation did not induce any response
in the circulation resistance of WT kidney (Fig. 6-5C).
6.3.6 Mechanism underlying optostimulaiton induced vasoconstriction
To address the underlying mechanism, two preeminent endothelium-derived
vasoconstrictors, ET-1 and TXA2 were tested in perfused hearts of cdh5-ChR mice. In the
presence of the ET-1A receptor blocker BQ-123 (10-6 M), blue light produced the same levels of
vasoconstriction (Fig. 6-6 A,B). The vasoconstriction by optostimulation was not attenuated with
the TXA2 receptor antagonist SQ-29548 (10-6 M) either (Fig. 6-6 C,D). Therefore, the
optostimulation-induced vasoconstriction does not seem to be mediated by these two
vasoconstrictors released from endothelium.
6.4

Discussion
To our knowledge this is the first report demonstrating the application of optogenetics to

the endothelium tissue. By taking the advantage of Cre-LoxP recombination system, we created
a new strain of mice that express ChR in ECs directed by the cdh5 promoter. In the cdh5-ChR
mice, we observed YFP expression in ECs from various tissues and organs. Our functional
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assays indicated that photo currents and depolarization can be produced in ECs, and
optostimulation evokes vasoconstriction in the heart and the kidney.
Several tissue-specific promoters have previously been used to direct gene expression in
ECs, such as Tie-1 and Tie-2-, PECAM, Flk-1, and SCL (Gothert et al., 2005; Gustafsson et al.,
2001; Kisanuki et al., 2001; Licht et al., 2004; Terry et al., 1997). Although EC expression of
desired genes are reported, unexpected expression has been found in these transgenic lines
including hematopoietic lineages and other cell types (Alva et al., 2006). Such non-specific
expression limits their transgenic applications, although they were widely used for gene
deletions. Thus, more selective promoters are needed to generate transgenic models with specific
expression in differentiated endothelium.
Cadherin-5 (Cdh5 or CD-144), a transmembrane glycoprotein, is an essential player in
the morphogenesis of the vascular system, modulation of blood flow, vascular endothelial
growth factor (VEGF) signaling, and vascular permeability in a variety of tissues (Carmeliet et
al., 1999; Corada et al., 2001; Venkiteswaran et al., 2002). The cdh5 promoter has been
characterized in adult/quiescent endothelium, and used to introduce specific gene expression in
ECs (Alva et al., 2006). The success of EC-specific expression thus has led to the generation of
mice with Cre recombinase expression in endothelium (Alva et al., 2006), which is now
commercially available (Jackson lab). These mice have also been successfully used to modify
gene expressions previously (Fioret et al., 2014; Guo et al., 2008). By taking the advantage of the
cdh5-Cre mouse strain and another commercially available ChR-loxP strain, we have generated a
new strain of mice. This strain of cdh5-ChR mice expresses ChR in a tandem with YFP. Fifty
percent offspring (cdh5-ChR) of the mating pair of cdh5-Cre and ChR-loxP mice showed both

95

Cre (100 bp) and ChR-EYFP (212 bp) bands without any detectable physical and behavioral
abnormalities.
Our morphological studies have shown that YFP fluorescence is detected in various
tissues and organs. The YFP fluorescence is observed in the luminal lining of arteries including
the aortic, pulmonary, coronary, renal, mesenteric and basilar arteries. It is also seen in renal,
dura, skeletal muscle veins as well as pericardium and mesentery. Therefore, the cdh5-ChR mice
appear to express ChR as expected.
These YFP positive ECs indeed express ChRs. Direct activation of these cationic
channels with 470 nm blue light in acute dissociated ECs evokes large and long-lasting inward
currents in voltage clamp with reversal potential at -10mV consistent to the cationic permeability
of the ChR. The photo currents show moderate inward rectification in the I-V plot with no clear
adaptation/inactivation in response to prolonged light exposure up to 100 ms. In current clamp,
optostimulation produces depolarization of the ECs. These electrophysiological studies indicate
that functional ChR is expressed in ECs obtained from the cdh5-ChR mice.
Consistent with the expression of ChR in ECs, we have found that the optostimulation
increases perfusion resistance in coronary and renal circulation in isolated organs from the cdh5ChR mice. This optostimulation is specific for blue light that activates ChR, and optical
vasoconstriction is produced in organs obtained from cdh5-ChR mice but not from the WT. This
suggests that the optical vasoconstriction is not produced by endogenous photo-sensitive
mechanisms. It is known that in addition to endothelium, cdh5 is expressed in other cells
including certain blood cells (Alva et al., 2006). The possibility of blood cell involvement may
largely be ruled out in our in-vitro organ perfusion, because the blood cells are mostly removed
in the preparations, and because the blood cells tend to release vasodilators rather
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vasoconstrictors. This light-produced vasoconstriction in heart and kidney is fast, reproducible
and long-lasting with no obvious decline in perfusion resistance in 6 min. This optical
vasoconstriction in coronary circulation is as strong as the popular clinical vasoconstrictor PE at
high concentration (10-5 M) and 60mM KCl. In the isolated kidney, the optical vasoconstriction
is less potent than both of that produced by 10-5 M PE and 60 mM KCl, which is likely to be a
result from the high expression level of α1 adrenoceptor and poor transparency of the organ.
In the heart, only can a part of coronary circulation (~ 30 % of surface area of the whole
heart) be illuminated by the light beam during experiments. Despite that, optostimulation still
produces potent vasoconstriction, which is comparable to that produced by 10-5 M PE or 60mM
KCl in the heart. In addition to the robust response, this optogenetic method also provides a high
temporal precision. The onset and offset time constant are short, within 11s in heart and 14s in
kidney. This spatial and temporal performance of optostimulation on ECs in isolated and
perfused organs seems to allow a selective access and manipulation of ECs with the optogenetic
approach.
We have realized some limitations of the optostimulation in the perfused organs: 1) The
tissue transparency is limited, especially in the isolated kidney. 2) Not all sections of blood
vessels can be covered by the light beam with ~ 3 mm in diameter and 20 mW/mm2 in strength.
With the limited light penetration, therefore, the optostimulation seems to be effective only in the
vessels on or near to the surface of the organ.
What produces the optical vasoconstriction is still unclear, which may involve several
potentials mechanisms. Optostimulation may increase the release of endothelium-derived
vasoconstrictors from ECs, such as ET-1, which is a peptide, while most peptide hormones and
transmitters are packed in vesicles inside the cell. The vesicle release is a Ca2+-dependent process
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that usually occurs with depolarization. Other vasoconstrictors including TXA2 and
hydroxyeicosatetraenoic acids are lipid metabolites. Their productions are more important in
their biological effects than the releasing mechanism. It is possible that some of their
biosynthetic and degradative enzymes are affected by certain events associated with
depolarization. Our results suggest that neither ET-1 nor TXA2 seems to play a major role in
optical vasoconstriction, as the optical vasoconstriction remains when their receptor antagonists
are present in the perfusion solution.
A decreased release of endothelium-derived vasodilators from ECs may be attributable as
well, including NO, prostacyclin, and 11,12-epoxyeicosatrienoic acids. The release and
production of these endothelium-derived vasodilators are regulated by several endotheliumtargeting substances such as acetylcholine, bradykinin and histamine. How these molecules are
affected by membrane potentials, and whether a decreased release of the endothelium-derived
vasodilators occurs with optostimulation are still not clear. K+ is a potential player too, which
can be released from ECs by optical depolarization, and subsequently produces depolarization of
the SM. Another possibility is the gap junction between ECs and SM cells, with which the light
induced EC depolarization may be coupled to the SM leading depolarization and
vasoconstriction. Testing these possibilities requires systematic studies including screening
potential contributors, pinpointing the critical players and elaborating their action mechanisms,
Clearly this is a major undertaking that cannot be accomplished in the present study.
Nevertheless, the demonstration of the feasibility of optoactivation of ECs in the present study
appears to affirm a powerful approach for further investigation of the vasoconstriction produced
by depolarization.
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The application of optogenetics to endothelium may have several implications on future
research and therapeutical agent tests. 1) This method may allow researchers to identify
endothelium-derived substances in situ without introducing any receptor agonists/antagonists
that tend to have widespread effects on vasculatures and nearby tissues. 2) The high temporal
and spatial precision may provide a new way to approach local ECs lining the vasculature
without systematical administration of drugs. 3) The local optostimulation-induced
vasoconstriction may be helpful to manipulate the interaction among ECs, SM cells, and immune
cells, as well as certain substances, including endothelium derived factors/mediators and
cytokines. 4) The optical manipulation of ECs may be useful to control the EC dysfunction,
vascular growth and inflammation that are known to participate in cardiovascular pathogenesis.
5) Beyond cardiovascular field, the accuracy in specific location of optical stimulation could be
used to reveal the mechanism of neuron-pericyte-vasculature coupling in certain brain area, as
neurons regulating homeostatic function may require constant blood supplies. 6) The activation
of ECs may affect the permeability of the capillary endothelium (Frohlich, 2002), helping drugs
to pass through certain tissue barriers such as the blood brain barrier and placenta barrier, which
may have impact on drug delivery. We expect that all of these potential applications of the
optical activation of ECs to develop and expand rapidly when further investigations take place.
In conclusion, the present study demonstrates a novel intervention to vascular ECs. This
method is based on newly developed optogenetics and the availability to transgenic mice, and
allows us to express selectively ChR in ECs. Positive ChR expression is identified with YFP
fluorescence in the endothelial lining in various tissues. Optostimulation of the ECs that express
ChR triggers large inward currents, leading to depolarization. In isolated and perfused organs,
optostimulation produces vasoconstriction that is vigorous, reproducible and sustained. These
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results indicate that the optogenetics in the endothelium seems to be a powerful intervention to
the cardiovascular system.
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Figure 6-1 Generation of cdh5-ChR transgenic mice.
A. Construction pattern of parental cdh5-Cre and ChR-loxP mice as well as their expected
offspring that express both Cre and ChR2-eYFP. In the presence of Cre recombinase, the stop
codon flanked by loxP (solid triangle) in the ChR-loxP mouse will be removed, resulting in
expression of the ChR2-eYFP in a tandem driven by the CAG promoter in cdh5-ChR mice. Note
that arrows indicate primers for genotyping with expected PCR fragment shown below. B.
Primers targeted at the 3' UTR of ChR2-eYFP produced a 212 bp PCR product, and primers
targeted at the Cre open-reading frame yielded a 100 bp. The presence of both 212 bp and 100
bp bands indicated positive Cre-loxP recombination producing the cdh5-ChR strain, while cdh5Cre and ChR-loxP mice have only the 100 bp and 212 bp bands, respectively. Note that a ~300
bp non-specific band was found in all mice. Abbreviations: CAG, cytomegalovirus-immediateearly (CMV-IE) enhancer/chicken β-actin/rabbit β -globin hybrid promoter; PolyA, bovine
growth hormone polyadenylation signal and flippase recognition target flanked
phosphoglycerate kinase-Neo-polyA cassette; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
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Figure 6-2 YFP fluorescence in various tissues and organs in cdh5-ChR (left column) and
WT mice (right column).
In cdh5-ChR mice, strong fluorescence was seen on lumen side of aorta (A,B), pulmonary artery
(PA) (A) and coronary artery (CA) (B). YFP fluorescence was also seen in pericardium (C),
blood vessels in dura mater (D), renal arcuate artery (E), glomerulus (E), mesenteric artery (F)
and mesenteric vein (F). In contrast, YFP fluorescence was not observed in these tissues and
organs from WT mice (G-L). Scale bar is 10 µm.
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Figure 6-3 Optical excitation of acutely dissociated ECs from aorta.
A. Whole-cell currents were recorded from an EC from a WT mouse in voltage clamp. Light
stimulation (10 ms) did not produce any change of membrane currents. Steps of voltage
commands (from -100 to 40 with a 10 mV increment) were applied to the cell at a holding
potential of -70 mV. B. Optostimulation with 10 ms pulses of blue light (470 nm) to an EC from a
cdh5-ChR mouse evoked inward currents. The amplitude of this current decreased with
depolarization, and reversed its polarity when the membrane potentials were more positive than
0mV. The photo currents decayed slowly after turning off the light, which are better seen in the
expanded display on the right panel. C. The inward photo currents responding to longer
durations (50 and 100 ms) of blue light stimulations showed almost no reduction in current
amplitudes. D. Current-voltage (I-V) relationship of the photo currents showed a reversal
potential at -10 mV with moderate inward rectification. E. In current clamp, blue light
stimulation produced strong depolarization in an EC from cdh-ChR mouse. F. Optostimulation
produced significant depolarization. Data are presented as means ± SE (*, P<0.05, Student’s ttest; n=4 cells).
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Figure 6-4 Optical vasoconstriction of coronary arteries by optostimulation.
A,B. In isolated and perfused hearts from cdh5-ChR mice, significant coronary constriction was
produced by blue light stimulation (470 nm), but not by yellow light (602 nm). C. Coronary
constriction was produced by optostimulation followed by PE and isoproterenol (Isop)
treatments. The optical coronary vasoconstriction was strong, long-lasting, reproducible with
repetitive optostimulation, and did not cause evident changes in heart rate and pulse pressure.
The latter both were augmented by Isop. Heart rate and pulse pressure were indicated by arrows
toward the enlarged pattern on the bottom of the figure. D. Optostimulation did not produce any
vasoconstriction in a heart from WT mouse. E. In the perfused heart from cdh5-ChR mouse, the
optical vasoconstriction with ~20 mW/mm2 blue light was competitive comparing to that
produced by 10-5 M PE and 60 mM KCl. F. The optostimulation triggered fast response in heart
perfusion with onset and offset time less than 11s. G. Optical vasoconstriction had no significant
effect on heart rate.
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Figure 6-5 Optical vasoconstriction in isolated kidney.
A. Blue light produced vasoconstriction in the kidney obtained from a cdh5-ChR mouse but not
that from a WT mouse (B). C. The optostimulation has fast onset and offset (10-14s). D.
Repetitive blue light stimulation produced up to 114.7% vasoconstriction in perfused kidney
from cdh5-ChR mouse with slight decline in the amplitude. Blue light intensity is ~20 mW/mm2
and stimulation duration is 2 min with 5 min interval.
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Figure 6-6 Effects of ET-1A and TXA2 receptor antagonists on optical vasoconstriction.
A,B. In isolated and perfused hearts from cdh5-ChR mice, coronary constriction was produced
by blue light stimulation. The optical vasoconstriction remained in the presence of the ET-1A
receptor antagonist BQ-123 (10-6 M). C, D. The optical vasoconstriction was not suppressed by
the TXA2 receptor antagonist SQ-29548 (10-6 M) either. Data are presented as means ± SE (n =
3 hearts, P > 0.05). Note that there is a gap of 10 min in A.
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7.1

Abstract
Rett Syndrome (RTT) is a neurodevelopmental disorder affecting multiple functions,

including the norepinephrine (NE) system. In the CNS, NE is mostly produced by neurons in the
locus coeruleus (LC) where defects in intrinsic neuronal properties, NE biosynthetic enzymes,
neuronal CO2 sensitivity and synaptic currents have been reported in mouse models of RTT. The
LC neurons in Mecp2-null mice show a high rate of spontaneous firing, while whether such
hyperexcitability may increase or decrease the NE release from synapses is unknown. To activate
the NE-ergic axonal terminals selectively, we generated an optogenetic mouse model of RTT
where NE-ergic neuronal excitability can be manipulated with light. Using commercially
available mouse breeders, we produced a new strain of double transgenic mice with Mecp2
knockout and channelrhodopsin knock-in in catecholaminergic neurons. Several RTT-like
phenotypes were found in the TH-ChR-Mecp2−/Y mice, including hypoactivity, low body weight,
hind limb clasping, and breathing disorders. In brain slices, optostimulation produced
depolarization and an increase in the firing rate of LC neurons from TH-ChR control mice.
Optostimulation of presynaptic NE-ergic neurons augmented the firing rate of hypoglossal
neurons in TH-ChR control mice, which was blocked by the α-adrenoceptor antagonist
phentolamine. Such optostimulation of NE-ergic terminals had barely any effects on hypoglossal
neurons from two to three TH-ChR-Mecp2−/Y mice, indicating that excessive excitation of
presynaptic neurons does not benefit NE-ergic modulation in mice with Mecp2 disruption. Also,
these results demonstrate the feasibility to generate double transgenic mice for studies of RTT
using commercially available mice, which are inexpensive, labor / time-efficient, and promising
for cell-specific stimulation.
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7.2

Significance Statement
RTT is a neurodevelopmental disease that occurs in 1 in 10,000 live-birth females

globally. Over 25% of RTT patients die of unexplained causes, which is mostly attributable to
their respiratory disorders and autonomic dysfunction involving the NE-ergic system in the
brainstem. Thus, understanding the cellular mechanism for the abnormal NE-ergic system in
RTT models is clinically significant. One characteristic feature of the NE-ergic defects is
hyperexcitability in LC neurons, while the effect of the hyperexcitability on NE release is
unclear. Here we created a double transgenic mouse model that allowed accesses to LC neuronal
excitability with light. Our results suggest that the Mecp2 disruption appears to impair NE
release from axonal terminals, which cannot be compensated with extensive neuronal excitation.
7.3

Introduction
Rett Syndrome (RTT) is a neurodevelopmental disorder seen in 1 of every 10,000 female

births. The disease affects multiple functions and systems including the norepinephrine (NE)
system. As a result of the NE defect, people with RTT have breathing abnormalities and other
autonomic dysfunctions that are also found in mouse models of RTT with Mecp2 disruption (Julu
et al., 2001). In the CNS, NE is mainly produced by neurons in the locus coeruleus (LC). These
NE-ergic neurons in the LC project to the frontal cortex, hippocampus, cerebellum, spinal cord
and multiple brainstem nuclei, brain regions that are involved in regulation of cognition, attention,
anxiety, psychosis, motor control, and cardiorespiratory functions. Several previous studies have
shown that LC neurons in Mecp2−/Y mice have decreased NE biosynthesis enzymes, defective
intrinsic membrane properties, insufficient GABA synaptic inhibition, and increased excitability
(Zhang et al., 2010; Zhong et al., 2015).
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The NE content in the brainstem and whole-brain preparations is markedly reduced in
Mecp2−/Y mice compared to the WT mice (Ide et al., 2005; Viemari et al., 2005). The NE
metabolite 3-methoxy-4-hydroxyphenylethylene (MHPG) is low in the cerebrospinal fluid of RTT
patients (Zoghbi et al., 1985). The decreases in NE content and NE metabolites occur earlier and
appear more severe than changes in other neurotransmitters (Zoghbi et al., 1989). Application of
exogenous NE or NE uptake inhibitors improves respiratory rhythm, increases the number of THpositive neurons in the medulla, and extends the lifespan of Mecp2−/Y mice (Roux et al., 2007;
Villard and Roux, 2006; Zhang et al., 2011b).
The defect in the NE system is associated with LC neuronal hyperexcitability or the
increased firing rate, while their relationship is unclear. An increase in LC neuronal firing
activity would theoretically enhance the NE release from presynaptic terminals, whereas the poor
expression of TH and DBH may reduce NE biosynthesis in LC neurons hindering the effect of
neuronal excitability. Although the increased LC neuronal excitability may be a compensatory
response of LC neurons to the deficiency in NE production, whether such a process is indeed
beneficial to the NE-ergic modulation remains to be demonstrated. The understanding of these
problems relies on an animal model that carries the Mecp2 defect and allows an access to the
NE-ergic neuronal excitability. Therefore, we generate a new optogenetic mouse model of RTT
by targeting on catecholaminergic neurons using commercially available mouse breeders,
characterized several RTT-like phenotypes, and studied the NE-ergic neuronal modulation in
brain slices.
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7.4

Results

7.4.1 Generation of double transgenic mice
We took advantage of two strains of commercially available mice (TH-cre and ChR-loxP)
and generated transgenic mice with ChR expression in catecholaminergic neurons. The
heterozygous TH-ChR mice obtained were then used to cross-breed with heterozygous female
Mecp2+/− mice. A half of their female offspring carrying ChR−/− was excluded for further studies.
In the other half, mice with Mecp2+/Y and Mecp2+/− genotypes as well as ChR+/− were identified
(Fig. 7-1A,B). The male TH-ChR-Mecp2−/Y and TH-ChR-Mecp2+/Y or TH-ChR mice were chosen
as the experimental and control groups in the present study. In addition, a TH-ChR female was
used as control as well.
In comparison to the littermate control TH-ChR mice 21.6 ± 1.4 g during age four to nine
weeks old, the TH-ChR-Mecp2−/Y mice showed lower body weight 15.1 ± 0.9 g (P = 0.018
unpaired t-test). All double transgenic mice also exhibited hindlimb clasping, the characteristic
features found in several mouse models of RTT at five weeks. The Fig. 7-1C was taken at week
five. (Fig. 7-1C,D).
7.4.2 Morphological Evidence for YFP expression in LC neurons
YFP fluorescence was observed in LC neurons in brain slices obtained from either THChR mice or TH-ChR-Mecp2−/Y mice (Fig. 7-1E). Immunocytochemical studies showed that
nearly all YFP-positive neurons were also immunoreactive to DBH antibodies (Fig. 7-1F-G). YFP
expression was clearly seen in other brainstem areas including area postrema (Fig. 7-1J,K), which
can be identified in dark filed images (Fig. 7-1I).
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7.4.3 Breathing Abnormality (f variation, apnea count)
Several RTT-like breathing abnormalities have been found in Mecp2-null mice, including
high apnea rate and breathing frequency (f) variation (Viemari et al., 2005; Zhang et al., 2011b).
Both of these breathing abnormalities were observed in double transgenic TH-ChR-Mecp2−/Y
mice showing alternating periods of fast and slow respiratory frequency and a high rate of apnea
(Fig. 7-2A). Such breathing abnormalities were not seen in TH-ChR mice (Fig. 7-2B). Statistical
analysis of breathing f variation in controls 0.21 ± 0.03 vs. double transgenic mice 0.34 ± 0.03 (P
= 0.003 unpaired t-test) and apnea counts 0 vs. double transgenic mice 75.5 (P<0.001, U9,10 =
2.5, Mann-Whitney U test) in the same age mice indicated that both RTT-like symptoms were
significantly higher in the TH-ChR-Mecp2−/Y mice than in the TH-ChR (Fig. 7-2C,D).
7.4.4 Electrophysiological Recording from LC neurons in TH-ChR-Mecp2−/Y mice
To confirm the functional expression of ChR in LC neurons, we patched these cells and
exposed them to blue light (470nm) in brain slices in vitro. In whole-cell recording, these cells
from the TH-ChR and TH-ChR-Mecp2−/Y mice displayed depolarization in response to a 10 ms
optostimulation (Fig. 7-3A,B), and strong inward rectification (Fig. 7-3C). The depolarization
amplitude increased with hyperpolarizing pulses and decreased with depolarizing pulses indicating
that it was produced by non-selective cationic channels. Optostimulation also raised firing activity
in spontaneously firing LC neurons, consistent with the ChR expression in the cell (Fig. 7-3D).
The LC cells from TH-ChR-Mecp2−/Y mice exhibited typical membrane properties of LC
neurons in Mecp2-null mice. Delayed excitation (DE) was seen, which as one of most
characteristic properties of LC neurons occurs as delayed action potentials following
hyperpolarization (Fig. 7-4A). LC neurons in the TH-ChR-Mecp2−/Y mice had a V½ of 81.4 ± 5.4
mV (n=4 cells/2 mice), which was not significantly different from Mecp2-null mice, 78.4 ± 1.8
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mV (n=5 cells/3 mice) (P = 0.585 unpaired t-test, Fig. 7-4B,C). The slope factor of double
transgenic mice is 4.4 ± 1.0, which had no significant difference compared to Mecp2-null mice at
3.4 ± 0.8 (P = 0.43, unpaired t-test, Fig. 7-4D). The input resistance of TH-ChR-Mecp2−/Y mice
was 416.5 ± 46.3 MΩ (n=4 cells/2 mice) and 461.3 ± 46.18 MΩ (n=5 cells/3 mice) in Mecp2null mice, which were not significantly different (P = 0.606 unpaired t-test, Fig. 7-4E). The
Inward Rectification ratio of double transgenic mice 1.4 ± 0.1 was not significantly different
from Mecp2-null mice 2.0 ± 0.4 (P = 0.166, unpaired t-test, Fig. 7-4F). The spontaneous firing
frequency of TH-ChR-Mecp2−/Y mice was 4.3 ± 1.0 Hz (n=4 cells/2 mice) and 5.5 ± 0.8 Hz (n=5
cells/3 mice) (P = 0.361, unpaired t-test, Fig. 7-4G). The average resting membrane potential of
TH-ChR-Mecp2−/Y mice was -43.7 ± 1. mV (n=4 cells/2 mice) compared to -41.9 ± 1.0 mV in
Mecp2-null mice (n=5 cells/3 mouse) (P = 0.321, unpaired t-test, data not shown). Thus, our
results indicated that the introduction of the exogenous ChR protein did not alter the membrane
properties of LC cells in double transgenic mice.
7.4.5 Modulation of brain stem neurons by optostimulation of NE-ergic neurons
In our previous study, we have shown the postsynaptic modulation of hypoglossal
motoneurons (HNs) by norepinephrine (Jin et al., 2013). These neurons may remain to be
modulated in the medullary slice preparation as the NE-ergic neurons are found in area postrema
(Viemari et al., 2005). To determine how optostimulation of NE-ergic cells expressing ChR
modulates HNs, we recorded HNs while giving optostimulation to NE-ergic terminals. The HNs
in TH-ChR mice (n=9 cells/2 mice) showed typical properties as shown in previous studies such
as resting membrane potential -58.1 ± 1.2 mV, input resistance 56.4 ± 11.0 MΩ (n=9 cells/2 mice),
whole-cell capacitance 63.1 ± 8.3 pF, and display of a sag potential in response to hyperpolarizing
currents with an average of 18.3 ± 3.3 mV which was followed by post-inhibitory rebound (Fig.
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7-5A). The sag was defined as the difference between the peak voltage during the current injection
and the steady-state voltage. HNs did not show delayed excitation (Fig. 7-5B) as LC neurons,
while displaying increased firing activity by each depolarizing pulse. The cells showed moderate
spike frequency adaptation (SFA), which is described as Fp/Fs ratio (Fig. 7-5C,D,E). In response
to the same depolarizing pulse, the firing rate of the first two action potentials at the peak state
(Fp) 48.5 ± 6.0 Hz was significantly higher than that at steady state (Fs) 34.4 ± 2.2 Hz (P = 0.043,
paired t-test, Fig. 7-5F)
HNs were typically silent at rest in brain slices except for one cell. Therefore, we measured
evoked firing activity of HNs by giving a depolarizing pulse at a level slightly above the firing
threshold. Firing activity of HNs was measured at baseline, during light stimulation, and without
light stimulation as washout. Light stimulation consisting of 20ms blue light pulses at 10 Hz
increased the evoked firing activity, which returned to baseline levels during washout when the
light was off (Fig. 7-6A, B). On average, the firing activity of these HNs in control TH-ChR mice
increased from baseline 8.4 ± 1.9 Hz (n=9 cells/2 mice) to 12.3 ± 1.5 Hz during light stimulation,
which was significantly increased (P = 0.003, paired t-test, Fig. 7-7C). Although optostimulation
augmented HN firing activity, the light did not produce any visible depolarization.
In our previous study, we have also shown that NE modulates HNs through postsynaptic
α-adrenoceptors. To determine if the effects of light stimulation were mediated through αadrenoceptors, HNs from control TH-ChR mice were measured during light stimulation in the
presence of the α-adrenoceptor antagonist phentolamine (10 μM). Light stimulation failed to
increase firing activity in the presence of phentolamine. The evoked firing rate was 9.1 ± 3.3 Hz
at baseline vs. 9.1 ± 3.5 Hz (n=4 cells/1 mouse) during optostimulation (Fig. 7-6C,D, Fig. 7-7D,
P = 0.985 paired t-test).
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7.4.6 Modulation of brain stem neurons by optostimulation of NE-ergic neurons in THChR-Mecp2−/Y Mice
The Mecp2 disruption in mice causes reductions in NE content (Roux et al., 2008). To
show how the NE-ergic synaptic terminals respond to optostimulation, we measured evoked
firing activity of HNs before, during and after light stimulation of presynaptic NE-ergic terminals
as mentioned above. The evoked firing rate of HNs from double transgenic mice was 10.2 ± 2.9
Hz (n=6 cells/2 mice) at baseline, which was not significantly different from controls (n=9
cells/2 mice, P = 0.908, unpaired t-test). Optostimulation augmented the firing rate of the HNs in
double transgenic mice modestly to 9.5 ± 3.7 Hz (Fig. 7-7A,B), which was not significantly
different from the baseline level (P = 0.595, paired t-test, Fig. 7-7E). In comparison to the THChR neurons (Fig. 7-7E), the average response of firing rate to light stimulation was significantly
lower in TH-ChR-Mecp2−/Y mice (-0.7 ± 1.6 Hz, n=6 cells/2 mice) than in control mice (3.8 ±
0.9 Hz, n=9 cells/2 mice; P = 0.01, unpaired t-test).
7.5

Discussion
We have shown the generation of a new double transgenic RTT mouse model with ChR-

eYFP expression in catecholaminergic neurons in this study. TH is a rate-limiting enzyme for
catecholamine synthesis. The TH promoter has been previously used to direct α-synuclein
expression in dopaminergic neurons to generate Parkinson’s disease model (Daher et al., 2009;
Richfield et al., 2002; Tofaris et al., 2006) and GFP expression in NE-ergic neurons (Lammel et
al., 2015; Wang et al., 2014). Consistently, our results indicate that ChR-eYFP is expressed in LC
neurons showing YFP fluorescence and functional ChR activity in our TH-ChR mice.
The mouse strain with the loxP ChR-eYFP was used in this study. The loxP ChR-eYFP
cassette was constructed in the ROSA26 locus known to be constitutively active, which is
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consistent with our finding that the heterozygous mice express ChR-eYFP. This as well as the fact
that the ROSA26 locus is located on chromosome 6, and the Mecp2 is on the X chromosome favors
the generation of double transgenic mice. Indeed, we have successfully obtained the TH-ChRMecp2‒/Y double transgenic mice with extensive mouse breeding and step-by-step genotyping. The
reasons for using the male mouse model are that 1) the Mecp2−/Y males offer a completely Mecp2null condition that is not always available in Mecp2+/− females owing to uncontrolled Xchromosome inactivation; 2) the male Mecp2−/Y mice have been widely used as a model of RTT,
and the results obtained from this model can be easily compared and evaluated with existing
literature.
The TH-ChR-Mecp2‒/Y mice exhibit typical phenotypes seen in other mouse models of
RTT, including hypoactivity, low body weight, short life span, and hind limb clasping. They also
show clear breathing disorders, including significant higher apnea counts and more frequent
breathing f variation than the TH-ChR control. Also similar to the existing mouse models of RTT
are the high infant fatality rate and short lifespan (not shown). Nevertheless, our breeding strategy
allows production of the TH-ChR-Mecp2‒/Y mice roughly in the same successful rate as other
mouse models of RTT that we have used.
The chance to get male double transgenic mice based on our breeding scheme is 12.5%.
We realized that the availability of the double transgenic mice limited the power analysis. It took
three to four months to generate F1 generation of double transgenic mice and the average litter
size was approximately 6 with 12.5% mutation ratio. This ratio can be enhanced to ~25% by
crossbreeding male TH-ChR and female TH-ChR-Mecp2‒/+ mice. The production rate and
sustainable generation of double transgenic mice suggest that these mice may provide another way
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to study RTT by targeting on specific neurons in central nervous system or certain tissues in
peripheral system as well.
Immunohistochemistry identification of catecholaminergic neurons with anti-YFP
antibodies in both pons and medulla were clearly seen while these neurons are exhibiting
endogenous genetically engineered fluorescence (Fig. 7-2). Further evaluation of ChR expression
indicates that ChR is fully functional in LC neurons in double transgenic mice, producing
depolarization and firing activity in the cells and NE-ergic modulation with blue light stimulation.
The knock-in of ChR in LC neurons did not alter intrinsic properties of LC neurons as well.
Therefore, this new strain of double transgenic mice, TH-ChR-Mecp2‒/Y, seems to allow access to
LC neurons with high specificity as well as excellent temporal and spatial resolutions.
One group of brainstem neurons targeted by NE modulation is the HNs. NE augments their
firing activity by pre- and post-synaptic mechanisms (Jin et al., 2013). Such an NE-ergic
modulation is defective in Mecp2-null mice, suggesting that HNs are ideal for testing NE
modulation in our TH-ChR-Mecp2‒/Y mice. However, the hypoglossal nucleus is located remotely
from the LC, making the joined brain slice studies of these two types of neurons very difficult, if
possible. Because of the existence of local NE-ergic neurons in the close vicinity of the hypoglossal
nucleus and because of the possibility of optostimulation of axonal terminals of NE-ergic neurons,
we have tested the NE-ergic modulation of HNs by optostimulation of NE release in this study. In
TH-ChR mice, the HNs firing activity is clearly augmented with optostimulation. Such an effect
was not seen in the presence of the non-selective α-adrenoceptors antagonist phentolamine,
indicating that HNs are modulated by NE through α-adrenoceptors. Notably, the HNs became
silent during washout, which seems due to residual NE modulation that is suppressed by
phentolamine.
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In TH-ChR-Mecp2‒/Y mice, we have found that the augmentation of HN firing activity by
optostimulation of NE-ergic neurons is drastically impaired. Indeed, optostimulation did not
show any significant effect on the HN firing activity. Previous studies indicate that the Mecp2
disruption causes defects in NE biosynthesis (Viemari et al., 2005). Thus, the impaired NE-ergic
modulation of HNs is likely to be caused by a decrease in NE content at synaptic terminals, a
reduction in NE release from NE-ergic synapses, or both. In the presence of these defects,
optoexcitation of NE-ergic neurons and axonal terminals apparently does not help to improve the
NE release. Because the strong optostimulation used in the present study fails to augment NEergic modulation, an increase in spontaneous firing of the NE-ergic neurons may not benefit
much to the NE release either. Instead, the excessive neuronal excitability might even worsen the
NE-ergic modulation by perhaps depleting NE in presynaptic terminals. Therefore, LC neuronal
hyperexcitability appears harmful to the NE-ergic modulation under the condition of Mecp2
disruption.
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Figure 7-1 Generation of double transgenic RTT mice model, TH-ChR-Mecp2−/Y.
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A. Breeding paradigm to generate double transgenic mice. Green, mouse strains available
commercially; red, mice generated be cross-breeding. B. Genotyping of transgenic TH-ChRMecp2−/Y and TH-ChR mice. TH-Cre expression: internal positive control = 324 bp, transgene =
~100 bp (this assay does not distinguish heterozygous from homozygous transgenic animals);
ChR-loxP expression: mutant = 253 bp, heterozygote = 253 and 297 bp, wild type = 297 bp;
Mecp2 expression: mutant = 240 bp, wild type = 465 bp. C. Photographs of TH-ChR-M and THChR mice at five weeks old. RTT-like phenotypes were observed in the double transgenic mice,
including hind limb clasping and low body weight. D. Significant lower body weight was found
in TH-ChR-M mice (n=11 animals) when compared with littermate TH-ChR mice (n=11
animals) during postnatal week four to nine. Data are presented as mean ± SEM. E. YFP
fluorescence in LC neurons obtained from a double transgenic TH-ChR-M mouse. F-H. Most
DBH-immunoreactive LC neurons showed YFP in a TH-ChR mouse. LC neurons were detected
with anti-GFP antibodies (F) and anti-DBH antibodies (G). The overlay of F and G indicates
most LC neurons express YFP (H). I. Non-fluorescent images of sections in J and K. J,K. In the
medulla oblongata, catecholaminergic neurons were labeled with anti-GFP antibodies in area
postrema. Arrow heads, the central canal; arrows, cell bodies of catecholaminergic neurons.
Note that J is obtained from the boxed area in I, and K is acquired from the boxed area in J.
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Figure 7-2 Breathing activity of TH-ChR-Mecp2−/Y and TH-ChR mice measured in
plethysmography.
A,B. Real-time trace of breathing activity of a double transgenic (upper) and control mice
(lower). Multiple apneas can be identified in double transgenic mice but not in control mice.
C,D. Statistically, the double transgenic mice (TH-ChR-M) exhibited significantly larger
breathing frequency (f) variability and more apnea counts than the control mice. *, P<0.05; **,
P<0.01, ***, P<0.001 (Mann-Whitney U test for apnea count and Student’s t-test for f
variation).
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Figure 7-3 Optostimulation of LC neurons.
A. Light-evoked depolarization in an LC neuron from a TH-ChR mouse by 10 ms blue light
pulses (470 nm) as indicated by the black bar. The light-evoked depolarization is larger with
hyperpolarization. Arrows indicate action potentials evoked by optostimulation. B. Light-evoked
depolarization an LC neuron from a TH-ChR-Mecp2−/Y mouse by 10 ms blue light pulses (470
nm) as indicated by the black bar. Arrows indicate action potentials evoked by optostimulation
(n=3 cells/1 mouse). C. I-V plot of a LC neuron from a TH-ChR-Mecp2−/Y mouse. D.
Optostimulation enhanced firing activity of an LC neuron with high fidelity from a TH-ChRMecp2−/Y mouse.
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Figure 7-4 Electrophysiological properties of LC neurons.
A. Whole cell current clamp recording from an LC neuron TH-ChR-Mecp2−/Y (TH-ChR-M) mice.
The LC neuron showed delayed excitation (DE) with a series of hyperpolarizing steps followed
by a depolarizing pulse. Step increases in hyperpolarization elongated the delay of the first spike
(indicated by arrows). B. The relationship between action potential delays and the conditioning
membrane potentials was fitted with the Boltzmann equations in TH-ChR-M and Mecp2-null
mice and plotted. C-D. There was no difference in the V½ and slope factor between TH-ChR-M
mice (n=4 cells/2 mice) and Mecp2-null (n=5 cells/3 mice). E-G. There was no significant
difference in input resistance (P = 0.606 unpaired t-test), inward rectification (P = 0.166,
unpaired t-test), and firing rate (P = 0.361, unpaired t-test) between TH-ChR-M mice (n=4
cells/2 mice) and Mecp2-null (n=5 cells/3 mice).
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Figure 7-5 Electrophysiological properties of hypoglossal neurons (HNs) from TH-ChR mice.
A. An HN was recorded in current clamp. The cell showed typical sag potential described as the
voltage difference between the peak and steady-state voltages in response to steps of
hyperpolarizing pulses (indicated with the arrow). The cell also displayed a post-inhibitory
rebound of depolarization, which is the difference between the baseline and rebound voltage,
after termination of hyperpolarizing pulses. B. The HN did not show DE. C. Increased firing
activity and SFA was seen in the cell with depolarization currents. D. The average firing rate
was calculated and graphed with depolarizing current injections, n=9 cells/2 mice. E. A
moderate SFA ratio was seen in the HN. F. Fp and Fs were compared, n=9 cells/2 mice. Data
are presented as mean ± SEM (*, P<0.05; Student’s t-test).
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Figure 7-6 The response of hypoglossal neurons to NE-dependent optostimulation in TH-ChR
mice.
A. Evoked firing activity of an HN was measured during baseline, optostimulation and light-off
recovery. B. Measurement of instantaneous firing rate (FR) of the HN. C,D. Firing activity of
another HN recorded in the presence of α-adrenoceptors blocker phentolamine (10 µM).
Recording traces in i through vi were obtained from their corresponding sites above with
expansion.
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Figure 7-7 The NE-dependent optostimulation has no effect on hypoglossal neurons in THChR-Mecp2−/Y mice.
A. Evoked firing activity of an HN from a TH-ChR-Mecp2−/Y mouse. B. The instantaneous firing
rate of the HN. Recording traces in i through iii were obtained from their corresponding sites
above with expansion. C. Optical NE-ergic stimulation augmented firing activity of HNs in THChR mice, n=9 cells/2 mice. Data are presented as mean ± SE (**, P<0.01; Student’s t-test). D.
The same optical NE-ergic stimulation failed to enhance firing activity in TH-ChR mice when
phentolamine (10 µM) was added to the perfusion solution (P>0.05, n=4 cells/1 mouse). E. The
NE-dependent optostimulation had no significant effect on firing in TH-ChR-Mecp2−/Y mice
(P>0.05, n=6 cells/2 mice).
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8
8.1

GENERAL DISCUSSIONS

Dysfunction of the ANS
Dysfunction of the ANS has severe impacts on multiple organs and systems. The

mechanisms of the dysfunction remain unknown. Thus, we utilized drastic and innovative
interventions to the ANS, such as the application of endotoxin, optogenetics, and transgenic
mice, and made several new findings.
One of the life-threatening dysfunction of the ANS is the irreversible hypotension and
vascular hyporeactivity in septic shock. To understand mechanisms, we reproduced
hyporeactivity of the mesenteric arteries with the treatment of endotoxin LPS overnight in vitro
and screened out a few vasoactive agents that have vasoconstriction effects. Three candidates,
ET-1, 5-HT, and vasopressin, are found effective, which have never been used for clinical
management for septic shock. Besides, U46619, an agonist of the TXA2 receptor, can partially
reverse the hyporeactivity. In the system, these vasopressors may play a role not only as an
individual but also as a combination with other vasoconstrictors. Indeed, we have found that the
vasoconstriction effects of these agents are significantly potentiated by co-application with PE.
Our results suggest that the endotoxin-induced vascular hyporeactivity is not attributed to
the damage of VSM in the early phase (first 24 hours) of septic shock, neither to the overreleased vasodilators from endothelium. The main reason for the septic hypotension seems to be
caused by vascular hyporeactivity to α adrenoceptors that are unfortunately the main targets in
the current therapeutic management of septic shock. Although the underlying mechanism for the
vascular hyporeactivity is still elusive, our dissections of intracellular signaling pathways
revealed that ET-1 acts on ETAR and works through Gi – AC – PKA and Gq/11 – PC – PLC –
DAG – PKC signaling pathway, while 5-HT activates ROK through 5-HT1BR leading to
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inhibition of the myosin light-chain phosphatase (MLCP) and vasoconstriction. Since some of
these signaling pathways are shared by the α adrenoceptor system, it is likely that the
dysfunction of the α adrenoceptor system may occur in upstream pathways. Taken together, this
pharmaceutical research may provide new and effective therapeutical intervention of septic
shock.
The endothelium regulates vascular homeostasis by releasing a variety of vasoactive
substances including vasoconstrictors and vasodilators, while how the endothelial activation
affects vascular tones is unknown. Current belief is vasodilation, as the overall function of the
endothelium in vasomotor is vasodilation through the NO-dependent signaling pathway. This
inner layer system we worked on is located inside of blood vessels. Therefore, it was a challenge
to choose an effective intervention method to activate ECs selectively without affecting the
VMS. To address this, we generated transgenic mice with ChR expression in the ECs throughout
the whole body persistently in a life-long time scale. Optostimulation on dissected EC evoked
depolarization and vasoconstriction in perfused heart and kidney. This is the first direct evidence
demonstrating that activation of EC leads to vasoconstriction. Also, our results indicated that
such opto-vasoconstriction is fast, reproducible, long-lasting that is comparable in strength to the
popular vasoconstrictor PE. Meanwhile, we performed another study applying optogenetics in
VSMC and demonstrated that optostimulation in VSMC induces significant vasoconstriction that
is fast, reproducible, light intensity-dependent, and comparable in strength to popular
vasoconstrictors (Wu et al., 2015).
These studies open a new avenue to applying optogenetics in peripheral system,
especially cardiovascular system, by passing potential inference from adjacent tissues, even as
close as VSMC and ECs are in blood vessels. With the successful application of optogenetics in
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peripheral system, we were confident to dig further with effective intervention in the CNS. We
chose the breathing control as it is the most important function of the ANS within the brain.
Dysfunction of breathing in certain genetic diseases, such as RTT. NE production and projection
play a critical role in the regulation of breathing in the CNS while NE synthesis is deficient in
both RTT mouse model and patients. Also, the primary area for NE production is located in LC,
where neurons are hyperexcitable. Such neuronal hyperexcitability may be a compensatory
response to the inadequate NE, or an adverse manifestation of the disease. To understand
whether the increased LC neuronal excitability improves NE modulation, we generated a new
strain of double transgenic mice with Mecp2 null and ChR expression in LC neurons. The THChR-Mecp2‒/Y mice exhibit typical phenotypes seen in other mouse models of RTT including
hypoactivity, low body weight, short life span, and hind limb clasping. They also show clear
breathing disorders, including significant higher apnea counts and more frequent breathing f
variation than the TH-ChR control. We found that the NE-ergic modulation of hypoglossal
neurons is impaired in the double transgenic mice but not in the control mice. The defected NE
projection is not improved with optostimulation, suggesting that LC neuronal hyperexcitability
does not seem beneficial to the NE modulation in RTT. Instead, the neuronal hyperexcitability
may worsen the homeostatic status of local neuronal networks in the LC.
8.2

Effective interventions in the ANS
By using innovative and/or drastic interventions, this dissertation addressed several

unsolved problems as to function and dysfunction of the ANS. It is worth noting that the
interventions in this dissertation are innovative, effective, robust and specific in terms of targeting
at each tissue or cell type. These all have shown potentials in addressing basic research questions
and clinical phenomena.
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This dissertation employed an in vitro disease model in which mesenteric arteries were
cultured with or without endotoxin or LPS for >20 hours. The blood pressure is mainly regulated
by resistance vessels, such as the mesenteric arteries. Thus, this model is ideal to study the
hyporeactivity in vasculature at the early stage of septic shock. Besides, this in vitro tissue model
ensures the specific study on the vascular reactivity by ruling out the interference from immune
molecules. Our study revealed the potential underlying mechanism of hypotension in septic shock
and the effective vasoconstrictors ET-1 and 5-HT that can reverse the excessive vasodilation. This
is significant for clinical management of septic shock and severe sepsis. The advantage of this in
vitro tissue disease model is that it is free from circulation environment, which is also a drawback
because the impact of certain natural circulating molecules was missing. Therefore, according to
the specific research purpose, disease and target tissue/organs, the interventions need to be welldesigned to gain the optimal results.
The in vitro study must be tested in vivo eventually with living animal models, which
enables closer approximation to a human response. Therefore, animal models have been widely
used in exploration and characterization of disease pathophysiology, target identification, and
evaluation of novel therapeutic management. The laboratory animal disease models can be
categorized into five types, induced disease models, spontaneous disease models, transgenic
disease models, negative disease models, and orphan disease models (Hau and Van Hoosier, 2003).
The induced models are generated from healthy animals in which the condition to be
studied is experimentally induced either through surgical and/or genetic modifications or chemical
injections. Theoretically, the induced model is the only category that allows a free choice of
species. Indeed, the etiology of a disease in an induced animal model is usually different from the
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corresponding disease in the human. The spontaneous animal models have naturally occurring
genetic variants and/or mutations. Many strains with inherited disorders modeling similar
conditions in the human have been conserved and characterized, such as the nude mice with a
genetic mutation that causes a deteriorated or absent thymus that has been used as metastasis
models. The majority of the spontaneous models are mice and rats. The spontaneous models are
often isomorphic, which means the animal’s symptoms or anatomy are similar to those in humans.
(Hau and Van Hoosier, 2003).
The transgenic disease models may be the most important type of animal disease model,
which emerged along with the rapid development of genetic engineering and embryo manipulation
technology during the past decade. Mouse are the most important and available resource for the
development of the transgenic model by far (Hau and Van Hoosier, 2003). Indeed, transgenic
models are the induced models carrying inserted DNA (known-in) or deleted DNA (knock-out) in
the genome. Transgenic animals are commonly produced with following procedures, 1) germline
modifications of gamete; 2) microinjection of DNA or gene constructs into zygotes; 3)
incorporating modified cells into later stage embryos. The resultant embryos will be matured to
term in recipient female. The advantage of transgenic disease models is significant because many
more animal models for human diseases have been developed through this technology (Pinkert,
2003). However, this model has drawbacks: 1) Many physiological functions are controlled by
more than one gene so that it requires research to identify the contribution of multiple genes to
normal and disease conditions. 2) The deletion or insertion of DNA from/into animal genome may
result in unpredictable outcomes including pathological interferences and animal well-being,
especially the first generation of animal produced. 3) The selection, breeding, and cloning of
transgenic lines remain challenging and can be inaccurate in some cases. To overcome these
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problems, the recent completion of the mouse and human genome maps can provide remarkable
clues for the generation of new homologous animal models with both genotype and phenotype of
the human.
The negative animal models are strains fail to react to a disease or particular stimulus that
are mainly used to study the mechanisms of disease resistance. Combining with transgenic
technology, the negative animal models become increasingly important, such as a generation of
novel transgenic mouse strains failed to develop certain diseases. The orphan models are the
opposite of negative models. They refer to the animals in which a functional disorder occurs
naturally in a non-human species. The negative models become the induced models when a similar
disease is recognized in humans later on (Hau and Van Hoosier, 2003).
The criteria to choose the appropriate animal disease model for the study involve research
factors, animal factors, and physical factors. Generally, the research factors include the
considerations of analogue animal species of the human diseases, transferability of the result
information between the animal models and humans, repeatable and verifiable data gained from
the animal models, ethical implications, number of the animal needed, and customary practice with
or without justification can be applied to the animal models, and existing literatures support. The
animal care factors include cost, availability, housing, husbandry, and stress factors of the animal
strains. Besides, genetic background, adaptability to experimental manipulation, size, life span,
age, sex, progeny need, and special features of the animals are also need to be considered in term
of animal factor aspect. Last but not the least, the physical and environmental criteria need to be
evaluated including ecological consequences, hazardous components, and environmental
influences.

131

Optogenetics is a novel combined intervention of physical light stimulation and transgenic
animal model that emerged over the last ten years. By employing this effective intervention, we
investigated and revealed some unknown mechanisms related to function and dysfunction of
vasomotor and respiration.
The optogenetics was originally invented by Boris Zemelman and Gero Miesenböck and
applied in testing neuronal activities in vitro and in vivo by Dr. Deissroth and his group members
since 2005 (Boyden et al., 2005). After that, the application of optogenetics has been limited within
the CNS for next 5 years (Aravanis et al., 2007; Deisseroth et al., 2006; Zhang et al., 2006). Until
2010, the application of optogenetics was extended in cardiomyocytes for the first time
(Knollmann, 2010).
At that time, our lab was concentrating on the underlying mechanisms and potential
treatment for certain cardiovascular diseases, such as septic shock, by using dramatic endotoxin
intervention. The major difficulty we met was to evaluate the VSMCs and ECs respectively and
specifically. The innovative optogenetic technology inspired us to apply it into the peripheral
vasculature so that we can adapt the spatiotemporal accuracy. We chose cross-bred commercially
available breeders to generate transgenic mice, cdh5-ChR, which has fluorescence labeling in
endothelium. The advantage of this strain is the persistent and extensive expression of ChR,
economic cost and commercial availability.
It is important to select effective ways to manipulate and read out of the optical response
of the ECs bypassing interference from the VSMC. We creatively modified and used Langendorff
heart perfusion and kidney perfusion to evaluate the endothelium with light stimulation. The
endothelium is composed of a single layer ECs inside of blood vessel, so the heart and kidney
perfusion allows better access of light to surface coronary arteries and renal vasculature without
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damage comparing to vascular rings preparation. Besides, the organ perfusion preparation provides
a superior level mimicking physiological condition in vivo. The light stimulation was also
evaluated with single EC using patch clamp, and our results indicated that direct stimulation of the
EC induces cell depolarization, which is consistent with our observation in organ perfusion that
light stimulation of endothelium causes vasoconstriction. This new finding uncovered the
unknown function of ECs, which is different form conventional understanding that ECs are mainly
responsible for the vasodilation. Taken together, modified optogenetics technology in our lab
effectively open a new realm of application of optogenetics in peripheral system.
After gaining successful experience from the first peripheral optogenetics study, we
decided to further develop this powerful intervention to understand more function and dysfunction
in the ANS, such as respiration, which extensively involves both the CNS and peripheral systems.
The etiology of the breathing disorder in RTT has been one of the major focuses in our lab.
Consistent with breathing abnormality occurs in RTT patients and mouse models, NE synthesis
and projection are found disrupted. In the CNS, over 70% NE is synthesized in LC area (Viemari,
2008), and most of the neurons located in LC area are found defective with hyperexcitability
(Biancardi et al., 2008). However, the causal relationship between disruption of NE synthesis and
the defection of LC neurons is unknown. Therefore, based on widely accepted MECP2 gene
knockout RTT mouse model, we knocked in light sensitive opsin ChR2 in the NEegic neurons to
generate a new double transgenic RTT mouse model, TH-ChR-Mecp2−/Y, by mating male THChR and female Mecp2−/+ mice. Indeed, an alternative approach to insert ChR is to inject virus
carrying ChR-loxP segment into LC area in Mecp2−/Y mouse model, or vice versa. The drawbacks
of this approach are 1) gene expression of opsin diminishes over 4-5 weeks, 2) the invasive
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injection procedure, 3) potentially unexpected damage to the CNS with multiple injections for
etiology study of the RTT because it is a neurodevelopmental disease.
The new double transgenic mice exhibited all of the phenotypes of other mice models of
RTT. Electrophysiology was performed in HNs on brain slices that receive NE projection from
LC neurons. We found NE projection is disrupted in double transgenic RTT mice comparing to
control TH-ChR mice, which indicate that it is feasible to evaluate neuronal modulation in RTT
animal model with the optogenetic tool. To furtherly evaluate the etiology of breathing disorder in
RTT, it would be ideal to insert optical fiber into LC region and observe the development of the
disease with and without light stimulation. In addition, the in vivo test would provide an effective
intervention to study the function and dysfunction of specific nuclei in neurodevelopmental
diseases and potential clinical treatment.
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